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ABSTRACT 
 
Understanding how metabolites contribute to anaplerosis, antioxidant effects, and 
hormetic pathways during aging is fundamental to creating supplements and dietary habits that 
may decrease age-associated disease and decline, thus improving the quality of life in old age. In 
order to uncover metabolic pathways that delay aging, the effects of large sets of metabolites 
associated with mitochondrial function on lifespan were investigated.   
Malate, the tricarboxylic acid (TCA) cycle metabolite, increased lifespan and 
thermotolerance in C. elegans. Addition of fumarate and succinate also extended lifespan and all 
three metabolites activated nuclear translocation of the cytoprotective DAF-16/FOXO 
transcription factor and protected from paraquat-induced oxidative stress. The increased 
longevity provided by malate addition did not occur in fumarase (fum-1), glyoxylate shunt (gei-
7), succinate dehydrogenase flavoprotein (sdha-2), or soluble fumarate reductaseF48E8.3 RNAi 
knockdown worms. Therefore, to increase lifespan, malate must be first converted to fumarate, 
then fumarate must be reduced to succinate by soluble fumarate reductase and the mitochondrial 
electron transport chain complex II. Lifespan extension induced by malate depended upon the 
longevity regulators DAF-16 and SIR-2.1. Malate supplementation did not extend the lifespan of 
long-lived eat-2 mutant worms, a model of dietary restriction. Malate and fumarate addition 
increased oxygen consumption, but decreased ATP levels and mitochondrial membrane potential 
suggesting a mild uncoupling of oxidative phosphorylation.  
xv 
 
Each of the twenty amino acids was individually supplemented to C. elegans and the 
effects on lifespan were determined. All amino acids except phenylalanine were found to extend 
lifespan at least to a small extent at one or more of the 3 concentrations tested with serine, 
histidine, and proline showing the largest effects. In most cases, amino acid supplementation did 
not extend lifespan in eat-2 worms, a model of dietary restriction or in daf-16, sir-2.1, rsks-1 (S6 
kinase), or aak-2 (AMPK) longevity pathway mutants or in worms fed RNAi to skn-1, the C. 
elegans Nrf2 homolog. Serine and tryptophan addition further protected worms from 
Alzheimer’s amyloid-beta toxicity. Tryptophan and its catabolites nicotinic acid, picolinic acid, 
and NAD further induced a broad heat shock response. These results indicate that dietary amino 
acid imbalance and amino acid catabolism affect organismal longevity.  
The ketone body beta-hydroxybutyrate (βHB) is a histone deacetylase (HDAC) inhibitor 
and has been shown to be protective in many disease models, but its effects on aging are not well 
studied. Therefore we determined the effect of βHB supplementation on the lifespan of C. 
elegans. βHB supplementation extended mean lifespan by approximately 20%. RNAi 
knockdown of HDACs hda-2 or hda-3 also increased lifespan and further prevented βHB-
mediated lifespan extension. βHB-mediated lifespan extension required the DAF-16/FOXO and 
SKN-1/Nrf longevity pathways, the sirtuin SIR-2.1, and the AMP kinase subunit AAK-2. βHB 
did not extend lifespan in a genetic model of dietary restriction indicating that βHB is likely 
functioning through a similar mechanism. βHB addition also upregulated ΒHB dehydrogenase 
activity and increased oxygen consumption in the worms. RNAi knockdown of F55E10.6, a 
short chain dehydrogenase and SKN-1 target gene, prevented the increased lifespan and βHB 
dehydrogenase activity induced by βHB addition, suggesting that F55E10.6 functions as an 
inducible βHB dehydrogenase. Furthermore, βHB supplementation delayed Alzheimer's 
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amyloid-beta toxicity and decreased Parkinson's alpha-synuclein aggregation. The results 
indicate that D-βHB extends lifespan through inhibiting HDACs and through the activation of 
conserved stress response pathways. 
Aging is a progressive disease caused by the time dependent decline of an organism and 
is the primary risk factor for many human ailments, including heart disease, cancer, and 
Alzheimer’s disease. Uncovering metabolic pathways and metabolites that delay the onset of 
age-related decline was the primary drive of this investigation. 
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
Age-related decline affects nearly every biological system in virtually all species, 
including humans. Although many theories overlap in the ever evolving biology of aging field, it 
is apparent that mitochondria are central to life and death. Typically as we age, the function of 
mitochondria declines in a tissue specific manner and results in a loss of energy production.  
Understanding how metabolites taken in and broken down in our diet contribute to anaplerosis 
(the re-filling of metabolites in metabolic pathways), antioxidant effects, and hormetic 
(beneficial at one dose, but detrimental at a higher dose) pathways during aging is fundamental 
to creating supplements and dietary habits that may decrease age-associated disease and decline, 
thus improving the quality of life in old age.  In order to discover metabolic pathways that delay 
aging, the effects of large sets of metabolites on lifespan were investigated.   
1.1 Mitochondrial dysfunction  
Mitochondria are responsible for the production of ATP through the electron transport 
chain (ETC) via oxidative phosphorylation (OXPHOS) located within the inner mitochondrial 
membrane. Because of their importance in cellular physiology, defects in mitochondria are 
linked to many human diseases and play a central role in aging. Particularly, mitochondrial 
dysfunction contributes to age-related decline and is itself a consequence of aging. Mitochondria 
are the major source and the main target of reactive oxygen species and regulate stress response, 
calcium homeostasis, and apoptosis [1].  
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Since mitochondria are crucial for biological processes, mitochondrial dysfunction has 
been postulated to lead to premature aging [2]. Conversely, slight inhibition of mitochondrial 
respiration extends the lifespan of yeast, C. elegans, Drosophila, and mice [3-6]. Electrons 
passing through the mitochondrial ETC leak out and combine with molecular oxygen to form 
reactive oxygen species (ROS) [7]. Continuous damage to cellular macromolecules via ROS 
results in the decline of mitochondrial function, and coincides with some age-related disorders 
[8]. The antioxidant enzymes superoxide dismutase, catalase, and glutathione peroxidase quench 
oxidants, and are considered oxidant  scavengers [9].Glutathione peroxidases rely on the reduced 
form of glutathione, a 3-amino acid peptide, to convert peroxides to water, while simultaneously 
oxidizing glutathione. However,  levels of small molecule antioxidants and oxidant  scavenger 
enzymes gradually decrease as organisms age, resulting in increased levels of oxidation, 
accumulation of damaged proteins, DNA, and lipids [10], and decreased mitochondrial function 
[11, 12]. This decrease in antioxidants as a consequence of aging is of great concern and a 
current target for anti-aging therapies.  
1.2 Mitochondrial disease  
ROS are responsible for damaging proteins, DNA, and lipids such as cardiolipin, which is 
localized in the mitochondrial inner membrane and makes up about 20% of the membrane’s 
mass. Cardiolipin (CL) is considered the glue by which the respiratory complexes are held 
together and is necessary for preserving the mitochondrial membrane potential [13]. Absence of 
CL leads to defects in protein import, translocation of cholesterol from outer to the inner 
membrane [14], and deficiency in major mitochondrial processes [15].  
One important process that CL regulates is the release of cytochrome c from 
mitochondria, which triggers apoptosis [16].  Recent evidence establishes a relationship between 
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the oxidation and depletion of CL to a decrease of cytochrome c oxidase activity and 
mitochondrial dysfunction in brain aging, which was alleviated by treatment with the natural 
antioxidant hormone melatonin. A rise in mitochondrial DNA oxidative damage was also 
observed in brains derived from Alzheimer’s disease patients, likely contributing to 
neurodegenerative decline [17, 18]. Although much research links mitochondrial dysfunction and 
Alzheimer’s disease (AD), the mechanism is not entirely clear. There is substantial evidence 
demonstrating progressive accumulation of mitochondrial amyloid-beta, a 40-42 amino acid 
peptide that forms extracellular plaques in Alzheimer’s brains [19], and these levels correspond 
with the degree of mitochondrial dysfunction [20]. Evidence also suggests that enhanced 
mitochondrial γ-secretase complex disrupts communication between the mitochondria and the 
endoplasmic reticulum in models of AD [21]. Huntington’s disease is characterized by a 
mutation in the Huntington gene (Htt), leading to protein aggregation, a reduction in 
mitochondrial membrane potential, and neurotoxicity resulting in striatal atrophy [22]. Mutated 
Htt weakens the mitochondrial outer membrane, increasing the sensitivity of the mitochondrial 
permeability transition pore to apoptotic stimuli such as  Ca2+ and ROS, resulting in cytochrome 
c release and caspase activation [23]. Mitochondrial fission is enhanced in Huntington's disease 
leading to fragmented mitochondria and the degree of fragmentation parallels disease severity 
[24]. Dopamine treatment increases the vulnerability of striatal neurons to mutant Htt by down-
regulating mitochondrial complex II activity [25]. Parkinson’s disease is characterized by 
intracellular α-synuclein-containing Lewy body formation [26], α-synuclein binds to the 
mitochondrial membrane causing a decrease in complex I activity paralleling an increase in ROS 
production [27]. Amyotrophic lateral sclerosis (ALS), another neurodegenerative disease 
commonly referred to as Lou Gehrig's disease, can be caused by  mutations in cytoplasic 
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superoxide dismutase 1, which translocates to mitochondria causing mitochondrial dysfunction 
[28]. Recent studies using ALS disease models suggest that disruption of the axonal transport of 
mitochondria along microtubules compromises axonal function [29]. Equally significant to note 
is that mitochondrial dysfunction is also associated with type 2 diabetes [30], cancer [31, 32],  
systemic lupus [33],  epilepsy,  autism, and developmental delay [34]. Interestingly, recent 
studies using young and aged rats subjected to heterochronic parabiosis (connection of their 
circulatory systems) indicate an increase in neurogenesis in the aged rats, and that the decline of 
cognitive abilities in the aged subjects can be reversed by factors in the plasma from the young 
individual [35, 36]. In a similar study, the protein GDF11 was identified as a blood factor in mice 
that can induce vascular restoration and increase neurogenesis suggesting a restored capacity of  
autophagy/mitophagy and mitochondrial biogenesis in aged rodents [37]. 
 
Figure 1.1:   Mitochondrial dysfunction underlies multiple age-induced 
diseases.  Diseases in red indicate strong experimental evidence to 
support malfunctioning mitochondria in disease pathology.  Diseases in 
green exhibit mitochondrial dysfunction as well. 
 
1.3 Calorie restriction 
Calorie restriction, a 20-40% lowering of caloric intake, is the most effective method 
known to extend lifespan in almost every species in which it has been tested, including mammals 
[38]. Numerous studies recognize calorie restriction (CR) as a successful method to alleviate 
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age-related decline, combat disease, and increase lifespan in model organisms [39]. CR-mediated 
lifespan extension suggests a possible conservation of longevity-regulating pathways among 
species [40]. Researchers have yet to completely unravel how CR extends lifespan, but research 
spanning the past few decades illustrates a hopeful glimpse at the power of dietary alterations.  
Some researchers initially hypothesized that CR would decrease overall metabolism. Aging and 
longevity have been shown to positively correlate with energy metabolism in some 
mitochondrial electron transport chain mutants. For example, a reduction in mitochondrial 
energy metabolism and respiration has been shown to increase lifespan in clk-1 and isp-1 
mutants in C. elegans [41]. However, more recent evidence has suggested that such a simple 
correlation does not always hold as calorie restriction has been shown to not alter or even 
increase mitochondrial electron transport chain function. Increased resistance to heat and 
oxidative stress are strong indicators of health and longevity and, as expected, a decline in heat 
tolerance and an increase in oxyradical damage are both markers of aging [42, 43]. Calorie 
restriction has been shown to be protective against oxidative and heat stress[43] and the greatest 
increases in C. elegans lifespan have been produced by culturing the worms in a defined  axenic 
media as a type of dietary restriction, which lacks the normal bacterial food source [44].  
Currently, there is a considerable amount of interest in finding pharmacological mimetics 
that act on the same pathways as CR, but compounds acting identical to CR will likely be 
impossible to identify due to the multiple distinct and overlapping pathways affected by a low 
calorie regimen. CR mediates an increase in antioxidant response pathways, genes responsible 
for stress resistance and cellular repair, while also down-regulating inflammatory pathways [45].  
Primary fibroblasts cultured with human CR sera induced upregulation of Nrf2, GSTK1, GSTT1, 
IDH2, GPX1 (glutathione peroxidase 1), and SOD2 (superoxide dismutase 2) [46], emphasizing 
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the importance of circulating factors in promoting health and longevity. Nrf2 is a transcription 
factor that induces gene expression protecting from oxidants and xenobiotics. GSTK1 and 
GSTT1 are glutathione-S-transferases which attach reduced glutathione to xenobiotic substrates 
for detoxification.  IDH2 is a subunit of a citric acid cycle isocitrate dehydrogenase complex that 
reduces NADP to NADPH, an essential cofactor for the reduction of oxidized glutathione by a 
glutathione reductase. A wide range of evidence supports the benefits of CR, but for the most 
part the mechanisms which mediate these benefits have remained elusive.  
The hypothesis that CR reduces damage mediated by ROS is supported by research 
demonstrating an increase in oxidized lipids, proteins, and DNA in the nuclear and mitochondrial 
genome with age that is decreased by the CR diet. CR has also been shown to delay the decline 
in  superoxide dismutase (SOD) activity and other cellular antioxidant defenses with age [47, 
48]. In support of this hypothesis, age-related decline in antioxidant defenses is linked to 
increased rates of stress-induced apoptosis, which is markedly reduced by CR [49]. CR animals 
exhibit lower levels of oxidatively damaged DNA and reduced lipid peroxidation [50, 51].   
Interestingly, data suggests that CR is responsible for both a decrease in ROS production and 
also an increase ROS defenses and repair [52]. However an increase in SOD and cellular ROS 
defenses may not play as large of a role in CR increased longevity as originally theorized, 
because mice lacking superoxide dismutase show increased oxidative damage, but they do not 
display signs of premature aging [53]. Pinning down the exact mechanisms through which CR 
increases longevity has been quite challenging, but there are a few pathways that have been 
identified that are well established as conserved mediators of longevity.  
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1.4 Calorie restriction and sirtuins 
  Studies indicate that CR enhances the intracellular NAD+/NADH ratio of yeast by up-
regulating respiration resulting in decreased NADH levels [54]. Cellular increases in metabolic 
redox reactions impacting NAD+/NADH ratios are important to  numerous biological processes 
including apoptosis[55], differentiation [56], and metabolism of fats and carbohydrates [57]. 
In mammals, disruption of mitochondrial metabolism and NADH shuttles have been associated 
with age-related diseases such as diabetes [58]. Glucose metabolism controls the secretion of 
insulin from mouse pancreatic β-cells and reduction of NAD+  to NADH is responsible for 
glucose signaling in β-cells [59]. NAD+  is also an essential pyridine nucleotide that functions in 
the vital processes of DNA repair and transcription [60].  Further studies in yeast indicate that 
deleting NADH shuttle components abolishes CR-mediated lifespan extension whereas over-
expressing NADH shuttle components extends lifespan [61]. Further studies in yeast showed that 
decreased NADH levels are associated with CR-induced activation of sirtuins, an event 
necessary for lifespan extension.  
  Sir2, the sirtuin or silent information regulator in Saccharomyces cerevisiae, is highly 
conserved from prokaryotes to humans [62], and catalyzes the formation of silent 
heterochromatin. Sirtuins are NAD+-dependent protein deacetylases that regulate lifespan in 
lower organisms and also play a role in mammalian cellular fate [63], and overexpression of 
sirtuins has been shown to extend the lifespan of some model organisms [64, 65]. By coupling 
NAD+ cleavage to modifications of target proteins, sirtuins operate as a possible molecular link 
between the cellular energy state and the mechanism of lifespan regulation.  
The Caenorhabditis elegans Sir2 homolog (SIR-2.1) is required for stress resistance, 
genomic stability, and lifespan extension [66] and increased longevity is seen when sir-2.1 
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expression is increased [67]. Sir2 overexpression in Drosophila extends lifespan, however when 
combined with CR, over-expression did not produce an additive affect [68]. The human homolog 
of Sir2p, SIRT1,  mediates stress resistance, apoptosis, and inflammatory responses by 
deacetylating transcription factors such as FOXOs [55, 69], nuclear factor Kappa β [70], and p53 
[71, 72], giving cells time to repair endogenous damage. Additionally, SIRT1 knock-out mice fed 
a CR diet did not exhibit the typical lengthened lifespan [73]. SIRT1 overexpression not only 
extends lifespan and improves healthy aging, but it also reduces tumor formation [74] and 
regulates insulin secretion [75]. Similarly, resveratrol activates SIRT1 and also improves the 
health in mice fed a high calorie diet [76].  
There are three mitochondrial sirtuins specific to mammals: SIRT3, SIRT4, and SIRT5.  
SIRT3, a mitochondrial specific sirtuin, is critical for maintaining mitochondrial homeostasis and 
cellular ROS levels. SIRT3 is responsible for activating isocitrate dehydrogenase by 
deacetylation during CR resulting in a decrease in oxidative stress and a protection from age-
related hearing loss in mice [77]. CR increases activity of SIRT3 and SIRT5 aiding in the 
metabolic shift from glycolysis to fatty acid oxidation [78, 79] and acetate metabolism  [80].  
SIRT4 deacetylates glutamate dehydrogenase. SIRT4 expression decreases during CR, removing 
the break from glutamate dehydrogenase, which allows for the catabolism of glutamine and 
glutamate into the TCA cycle, providing energy during CR [81].  Recently SIRT1 has emerged 
as an important regulator of hypothalamus function, which regulates global metabolism and 
aging in mammals [82]. Histone deacetylases regulate pro- and anti-inflammatory gene 
expression[83] and pro-inflammatory cyclooxygenase-2 (COX-2) gene expression is suppressed 
by SIRT1 [84].  Increased SIRT1 activity during CR also reduces inflammation by suppressing 
the expression of pro-inflammatory genes such as NF-ĸβ, AP1, and iNOS [85]. SIRT1 is 
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responsible for deacetylating glycolytic enzymes resulting in the reduction of glycolytic 
metabolism [86] and repression of HIF-1α [87]. Piceatannol, a structural homolog of resveratrol 
[88], asserts a stronger effect than resveratrol [89] and acts as  an anti-inflammatory compound 
that decreases the intracellular accumulation of ROS in PC12 cells engineered to produce high 
levels of Aβ, while preventing Aβ-induced apoptosis [89]. Identifying CR mimetics are highly 
sought after, but sirtuin activating compounds (STACs) are not the only high rollers in drug 
discovery. 
1.5 Altering epigenetics to increase longevity 
There are several compounds that have been shown to extend lifespan through epigenetic 
modifications DNA methylation status regulates gene expression, maintenance of DNA, and 
aging [90]. DNA methyltransferases (DNMT) play a crucial role in controlling age-related 
diseases and DNMT inhibitors have been used in the treatment of cancer [91]. The green tea 
polyphenol (-)-epigallocatechin-3-gallate (EGCG) reduces DNA hypermethylation induced by 
cancer-causing agents [92] and several studies reveal that CR decreases DNA methylation and 
increases genomic stability during aging [93]. Another epigenetic modification of interest is 
histone modification. Histone modifications include acetylation, methylation, ubiquitination, and 
ADP ribosylation. Of these, histone acetylation status is the most common modification 
associated with gene activation.  
  Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are enzymes that 
alter histone acetylation. There are four classes of HDACs: class I, II, III (which includes all 
seven mammalian sirtuins), and IV. HAT modifications depend on nuclear acetyl-CoA 
concentrations, whereas class III HDAC activity is dependent upon NAD
+
 concentrations. In 
contrast, class I, II, and IV HDACs are zinc-dependent enzymes.  
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Calorie restriction increases activity of SIRT1, while SIRT1 inactivation abrogates 
lifespan extension by CR [94].  An increase in HDAC activity during CR suggests the possibility 
that HDAC inhibitors may be beneficial in the treatment of aging and age-related diseases. 
HDAC inhibitors such as valproic acid and phenylbutyrate exhibit strong antitumor activity, yet 
have fairly low toxicity [95]. Curcumin effects histone acetylation status by inhibiting p300/CBP 
HAT [96] and has also been shown to have anti-cancer properties [97]. As previously referenced, 
the red grape polyphenol resveratrol is a potent SIRT1 activator and increases the mean lifespan 
of mice [76]. Butyrate is a short-chain fatty acid (SCFA) that is the end result of bacterial acetyl-
CoA fermentation.  Butyrate inhibits class I and class II HDACs and increases both C. elegans 
[98] and Drosophila [99] lifespans. The ketone D-beta-hydroxybutyrate is structurally very 
similar to butyrate and is synthesized in the liver from fatty acid oxidation of acetyl-CoA under 
fasting or ketogenic diet conditions. Beta-hydroxybutyrate has also been shown to be an 
endogenous HDAC I inhibitor [100] and so therefore may have many uses in the treatment of 
age-related diseases (Section 1.9).  Much more work is needed to fully understand and utilize the 
benefits of drug induced epigenetic modifications. One exciting possibility is that these 
modifications are part of a larger phenomenon called hormesis and that epigenetic modifications 
may be involved with hormetic responses [101]. 
1.6 Hormesis  
Recent studies challenge the theory that mitochondrial reactive oxygen species (ROS) 
have only a deleterious outcome on cell function and organismal aging. It is becoming clearer 
that mitochondrial ROS perform vital roles in activating cell survival and disease resistance 
signaling pathways. ROS may actually act as double-edged swords. This concept is supported by 
hormesis, a proposed process by which mild stress activates biological stress responses, thereby 
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improving the health and increasing the lifespan of an organism [102]. Activation of hormetic 
pathways overcome immediate stresses and may actually repair prior damage in organisms [103] 
by inducing the expression of genes that encode antioxidant enzymes and cytoprotective proteins 
(Figure 2) [104]. Proposed examples include exercise, which temporarily produces substantially 
higher than normal levels of damaging ROS [105], and calorie restriction, which represent a 
metabolic stress for organisms [106].Other hormetic response activators include low levels of 
ionizing radiation, which reduces the incidence of cancer [107], consumption of plant 
phytochemicals, which protect the plant from herbivores and pests, while producing a beneficial 
health response in humans [108], and exposure to mild heat, responsible for induction of gene 
expression leading to transcription and translation of heat shock proteins [109, 110]. Ischemic 
preconditioning also induces the expression of genes encoding protective proteins including 
heat-shock proteins (HSP) [111]. HSPs are key defense responses that enable proper refolding of 
damaged protein structure induced by heat, alcohol, heavy metals, age, disease, or oxidative 
stress, avoiding inactivation of proteins and irregular protein aggregates [112]. The C. elegans 
heat-shock factor (HSF-1) is a transcription factor that regulates response to heat and oxidative 
stress and serves as a molecular chaperone to slow the rate of aging [113].  More examples of 
hormetic response pathways include the sirtuin/FOXO pathway [114], the NF-κB pathway [115], 
the cAMP-response-element-binding protein (CREB) pathway, the AMP kinase pathway [116], 
the Nrf2–ARE pathway [108], and the DAF-16/Ins/IGF-1 signaling pathway [117]. SKN-1/Nrf is 
involved with multiple roles in development and cellular homeostasis. The DAF-16/FOXO 
family of Forkhead transcription factors act as sensors of the insulin signaling pathway and 
activate protective genes that increase stress resistance and longevity [118-120].  
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Many flavonoids, such as EGCG from green tea, and other plant-derived polyphenols 
may promote healthy aging through hormesis. EGCG has been shown to upregulate 
hemeoxygenase-1 (HO-1) expression in endothelial cells by activation of the Nrf2/ARE pathway, 
triggering resistance against H2O2 induced apoptosis [121]. Likewise, FOXO transcription 
factors are activated by the polyphenol resveratrol, up-regulating genes involved in energy 
metabolism and antioxidant pathways [122]. The C. elegans transcription factor SKN-1, an 
ortholog of Nrf2, was shown to mediate the protective responses to oxidative stress and 
increased lifespan induced by low doses of the plant-derived toxin, plumbagin [123]. As more 
evidence is published, the concept of hormesis is gaining acceptance as a major regulator of 
lifespan. 
1.7 Hormesis hypothesis of CR 
The hormesis hypothesis of CR [124] proposes that food restriction introduces mild stress 
to an organism and initiates upregulation of cellular defenses, while also altering metabolism, 
resulting in increased longevity. The hormesis hypothesis of CR was recently altered to include 
xenohormesis, which refers to the idea that organisms recognize and react to chemical signals 
produced by other organisms undergoing stress, such as CR.These chemicals can be ingested 
through food, as in the case of polyphenols [125], and can lead to the activation of internal 
defense mechanisms [126].The hormesis hypothesis of CR unites much of the unrelated 
observations originating from different species and laboratories. CR prompts an upregulation of 
longevity genes that protect an organism and delays reproduction, which are keys to surviving 
through a shortage of food or specific nutrients.  
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Figure 1.2: A low dose of a stressor may initiate hormetic response pathways that increase 
lifespan and healthspan of an organism. Too much of the stressor overrides this stress response 
and is deleterious to the health of the organism. 
 
1.8 Mitohormesis  
Mitohormesis is a term used to describe reactive oxygen species (ROS)-induced stress 
responses within mitochondria [127].  Research strongly suggests that transient endogenous free 
radical production, caused by glucose restriction, extends the lifespan of C. elegans in an aak-2 
(AMPK homolog)-dependent manner.  Interestingly, this increase in lifespan is abrogated by 
antioxidants, suggesting that toxic radicals may mitohormetically extend lifespan and promote 
overall health [128].This phenomenon has also been observed in insulin-secreting cells following 
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exposure to sub-lethal levels of H2O2 [129]. The mitohormetic protective response is also 
activated by statins, which generate ROS and lead to an increase in peroxisome proliferator-
activated receptor gamma coactivator 1α (PGC-1α) and other mitochondrial-associated genes 
[130, 131]. Low-dose arsenite has been shown to stimulate resistance against thermal and 
chemical stressors, while extending the lifespan of C. elegans [132] and recent evidence 
indicates that lipoxidative stress induced by EPA/DHA treatment may contribute to the 
therapeutic effects observed [133].  
  Mutations in mitochondrial ETC genes, encoding proteins such as ISP-1 (of complex III) 
and NUO-6 (of complex I) result in lifespan increases in C. elegans. These mutations lead to an 
increase in superoxide production, although a rise in overall ROS was not detected [134].  
Longevity was abolished upon use of antioxidants, again supporting the idea that gradual 
increases in ROS and minor mitochondrial damage activate mitohormesis [134]. Additionally, 
oxidative stress-induced hormesis by a transient hypoxia treatment is associated with a reduction 
of mitochondrial superoxide production through activation of the  Ins/IGF-1 signaling pathway 
[135]. Interestingly, lifespan extension by TCA metabolites may be due to activation of hormetic 
stress response pathways in conjunction with anaplerosis.  The addition of malate to C. elegans 
media leads to lifespan extension and a dramatic increase in  NAD+ [136], which may lead to 
SIRT1-mediated deacetylation and activation of PGC-1α in mammals [137]; PGC-1α 
upregulates antioxidant and mitochondrial metabolic protective genes in response to CR and 
exercise [137].   
1.9 TCA cycle metabolites 
The TCA cycle is a central pathway for the metabolism of sugars, lipids, and amino acids.  
Although many factors contribute to aging, dysregulation in metabolism has been indicated as a 
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contributing factor of sarcopenia, the loss of muscle mass, in the elderly [138]. The aging process 
in C. elegans is associated with a disruption in metabolism that could partially be corrected by 
metabolite supplementation.  For instance, the long-lived dauer life cycle stage is accompanied 
by a metabolic shift toward anaplerosis of the TCA cycle [139]. Metabolomics data from our lab 
identifies a change in certain C. elegans metabolite concentrations with age, including the TCA 
cycle metabolites citrate, which was upregulated in aged worms, and fumarate and malate, which 
were downregulated in older worms. Consistent with these findings, we also established that 
supplementation of fumarate and malate to C. elegans diet extends lifespan through the DAF-16 
and SIR-2.1 pathways [136]. Fumarate reduction, glyoxylate shunt activity, and mild 
mitochondrial uncoupling may also contribute to the lifespan extension induced by malate and 
fumarate by increasing the amount of oxidized NAD and FAD cofactors [136]. Addition of the 
TCA cycle intermediate oxaloacetate has been shown to extend lifespan in C. elegans through an 
aak-2/AMP kinase and daf-16/FOXO-dependent mechanism [140] and protect against seizures 
induced by kainic acid in rodents [141]. 
The TCA cycle intermediate alpha-ketoglutarate is the entry point in the citric acid cycle 
for glutamate and glutamine. Alpha-ketoglutarate can cross the blood-brain barrier and then be 
converted to glutamate, a precursor of the antioxidant glutathione. By inhibiting ATP synthase 
and target of rapamycin (TOR) kinase, alpha-ketoglutarate dramatically extended the lifespan of 
C. elegans. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes  a 
mitochondrial complex 1 deficit similar to that observed in Parkinson’s disease. Alpha-
ketoglutarate was found to protect against cell death induced by MPTP [142] and seizure 
induction by kainic acid [141]. A high dose of arginine alpha-ketoglutarate is found in the 
Deanna Protocol, which combines a ketogenic diet with natural supplements, and has been 
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shown to postpone disease progression in an Amyotrophic Lateral Sclerosis (ALS) mouse model 
[143]. 
Remarkably, mice overexpressing wild-type frataxin showed an increase in mitochondrial 
metabolism prompting mitohormesis. This increase in mitochondrial energy metabolism 
improved survival and protection from doxorubicin-induced cardiac myopathy [144].  Reducing 
the metabolic requirements of the mitochondria through decreased substrate metabolism is 
thought to lead to a decrease in cellular damage and ROS production, and CR, which prevents 
aging-related mitochondrial dysfunction, also increases lifespan.  The prevention of aging-related 
mitochondrial energy deficits or redox imbalance are possible mechanisms of TCA cycle 
metabolite-induced lifespan extension. Mitochondrial electron transport chain function declines 
by over 2-fold during aging with a 5-fold decline in cellular ATP levels [145]. Given the role of 
specific metabolites as activators of hormesis, TCA cycle metabolites may also act in a similar 
manner.  
1.10 Amino Acids, disease, and aging 
  Of all of the classes of metabolites in the cell, current knowledge suggests that cellular 
levels of amino acids may affect longevity the most, at least in short-lived model systems.  
Amino acids are degraded into mitochondrial TCA cycle intermediates  [146],  many of which 
have been shown to extend lifespan in C. elegans including oxaloacetate [147], malate, and 
fumarate [136], as well as related metabolites pyruvate [148] and acetate [149], which can be 
directly converted into the TCA cycle metabolite acetyl-CoA. Amino acids are likely signaling 
through distinct pathways to affect lifespan. Therefore consuming an optimized ratio  of amino 
acids in the diet is hypothesized to be one possible way for increasing lifespan.  Metabolomics 
analysis of worms has found that many amino acids, including glutamine, valine, and isoleucine 
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were increased in long-lived daf-2 insulin receptor mutant worms, while glutamate levels 
declined [150]. Valine and isoleucine levels returned to wild-type levels in daf-2; daf-16 double 
mutants as did lifespan. These results suggest that increased valine and isoleucine levels may 
mediate lifespan extension in daf-2 mutants in a daf-16 dependent manner. Amino acids were 
once commonly thought of as only nutrients and not signaling molecules, but this idea is not only 
incorrect, it undermines how functionally diverse these compounds really are.  
1.10.1 Alanine  
Alanine is a non-essential amino acid and also one of 13 exclusively glucogenic amino 
acids, meaning it is readily converted to glucose within the liver [151]. Alanine is crucial for 
regulating nitrogen and glucose levels in the body. Following entry into the liver alanine is 
converted to pyruvate, which participates in gluconeogenesis to supply energy to the TCA cycle. 
In a fasted state skeletal muscles release profuse amounts of alanine and glutamine into the 
circulating blood [152]. Additionally, alanine was shown to strengthen the immune system and 
increase aerobic and anaerobic endurance in long distance runners [153]. More recent studies 
indicate that alanine assists in the secretion of glucose [154] and supplementation may enhance 
protection from cardiovascular diseases [155].  
1.10.2 Arginine  
Arginine is a semi-essential amino acid that plays important roles in nitric acid synthesis, 
[156] growth hormone secretion [157],  and  in the removal of excess nitrogenous waste through 
the urea cycle [158]. Arginine is found in large concentrations in the skin and muscles and is 
responsible for stimulating the immune system to aid in rapid wound healing [159]. Arginine 
was also shown to stimulate repair in aged coronary endothelial tissue in humans [160] and also 
improved depressed macrophage function following trauma-induced hemorrhage in rats [161]. 
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1.10.3 Asparagine 
Asparagine is a non-essential amino acid that is important for regulating metabolism and 
maintaining central nervous system equilibrium. Interestingly, depletion of asparagine by 
asparaginase resulted in increased survival among lymphoblastic leukemia patients [162], which 
may be in part  due to cell cycle inhibition created by asparagine deprivation [163]. There 
remains a large gap of knowledge on the effects of asparagine when taken as a supplement. 
1.10.4 Aspartic Acid 
The non-essential amino acid, aspartic acid, participates in a range of important cellular 
functions, such as lowering blood ammonia by way of the ornithine cycle and it is often 
prescribed for fatigue [164]. Aspartic acid is important for generating cellular energy through the 
TCA cycle by transporting NADH equivalents into the mitochondria, and within the brain 
aspartic acid acts as a neurotransmitter  [165] to regulate synaptic plasticity [166]. Nevertheless 
increased amounts of aspartic acid may contribute to cognitive impairment by increasing damage 
to hippocampal neurons [167]. 
1.10.5 Cysteine 
Cysteine is a non-essential amino acid that promotes the production of T4 lymphocytes, 
which are necessary for immune system activation [168]. An increase in oxidative stress 
associated with aging results from the decline of antioxidants, such as reduced glutathione [169], 
which is synthesized from cysteine, glycine, and glutamate. Although these three amino acids 
parallel the decline of glutathione with age, supplementation with cysteine and glycine resulted 
in an increase in plasma glutathione levels matching that of young controls. This elevation of 
amino acids corresponded with a marked decrease in oxidative damage to tissues [170], 
emphasizing the importance of amino acid supplementation in alleviating age-related decline. 
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1.10.6 Glutamine  
Glutamine is the most abundant essential amino acid in the body and exists as a 
prominent source of cellular energy as well as an important anaplerotic donator of carbon to the 
TCA cycle [171]. Glutamine inhibits fatty acid oxidation, reduces blood plasma glucose, and 
attenuates weight gain in mice prone to obesity [172]. Following prolonged exercise, an 
increased T-helper cell/T-suppressor cell ratio was seen corresponding to a decrease in infections 
in athletes supplementing with glutamine [173] and long-term supplementation may be 
beneficial for maintaining intestinal immunity in the elderly [174]. Glutamine regulates genes 
involved with cellular proliferation and survival, as well as genes involved with inflammation, 
such as NFҠβ [175]. Additionally, glutamine is synthesized from glutamate through glutamine 
synthetase, which is found in much higher concentrations in the brain [176] and is crucial for 
both brain development and protection [177]. Glutamine synthetase is increased in AD patients 
[178] and supplementation with glutamine was shown to be neuroprotective in the disease [179]. 
1.10.7 Glutamate  
Glutamate is a non-essential amino acid often used to enhance the flavor of foods. This 
amino acid acts as the main player in learning, cognition, and memory and is the most excitatory 
transmitter in the brain. Glutamate is required for synaptic transmission, but at high levels 
glutamate induces neuronal excitotoxicity, contributing to neuronal injury in neurodegenerative 
disorders and diseases including AD [180] ALS [181], mental illness, and brain damage[182], as 
well as causing myelin damage [183].The crucial balance between low extracellular 
concentrations and high intracellular concentrations of glutamate are kept in check by glutamate 
transporters. Much research focuses on finding compounds that can reduce glutamate induced 
excitotoxicity. Oxaloacetate injection was shown to reduce glutamate levels in rats [184] and in a 
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separate study it protected the brain following ischemic stroke through the stimulation of 
oxaloacetate transaminase, responsible for clearing glutamate from the blood [185]. Dopamine, 
through regulation of calcium hemostasis, was shown to inhibit glutamate excitotoxicity and 
prevent neuronal death [186]. Although dietary monosodium glutamate (MSG) has gained a bad 
reputation, it still is not known if the small amount used in food is actually harmful. If so, it is 
possible that the sodium may be more harmful than the glutamate. 
1.10.8 Glycine 
Glycine is the smallest of the amino acids and is considered conditionally essential, 
meaning that there are situations when synthesis of it is limited in the body.  One group found 
that dietary glycine supplementation mimicked lifespan extension by dietary methionine 
restriction in rats through the clearance of hepatic methionine [187]. Glycine and cysteine 
supplementation increases glutathione synthesis resulting in a decrease in oxidative stress [188], 
an increase in insulin sensitivity [189], and may protect tissues from the side effects of 
radiotherapy [190]. A recent study showed that mitohormesis promoted skeletal muscle cell 
survival by triggering the serine/1-carbon/glycine pathway to increase protein turnover and 
amino acid metabolism [191]. 
1.10.9 Histidine 
Histidine is an essential amino acid that acts as a potent anti-glycating agent, free radical 
scavenger [192], and a powerful metal chelator in plants [193] and mammals [194]. Histidine 
supplementation is associated with increased insulin secretion and glycemic control, increased 
glutathione peroxidase activity in diabetic mice, and decreased pro-inflammatory cytokine levels 
[195]. Histidine has also shown efficacy in treating chronic alcoholic liver injury by increasing 
glutathione levels and by enhancing catalase activity [196]. In mammals cysteine, histidine, and 
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glycine addition inhibited NF-κB activation and the expression of E-selectin, which is expressed 
only on endothelial cells activated by cytokines, suggesting that these amino acids may 
demonstrate anti-inflammatory effects during endothelial inflammation [197]. Histidine also acts  
as an antioxidant and scavenger of singlet oxygen and hydroxyl radicals [198] and 
supplementation was beneficial in treating chronic kidney failure in elderly patients [199].  
Although histidine administration shows promise in many areas of health, its supplementation to 
the diet showed no effect on the mean lifespan of Drosophila [200], nor have studies, except my 
recent study in C. elegans, focused on its ability to affect lifespan in other model organisms. 
1.10.10 Isoleucine 
Isoleucine, another essential amino acid, is part of the branched-chain amino acid 
(BCAA) family and is best known for its ability to repair injured muscle tissue and stimulate 
muscle synthesis [201]. Isoleucine stabilizes energy levels by stimulating glucose uptake into 
skeletal muscle cells, a process mediated by phosphatidylinositol 3-kinase [202]. High blood 
levels of isoleucine have been associated with hypoglycemia in rats [203], but little research 
involving life span or health span exists. 
1.10.11 Leucine 
Like isoleucine, leucine is an essential branch-chained amino acid that works with 
isoleucine and valine to repair muscle tissue. A diet high in the BCAAs leucine, isoleucine, and 
valine is associated with longevity and protection from disease [150]. Leucine, isoleucine, valine, 
and threonine have all been shown to extend chronological longevity in yeast [204]. Leucine is 
an exclusively ketogenic amino acid, so it is broken down into acetyl-CoA and potentially ketone 
bodies if glucose levels are low. It is the major amino acid regulating the rate of protein synthesis 
by the ribosome. The enhancement of mitochondrial biogenesis, cell growth, and differentiation 
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driven by leucine occurs through the protein kinase mTOR (mammalian target of rapamycin) 
[205], which stimulates cell growth and division. mTOR also  increases PGC-1α levels in some 
tissues to stimulate mitochondrial function to match the energy supply with the demand [206].  
Administration of leucine prevents muscle degeneration in vitro [207] and may increase overall 
muscle anabolism in humans [208, 209]. Leucine promotes fatty acid oxidation, stimulates 
mitochondrial biogenesis, increases NAD+ levels, upregulates SIRT1 activity, and promotes 
AMPK signaling in skeletal myotube cells [210]. Although leucine is commonly used by body 
builders for growth, there is little evidence to support the long-term use of leucine 
supplementation for the amelioration of sarcopenia in the elderly [211]. 
1.10.12 Lysine 
Lysine, the other fully ketogenic amino acid, is an essential amino acid with the capacity 
to interrupt replicating viruses and is often used for the treatment of Herpes simplex virus 
infections [212]. Lysine inhibits Herpes viral growth by blocking and preventing arginine 
absorption necessary for replication [213]. Another vital job of lysine is the regulation of neural 
plasticity in the prefrontal cortex and the release of noradrenaline from the hypothalamus [214]. 
Supplementation with lysine not only improves symptoms of schizophrenia, but increases 
problem solving speed and capacity in patients [215]. 
1.10.13 Methionine 
Methionine is an essential amino acid. Reducing its dietary levels in rodents has been 
shown to partially mimic CR and induce lifespan extension. Methionine restriction can also 
occur when people adhere to a strict ketogenic diet due to the low protein intake prescribed to 
this diet, and the addition of methionine to the diet of ketogenic fed mice resulted in reversal of 
weight loss [216]. A diet deficient in methionine is associated with many positive effects such as 
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enhanced fatty acid oxidation, increased energy, decreased ROS production, reduced oxidative 
damage [217]. Most notably, methionine restriction extended lifespan in mice by nearly 7% 
[218], rats by 44% [219], and drosophila by 36% [220]. Similar to CR, methionine restriction 
produced a lifelong reduction in fatty body mass [221]. Unexpectedly, glycine supplementation 
mimics the effects of methionine restriction though the clearance of hepatic methionine [222]. 
Remarkably, when fruit flies were placed on a protein-deficient diet that extended lifespan, the 
addition of methionine could restore fecundity without decreasing lifespan,  suggesting that it 
may be possible to design a modified amino acid diet that offers the positive effects of dietary 
restriction without the negative effects [223]. 
1.10.14 Phenylalanine  
Phenylalanine is an essential amino acid that is converted to tyrosine by phenylalanine 
hydroxylase. Phenylalanine is necessary for proper central nervous system and memory function 
and was protective against acetylcholine reduction generated by hydroxide radicals [224], which 
may be beneficial for treating AD related acetylcholine deficiency. Many foods such as meat and 
most cheese products contain normal and safe amounts of phenylalanine. However, increased 
phenylalanine has not been associated with benefits; on the contrary, elevated serum 
phenylalanine has been linked to inflammatory disease [225] and was recently shown to be 
raised in AD [226]. 
1.10.15 Proline  
Proline is a non-essential amino acid that is broken down into glutamate and, along with 
glycine, is one of the main components of mammalian collagen. Dietary proline supplementation 
stimulates the immune system [227]. The topical application of proline to cutaneous wounds led 
to a rapid acceleration of healing in rats [228]. Further, proline was shown to extend the lifespan 
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of C. elegans by transiently increasing ROS levels, which then stimulated mitohormetic 
pathways to upregulate superoxide dismutase and catalase [229]. 
1.10.16 Serine 
Serine is a non-essential amino acid that is required for sphingolipid synthesis as well as 
neuronal survival [230].L-serine is synthesized from 3-phosphoglycerate dehydrogenase, 
whereas non-proteogenic D-serine is derived from L-serine through serine racemase [231]. 
Unlike L-serine, the D isoform inhibits sphingolipid synthesis [232].Deficient 3-
phosphoglycerate dehydrogenase leads to a decline in L-serine levels in plasma and 
cerebrospinal fluids resulting in serine deficiency syndrome, which is characterized by seizures, 
congenital microcephaly, and retardation [233]. 
1.10.17 Threonine 
Threonine is an essential amino acid necessary for glycine and serine production, 
regulation of the G1/S phase transition, and proliferation of embryonic cells [234, 235]. 
Threonine supplementation in laying chickens led to an increase in egg production and improved 
immune response [236], whereas threonine deficiency was associated with depression and 
neurological dysfunction in kittens [237]. To date, few if any, studies focus on the efficacy of 
threonine for the alleviation of age-related decline. 
1.10.18 Tryptophan 
Tryptophan is an essential amino acid that was long touted as the reason for After Turkey 
Fatigue Syndrome, the exhaustion that many people feel after eating a large Thanksgiving dinner. 
Scientists realize that this fatigue syndrome is due to gluttony and not so much the trivial 
amounts of tryptophan in turkey, which coincidentally is no more than the amounts found in 
most meats. In any case, tryptophan is a vital precursor of many metabolites, including melatonin 
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and serotonin, which regulate immunity, inflammation, and circadian cycles. Increased 
tryptophan boosts neurotransmission and improves memory tests in aged rats [238], while 
tryptophan enriched cereals improved the sleep/wake cycle in elderly humans [239]. Serotonin 
production is dependent upon tryptophan levels [240] and tryptophan depletion results in 
increased aggression in conjunction with a decrease in pain tolerance in humans [241]. As 
expected, increased tryptophan reduced aggression in pigs [242], alleviated depression and 
aggression in people [243, 244], acted as a powerful sleep aid [245], and blocking tryptophan 
catabolism decreased aging and aging-related proteotoxicity in C. elegans [246].  
1.10.19 Tyrosine 
Tyrosine, a non-essential amino acid, is produced from phenylalanine. Tyrosine 
supplementation may ameliorate cognitive decline induced by stress and fatigue through the 
sparing of norepinephrine [247]. Supplementation with tyrosine in both hypertensive rats and 
humans led to a decrease in blood pressure [248], alleviated symptoms of nemaline myopathy 
[249], and enhanced dopaminergic neurotransmission in Parkinson’s disease patients [250]. 
1.10.20 Valine 
Valine is an essential BCAA that together with leucine and isoleucine are broken down to 
provide the body with energy. BCAA supplementation improves the quality of life and prognosis 
in patients suffering from hepatitis [251] and may contribute to lower obesity rates in middle-
aged adults [252]. BCAA supplementation promotes survival and mitochondrial biogenesis in 
mice [253], whereas valine supplementation alone was protective against paraquat-induced 
toxicity in rats [254]. Like isoleucine, little research has been dedicated to this amino acid 
outside of overall BCAA activity.  Elucidating metabolic byproducts and signaling pathways 
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through which amino acids extend healthy lifespan is not only important for delaying aging 
itself, but for improving the quality of life for aged individuals. 
1.11 Beta-hydroxybutyrate 
CR in animals is defined as a daily reduction of food intake. Intermittent fasting (IF) is 
associated with many of the same benefits as CR, yet IF leads to a greater increase in blood 
levels of the ketone body β-hydroxybutyrate  [255], which is produced by the liver when 
the body is in ketosis. Ketone bodies work to provide energy to the body, most importantly, the 
nervous system, during ketosis. Through a complex II-dependent mechanism leading to 
improved mitochondrial respiration and ATP production, mice treated with β-hydroxybutyrate 
showed partial protection from neurodegeneration and motor deficiency induced by MPTP [256].  
Parkinson’s disease patients treated with a ketogenic diet for one month improved their Unified 
Parkinson’s Disease Rating Scale scores by a mean of 43% [257].  β-hydroxybutyrate inhibited 
the growth of malignant cancer [258] and evidence suggests that a low carbohydrate, high ketone 
diet can halt the growth of cancer completely [259]. Oral ingestion of medium chain triglycerides 
MCTs increased HB levels and improved cognitive function in patients with AD [260].  
and acetoacetate have been reported to inhibit mitochondrial production of ROS in mouse 
neocortical neurons following glutamate excitotoxicity, by increasing the NAD+/NADH ratio 
and improving mitochondrial respiration [261]. Butyrate is a short-chain fatty acid that that 
inhibits class I and class II HDACs and increases both C. elegans [98] and Drosophila [99] 
lifespans. HB is structurally similar to butyrate and has been shown to be an endogenous class 
I HDAC inhibitor [100]. In addition, people on a ketogenic diet show increased rates of oxidative 
metabolism and antioxidant defense due to a rise in fatty acid beta-oxidation [262]. A ketogenic 
diet, which stimulates the downstream targets of the PGC-1α pathway, protected mice from 
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neurodegeneration by increasing mitochondrial uncoupling protein levels [263]. The ketogenic 
diet also delayed progression of motor decline and neuron loss in a murine model of ALS [264].  
Although, much more work is needed in the study of the protective effects of ketones and a low 
carbohydrate diet, there is some evidence that a high fat, medium to low protein, and very low 
carbohydrate diet is one possible way to delay aging-related disorders. 
1.12 C. elegans as a model to study nutritional effects on lifespan 
C. elegans nematode worms are a well-studied model organism often used in biomedical 
research as a model for human aging and disease and share almost all central metabolic pathways 
with humans. After reproduction, the worm gradually ages and dies in a similar pattern as 
humans [265]. Mutations in many mitochondrial-localized proteins in C. elegans have been 
shown to alter lifespan, either increasing or decreasing the rate of aging. These mutations directly 
impact overall energy metabolism by affecting the ETC complexes. The metabolic pathways 
studied in these chapters are also present in mammals, so the information gained using C. 
elegans may be applicable to human health and disease. In order to study the effect of 
metabolites on mitochondrial energy metabolism and the reliance on common longevity 
pathways, we selected the well-characterized mutant strains of C. elegans, daf-16(mgDf50), daf-
2(e1370), age-1(hx546), aak-2(ok524), sir-2.1(ok434), eat-2(ad1116), gcn-2, and rsks-1 mutants, 
and skn-1/Nrf and CREB binding protein-1 (cbp-1) RNAi worms. 
Through the use of six different stress response reporter strains of worms, potential stress 
responses to dietary supplementation with metabolites were monitored. These reporter strains use 
GFP driven by stress response promoters. We monitored expression of  hsp-70::GFP (HSF-1 
target), hsp-16.2::GFP (HSF-1 target), hsp-6::GFP (mitochondrial unfolded protein response), 
hsp-4::GFP (ER unfolded protein response), sod-3::GFP (DAF-16/FOXO reporter), and gst-
28 
 
4::GFP (SKN-1/Nrf reporter). All C. elegans strains were acquired from The University of 
Minnesota’s Caenorhabditis Genetics Center. 
Amyloid-β (Aβ) toxicity is responsible for neuronal degeneration seen in AD. The 
transgenic CL4176 (smg-1(cc546
ts
) I; dvIs27 [myo-3/ Aβ minigene + rol-6(su1006) marker 
gene] is a commonly used C. elegans model that employs a temperature-sensitive mutation in the 
mRNA system to initiate muscle expression of the Aβ1–42 transgene, resulting in paralysis of the 
body wall muscle upon temperature upshift from 16 to 25 °C. In conjunction with the CL4176 
strain, the CL2006 strain constitutively produces Aβ3–42 in the body-wall muscles, resulting in a 
decreased lifespan and paralysis. The CL2006, CL4176, and CL802 (control) strains all contain 
the dominant mutant roller phenotype [rol-6 (su1066)] as morphological marker.  Parkinson’s 
disease is a neurodegenerative disease associated with the aggregation of alpha-synuclein and 
death of dopaminergic neurons leading to cognitive and motor decline in patients. The use of 
transgenic models of C. elegans expressing human alpha-synuclein is rapid and economical for 
exploring the anti-Parkinson’s disease effects of compounds. The NL5901 (Punc-54::alpha 
synuclein::YFP+unc-119), strain is commonly used for drug screens to visualize alpha-synuclein 
aggregation. Identifying compounds that suppress Aβ-induced paralysis, polyglutamine 
paralysis, and alpha-synuclein aggregation could lead to the identification of compounds for the 
prevention and treatment of AD, Parkinson’s disease, and ALS. 
1.13 Hypothesis and objectives 
C. elegans share almost all metabolic pathways with humans. Therefore, we hypothesize 
that C. elegans, both wild-type models and models displaying age-related decline related to 
humans, are promising candidates for screening dietary metabolites. A wide range of metabolites 
have been found to have altered concentrations in older C. elegans, which may be indicative of 
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an age-related change in metabolic homeostasis. We therefore proposed the following 
hypotheses: First, we hypothesized that alterations in metabolite concentrations may represent 
homeostatic dysregulation.  In accordance with this hypothesis, we expected that systematically 
supplementing the diet of C. elegans with metabolites shown to have lower concentrations in 
older age would compensate for this dysregulation to increase lifespan.  Second, we postulated 
that small changes in many dietary metabolites would result in minor dietary stress, resulting in a 
hormetic effect.  As such, we hypothesized that supplementing the diet of C. elegans with 
metabolites would result in an increase in lifespan and stress resistance, with an accompanying 
increase in stress signaling and resistance to disease. We have determined that the TCA cycle 
metabolites fumarate, malate, and oxaloacetate extended lifespan in C. elegans, while all of the 
amino acids except phenylalanine and aspartate extended lifespan at least to a small extent at one 
or more of the 3 concentrations tested with serine and proline showing the largest effects.  
Although much is known about the effects of βHB on neurodegenerative and other aging-
associated diseases, not much is known about its effects on aging. Moreover, the mechanisms 
through which βHB are protective are not entirely clear. We hypothesized that βHB would 
increase the lifespan of C. elegans and we determined the cytoprotective signaling pathways 
required for this effect. 
The major aim of this study was to understand the mechanisms by which natural 
metabolites influence the lifespan of C. elegans.  
Specific Aim1 (Chapter 3): Determine the signaling pathways through which TCA cycle 
metabolites increase lifespan and stress tolerance in C. elegans. 
Aim 1.1: Determine the metabolic pathways through which addition of TCA cycle metabolites to 
the culture medium extend lifespan.   
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Aim 1.2: Determine the enzymes and signaling pathways through which TCA cycle metabolites 
extend lifespan through RNAi knockdown and mutant strains.   
Aim 1.3: Determine the effects of TCA cycle metabolites on C. elegans models of 
neurodegenerative disease.   
Specific Aim2 (Chapter 4): Determine the metabolic pathways through which the twenty amino 
acids increase lifespan and stress tolerance in C. elegans. 
Aim 2.1: Outline the signaling pathways through which individual addition of each of the twenty 
amino acids to the culture medium at varying concentrations extend lifespan.   
Aim 2.2: Determine the enzymes and signaling pathways through which amino acids extend 
lifespan through RNAi knockdown and mutant strains.   
Aim 2.3: Determine the effects of the top performing amino acids on C. elegans models of 
neurodegenerative and diabetic disease.  
Specific Aim3 (Chapter 5): Determine the signaling pathways through which βHB increases 
lifespan and stress tolerance in C. elegans. 
Aim 3.1: Determine the metabolic pathways through which addition of βHB to the culture 
medium extend lifespan.  
Aim 3.2: Determine the enzymes and signaling pathways through which βHB extends lifespan 
through RNAi knockdown, enzyme activity assays, and mutant strains.   
Aim 3.3: Determine the effects of βHB on C. elegans models of diabetic and neurodegenerative 
disease.   
1.14 Impact and significance  
The overall goal of this study was to obtain a better understanding of the role of 
metabolites in the control of C. elegans aging. Metabolite supplementation may prove to be a 
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valuable inducer of hormesis and partially compensate for age-related metabolic dysfunction.  
The metabolic pathways studied in this proposal are also present in mammals, so the information 
gained using C. elegans is likely applicable to human health and disease. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 C. elegans strains 
 
All strains used in this study were purchased from the University of Minnesota 
Caenorhabditis Elegans Center unless otherwise noted in Table 1. Strains were cultured at 20°C 
in either liquid S media or NGM agar media [1] as indicated.  
2.2 Chemicals 
 
L-malic acid was purchased from Chem-Impex International. Succinic acid and fumaric 
acid were obtained from Fisher Scientific. L-Amino acids were purchased from Acros Organics 
and Research Products International Corp.  Glycine was obtained from Fischer Chemical 
Company.  D-amino acids were purchased from P212121, LLC.  When no D or L letter is 
present before the name of the amino acid (except for glycine), the L isomer was used.   Sodium 
DL-3-hydroxybutyric acid (βHB), sodium butyrate, valproic (2-propylpentanoic) acid, ethidium 
bromide, and potassium cyanide were purchased from Acros Organics. Sodium D-3-
hydroxybutyric acid and L-3-hydroxybutyric acid were obtained from Sigma. 5-fluoro-2′-
deoxyuridine (FUdR) was purchased from Research Products International Corp. and Biotang, 
Inc. Sodium hydroxide (Fischer Scientific) was added to metabolite stock solutions to obtain a 
pH of 7.0. 
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Table 2.1 Caenorhabditis elegans models.  C. elegans strains acquired and used for dissertation. 
 
Strain Genotype Purchased/Gifted from 
N2 Bristol Wild isolate University of Minnesota CGC 
TJ356 daf-16::GFP zIs356 IV University of Minnesota CGC 
GR1307 daf-16(mgDf50) University of Minnesota CGC 
TG38 aak-2(gt33) University of Minnesota CGC 
DA1116 eat-2(ad1116) University of Minnesota CGC 
TK22 mev-1(kn1) University of Minnesota CGC 
CW152 gas-1(fc21) University of Minnesota CGC 
VC199 sir-2.1(ok434) University of Minnesota CGC 
RB1206 rsks-1(ok1255) University of Minnesota CGC 
RB967 gcn-2(ok871) University of Minnesota CGC 
VC983 hda-2(ok1479) University of Minnesota CGC 
RB1618 hda-3(ok1991) University of Minnesota CGC 
RB758 hda-4(ok518) University of Minnesota CGC 
RB2416 hda-10(ok3311) University of Minnesota CGC 
CL2166 pAF15(gst-4p::GFP::NLS)] University of Minnesota CGC 
SJ4100 hsp-6::gfp(zcIs13) University of Minnesota CGC 
SJ4058 hsp-60::gfp(zcIs9) University of Minnesota CGC 
SJ4005 hsp-4::gfp(zcIs4) University of Minnesota CGC 
ZG449 nhr-57p::GFP + unc-119(+) University of Minnesota CGC 
CL2070 hsp-16-2::gfp(dvIs70) University of Minnesota CGC 
LD1008 skn-1(operon)::GFP + pRF4(rol-6(su1006) University of Minnesota CGC 
PS3551 hsf-1(sy441) University of Minnesota CGC 
SM481 pha-4::GFP::CAAX + (pRF4) rol-6(su1006) University of Minnesota CGC 
CF1874 muIs84 [(pAD76) sod-3p::GFP + rol-6] University of Minnesota CGC 
ZG31 hif-1(ia4) University of Minnesota CGC 
AM140 unc-54p::Q35::YFP Sandra Westerheide 
NL5901 pkIs2386 (unc-54p::alphasynuclein::YFP (+)) University of Minnesota CGC 
CL4176 smg-1ts [myo-3::Aβ1–42 long 3′-UTR] Christopher Link  
CL6049 dvls62 (snb-1::hTDP-43 + pCL26 (mtl-2::GFP) Christopher Link  
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2.3 Lifespan measurements 
  
 All lifespans were cultured at 20°C unless otherwise specified. 
 
2.3.1 Lifespan measurements in 250 mL liquid culture 
 
The worms were bleach-synchronized as follows: 2 mL of 6% NaOCl were mixed with 1 
mL of 5 M NaOH per 7.5 mL of concentrated worm suspension, and shaken for 4–7 minutes 
until the carcasses dissolved as monitored by direct observation. The remaining eggs were then 
washed 3 times by pelleting at ~1150 g for 2 minutes at room temperature, followed by 
aspiration of the supernatant and resuspension in 50 mL of 0.1 M NaCl. A final pellet of eggs 
was obtained by centrifugation at ~1150 g for 2 minutes at room temperature, followed by 
aspiration of the supernatant. Eggs were then added to a 250 mL liquid culture, as described 
above. For experiments without RNAi treatment, bacteria were heat killed at 80°C for 60 
minutes. The worms were cultured at 20°C and monitored until they reached adulthood (~72 h), 
at which time FUdR was added to a final concentration of 400 uM. Worm viability was scored 
every two days by taking ten 10 µL drops (initially ~20 worms per drop) of the culture and 
counting the living worms under a microscope. The average number of living worms was then 
calculated. S medium or deionized water containing 10 mM malate, succinate, or fumarate was 
added back every three days to compensate for metabolism of the compounds and evaporation, 
and S medium containing FUdR and bacteria was replaced every 6 days. At least two replicates 
of each experiment were performed. 
When the worm strains were sickly, limiting body movement, and survival in liquid 
medium, lifespans were performed using standard NGM agar media as described in [2]  with 400 
uM FUdR under standard conditions [3].  
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2.3.2 Lifespan measurements in cell culture inserts 
Gravid C. elegans adults were bleached synchronized as previously described in 2.3.1 to 
yield eggs in S-medium. Most lifespan experiments were performed in liquid media using 0.4 
µM or 3 µM transparent cell culture inserts (BD Falcon #353180 and #353181) in 12-well and 
24-well microplates as first described in [4] on an orbital shaker at 135 rotations/min at 20°C. 
12-well microplates were found preferable due to the easier visualization of the worms through 
the suspension of bacteria after swirling the microplate. 3 µM inserts were found preferable due 
to the increased E. coli permeability. Initially 1.25 mL of S-medium containing 9×10
9
 HT115 
(DE3) E. coli per mL was placed in each well of a 12-well microplate. Then bleach synchronized 
worm eggs were suspended at a concentration of 100–200 eggs/mL in S-medium containing 
9×10
9
 HT115(DE3) E. coli per mL. Lastly, a cell culture insert was placed in each well followed 
by 0.25 mL of the egg/bacterial suspension (25–50 eggs) into each insert (n = 3–6 wells per 
condition). 
E. coli were grown for 20 hours in 2 L flasks with LB media. The E. coli were then spun 
down, the supernatant poured off, and the pellet frozen until use.  The E. coli were de-thawed 
and heat-killed at 80°C for 1 hour with vibration using a Kendal model HB-S-23DHT ultrasonic 
cleaner. The E. coli pellets were then resuspended in an equal volume of S-medium. A 1.3 mL 
suspension of S-medium containing 9×10
9
 HT115 (DE3) E. coli per mL was placed in each well 
of a 12-well or 24-well microplate. Bleach synchronized worm eggs were suspended at a 
concentration of 100-200 eggs/mL in the suspension of E. coli in S-medium. Lastly, a cell 
culture insert was placed in each well followed by 0.25 mL of the egg/bacterial suspension (25-
50 eggs) into each insert (n = 3 wells per condition). Synchronized cultures of worms were 
placed on an orbital shaker at 135 rotations per minute at 20°C and monitored until they reached 
adulthood (~72 h), at which time FUdR was added to a final concentration of 400 uM.  Worm 
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viability was scored every two days. Worms that did not respond to repeated stimulus were 
scored as dead and those that contained internally hatched larvae were excluded. The culture 
media containing E. coli in the 12-well plates below each culture insert (>80% of total culture 
media volume) was changed every 3 days.  
2.3.3 High glucose lifespan measurements 
 
C. elegans lifespan assays as described above with the addition of 40 mM glucose to the 
culture medium. Worms were scored for viability every day. The media containing bacteria in 
the wells into which the culture inserts were submerged was changed every two days. 
2.4 RNAi feeding experiments 
 
The E. coli skn-,  cbp-1, hda-1, hda-2, hda-3, F55E10.6, dhs-2,dhs-16, dhs-20, fum-1, 
gei-7, men-1,  sdha-2,  F48E8.3, qns-1, and  W06B3.1RNAi clones from the Ahringer C. elegans 
RNAi library (Source BioScience
 
LifeSciences) was grown 16 hours and then 1mM IPTG was 
administered to the E. coli for the last 4 hours of growth to induce expression of the double 
strand RNA. Lifespan experiments were performed using live instead of heat-killed bacteria.  
The culture media containing bacteria in the 12-well plates into which the culture inserts were 
submerged was changed daily instead of every 3 days to decrease the chance of E. coli 
metabolism depleting the culture level of the supplemented amino acid. 
2.5 GFP reporter strains 
 
The GFP fluorescence of C. elegans populations was assayed using a Biotek Synergy 2 
microplate reader. Strains were age synchronized and cultured in 12-well microplates as 
described above. At the L3 stage of larval development animals were treated with βHB or other 
compounds. Following 24 hours of treatment, worms were washed 3 times in S-medium and 
approximately 400 worms per 200 μL were added to a clear 96-well microplate and GFP 
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fluorescence was measured using 485/20 nm excitation and 528/20 nm emission filters (n=10 per 
treatment group). 
2.6 Microscopy and quantification 
Worms used for microscopy were anesthetized using 1 mM levamisole and transferred to 
agar pads with glass coverslips and analyzed using an EVOS fluorescence microscope. 
Comparable results were established in the absence of levamisole (data not shown).  
Approximately 20 worms per condition were used and all experiments were repeated at least 
three times.  ImageJ™ software was used to quantify pixel intensities. 
2.7 Thermotolerance assays 
 Thermoterance assays were performed on both liquid and solid media as described 
below. 
2.7.1 Thermotolerance assays performed in liquid media 
A synchronized population of N2 C. elegans eggs was obtained as described in 2.3.1 for 
the lifespan measurements. Eggs were placed in an aerated longneck glass bottle filled to 250 mL 
with liquid S medium and 4 g of HT115(DE3) E. coli with and without treatment. On day 5 of 
the lifespan, the worms were removed and diluted to approximately 10 worms per well in a 96 
well microplate. The 96 well microplate containing treated and untreated worms was placed in 
an incubator at 38°C. Worms were scored for movement as a marker of survival every 20–30 
minutes for 430 minutes. 
2.7.2 Thermotolerance assays performed on NGM agar  
A synchronized population of N2 C. elegans eggs were placed on treated or non-treated 
NGM plates and allowed to hatch at 20°C. At the L4 stage of development animals were 
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transferred to a 35°C incubator. Survival was scored as the number of worms responsive to 
gentle prodding with a worm pick.  
2.8 Alpha-synuclein aggregation assays 
Eggs were collected from the NL5901 strain of C. elegans following treatment with 
alkaline bleach and placed in 12 well cell culture inserts as described above, with or without 
amino acid treatment. Following 2 days of treatment, 400 µM FUdR was added to the inserts to 
prevent progeny. On day 8 worms were washed 3 times with M9 media and either placed on 1% 
agarose pads to slow movement or immobilized with 10 mM levamisole.  Quantification of the 
number of inclusions expressing alpha-synuclein-YFP was measured using an EVOS 
fluorescence microscope.  Foci larger than 2 µm
2 
were counted for each group (n=30). Image 
analysis was performed using ImageJ
TM
 software and the assay was completed at least 3 times 
[5]. Statistical analysis was completed using GraphPad software and calculation of statistical 
significance between groups was carried out using Student’s t-test. 
2.9 Aβ-mediated paralysis assays 
Paralysis assays were carried out as outlined in [6].Briefly, second generation 
synchronized gravid C. elegans strain CL4176 were placed on treated or untreated 6 cm NGM 
plates and allowed to lay eggs for 2 hours. After two hours, adults were removed and plates were 
placed in a 16°C incubator for 48 hours. Following 48 hours, plates were upshifted to a 25°C 
incubator. Scoring for paralyzed worms began 20 hours after upshift. Animals were scored for 
movement every two hours. Worms were considered paralyzed if they could not complete a full 
body movement after stimulation with a worm pick. 
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2.10 Polyglutamine aggregation assays 
AM140 [unc-54p::Q35::YFP] worms were synchronized and placed onto NGM plates 
supplemented with either 1 mM tryptophan, 10 mM serine, or 5 mM proline.  Plates were seeded 
with 90% heat-killed OP50 and 10% live OP50. Images were taken at Day 3 of adulthood.  
Progeny were avoided by picking daily after day 1. Aggregates were scored for 50 worms per 
condition in independent biological duplicates.   
2.11 Lifespan assays using transgenic TDP-43 nematodes 
CL6049 [snb-1::hTDP-43 + mtl-2::GFP] second generation synchronized gravid animals 
were placed on treated or untreated 6 cm NGM plates and allowed to lay eggs for 2 hours. After 
two hours, adults were removed and plates were placed in a 16°C incubator. At the L4 larval 
stage worms were transferred onto treated or untreated NGM plates with added 5-fluoro-2′-
deoxyuridine (FUdR, 0.05 mg/mL) to inhibit growth of progeny. Worms were scored everyday 
by gentle touching with a platinum wire. Failure to respond to touch or move forward or 
backwards was scored as dead.  
2.12 Protein assay 
Protein was assayed essentially as in [7]. Briefly, one mL of worms suspended in S 
medium or M9 medium was snap frozen in liquid nitrogen and stored at −10°C until analysis. 
For analysis 500 µL of a worm suspension was sonicated on ice, using a W-380 sonicator (Heat 
Systems-Ultrasonics, Inc.) (5-second pulses, 50% duty cycle, max power, 12 pulses). 1.5 mL of 
1:1 ethanol/acetone was added and the suspension was vortexed, and incubated for 30 minutes at 
4°C. The tube was then centrifuged at 15,000×g for 10 minutes at room temperature. The 
supernatant was decanted, and the tube was inverted on a paper towel while the pellet dried. The 
pellet was then resuspended in 180 µL of 1 N NaOH, and incubated at 70°C for 25 minutes to 
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degrade lipids that could have interfered with analysis. The NaOH was then diluted with 1.26 
mL of deionized water and 360 µL of 10% SDS. The sample was then mixed by inversion and 
centrifuged at 1,500×g for 2 minutes at room temperature. The protein content of the supernatant 
was then analyzed by the BCA assay (Pierce) according to the manufacturer’s protocol. 
2.13 NAD, NADH, NAD, and NADPH measurements 
The C.elegans MH1317strain having genotype kuIs29[unc-119(+) egl-13::GFP(pWH17)] 
V was used. Worms were synchronized and cultured with heat-killed OP50 E. coli as food in the 
presence of no treatment, 10 mM malate or 10 mM succinate. On day 4 of the lifespan a 2 mL 
aliquot of each culture was snap frozen in liquid nitrogen. The samples were thawed and 50 µL 
was added in duplicate to the wells of a 96-well plate. NAD, NADH, NAD, and NADPH 
measurements were performed using the Elite Fluorimetric NAD/NADH Ratio Assay and Elite 
NADP/NADPH Ratio Assay Kits (eENZYME, LLC), according to the manufacturer’s 
instructions. Fluorescence was normalized by the GFP expression of each sample. 
2.14 GST-4::GFP fluorescence analysis 
C. elegans of strain CL2166 having genotype dvIs19[pAF15(gst-4::GFP::NLS)] as 
described in [8] were used. Approximately 300 age-synchronized worms were grown in cell 
culture inserts in liquid culture medium containing HT115(DE3) E. coli as food as described 
above. Cultures were supplemented with 10 mM succinate, 10 mM malate, or 10 mM fumarate 
on day 1 of the lifespan. 10 mM paraquat was added on day 4. 24 hours later on day 5 
approximately 20 adult worms from each treatment group were removed and assayed by 
fluorescence microscopy. Worms in the images were analyzed for fluorescence intensity 
following background subtraction using NIH ImageJ software version 1.44p. 
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2.15 DAF-16::GFP and SKN-1::GFP nuclear translocation assays 
C. elegans strains N2, TJ356 (DAF-16::GFP), and LD1008 (SKN-1::GFP) were bleach 
synchronized and eggs were placed in 3 µM cell culture inserts with heat-killed HT115(DE3) E. 
coli in shaken 12-well plates untreated or treated (3 wells per treatment). On day 4 of the 
lifespan, worms were chilled on ice to slow movement and 40–50 worms per treatment group 
were photographed and analyzed for nuclear translocation. 
2.16 Thrashing measurements 
For the thrashing assays N2 worms were grown on NGM agar with live HT115(DE3) 
control E. coli or HT115(DE3) E. coli expressing RNAi to malic enzyme (men-1) essentially as 
in [9]. Some worms were grown in the presence of heat-killed HT115(DE3) E. coli with 10 mM 
malate, 10 mM fumarate, or 10 mM succinate, or no addition. Worms were transferred to 50 µL 
of S medium. After a one minute recovery period thrashes, defined as changes in the direction of 
bending at the mid body, were counted for 30 seconds (n = 8 for the control N2 worms and the 
N2 worms feeding on malic enzyme (men-1) RNAi-expressing bacteria and n = 16 for malate, 
fumarate, succinate, and control treated N2 worms).  
2.17 Pharyngeal pumping measurements 
Pharyngeal pumping assays were performed essentially as in [10]. Briefly, age-
synchronized eggs from N2 worms were placed on 6 cm agar plates seeded with OP50 E. 
coli suspended in S medium with or without treatment. Video of 3 day old worms (n = 16 for 
each group) was recorded with a Scopetek 3.2 megapixel microscope eyepiece camera at a 
resolution of 1028×764 pixels and quality setting of 50 out of 100 in black and white. Full 
pumps were manually counted for 20 seconds during reduced speed video playback using the 
VLC media player. 
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2.18 Oxygen consumption measurements 
 Oxygen measurements were performed with live worms using two different methods. 
2.18.1 Oxygen measurements using the Clark Oxygen Electrode 
N2 worms were grown in 12-well cell culture plates and fed HT115 (DE3) control or 
F55E10.6 RNAi knockdown-expressing E. coli as food for 4 days in the absence or presence of 
20 mM βHB. Worms were washed 4 times using M9 buffer to free them of the bacteria and then 
resuspended in the culture media in which they were grown except without the bacteria. The 
average concentration of worms was obtained by taking ten 10 μL drops and counting the 
number of living worms in each drop. The volume of the culture was then adjusted to obtain a 
final concentration of 2 worms per μL. 300 μL of the worm suspension was then added to the 
chamber of a Clark oxygen electrode (MT200A chamber, Strathkelvin Instruments) and the 
respiration was monitored for 5 minutes. The respiratory rate was normalized to protein content 
by performing a protein assay on the worm suspension. 
2.18.2 Oxygen consumption using PreSens OxoPlates 
All measurements were acquired using the PreSens OxoPlate protocol supplied with the 
OxoPlates. Worms were synchronized with and the eggs were placed in 12-well cell culture 
plates in 1mL of S-medium or appropriate amino acid with live HT115 (DE3) bacteria.  The pH 
and volume of the media were monitored daily. At the L4 stage, worms were washed 3 times 
with S-medium or appropriate amino acid. Following rinsing, the worms were concentrated to 
approximately 10 worms per microliter and 200uL of each treatment group was placed in the 
OxoPlate in replicates of 3-4. Oxygen consumption was measured using 540/650 and 540/590 
filters on a Biotek Synergy 2 microplate reader. 
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2.19 ATP assays 
One mL samples of the N2 C. elegans cultures grown with either heat-killed E. coli or 
live RNAi-expressing E. coli were snap frozen on day 4 of the lifespan in liquid nitrogen. The 
samples were thawed and then 50 µL was added to a well of a 96-well microplate in a 1:1 ratio 
with 50 µL of CellTiter Glo solution (Promega, Madison, WI). The plate was shaken for 2 
minutes and then incubated at room temperature for 10 minutes. Luminescence of the samples 
was measured in a Biotek Synergy 2 microplate reader. ATP levels were obtained through the 
use of a standard curve. 
2.20 Mitochondrial membrane potential determination 
N2 C. elegans were bleach synchronized and 500 eggs were placed in each well of a 12-
well shaken microplate along with heat-killed HT115(DE3) E. coli. 24 hours later each well was 
treated with 100 nM tetramethylrhodamine ethylester (TMRE). In addition specific wells were 
treated with 10 mM malate, 10 mM fumarate, 10 mM succinate, or 10 µM FCCP 
(trifluorocarbonylcyanide phenylhydrazone) (3 wells per treatment). 24 hours following 
treatment the worms for each treatment group were washed with 10 mL of S-medium and 
resuspended in 5 mL of S-medium. 100 µL of worms were added to each well of a 96-well 
microplate (n = 6) and fluorescence was measured using a 540/30 nm excitation filter and a 
590/35 nm emission filter. 
2.21 BHB dehydrogenase assays 
D-βHB or L-βHB dehydrogenase activity was assayed as in [11], slightly modified from 
the original method published in [12]. The reaction mix contained 100 mM Tris-HCl pH 8.0, 10 
mM MgSO4, 5 mm K
+
 EDTA, 400 mM hydrazine hydrate, 1 μM rotenone, 10 mM NAD, 20 mm 
D-βHB or L-βHB, and 10 μL of Halt protease inhibitor cocktail (Thermo Scientific).Worms 
were grown with or without D-βHB or L-βHB as indicated. On day 4 of development, worms 
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were washed 3 times with M9 buffer to free them of bacteria and condensed to 50 worms per 
microliter. 1 mL of concentrated worms was subjected to 3 freeze-thaws cycles in liquid 
nitrogen. 50 μL of each sample (~ 2,500 worms) was added to a clear bottomed 96-well 
microplate, followed by addition of 100 μL of the reaction mix above. NADH fluorescence was 
measured kinetically for 20 minutes using 360/40 nm excitation and 460/40 nm emission filters 
(n=5) on a Biotek Synergy 2 microplate reader. 
2.22 Statistical analysis 
Kaplan-Meier survival analysis and log-rank tests were performed using Sigmaplot 
version 11.0. Student’s t-tests and ANOVA were used in other analyses. 
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CHAPTER 3 
MALATE AND FUMARATE EXTEND LIFESPAN IN CAENORHABDITIS ELEGANS
1
 
3.1 Abstract 
Malate, the tricarboxylic acid (TCA) cycle metabolite, increased lifespan and 
thermotolerance in the nematode C. elegans. Malate can be synthesized from fumarate by the 
enzyme fumarase and further oxidized to oxaloacetate by malate dehydrogenase with the 
accompanying reduction of NAD. Addition of fumarate also extended lifespan, but succinate 
addition did not, although all three intermediates activated nuclear translocation of the 
cytoprotective DAF-16/FOXO transcription factor and protected from paraquat-induced 
oxidative stress. The glyoxylate shunt, an anabolic pathway linked to lifespan extension in C. 
elegans, reversibly converts isocitrate and acetyl-CoA to succinate, malate, and CoA. The 
increased longevity provided by malate addition did not occur in fumarase (fum-1), glyoxylate 
shunt (gei-7), succinate dehydrogenase flavoprotein (sdha-2), or soluble fumarate reductase 
F48E8.3 RNAi knockdown worms. Therefore, to increase lifespan, malate must be first 
converted to fumarate, and then fumarate must be reduced to succinate by soluble fumarate 
reductase and the mitochondrial electron transport chain complex II.  Reduction of fumarate to 
succinate is coupled with the oxidation of FADH2 to FAD. Lifespan extension induced by malate 
depended upon the longevity regulators DAF-16 and SIR-2.1. Malate supplementation did not 
extend the lifespan of long-lived eat-2 mutant worms, a model of dietary restriction. Malate and
                                                          
1
 This chapter have been previously published in PLOS ONE, 2013, 8(3): e58345., and have been 
reproduced with permission from PLOS ONE 
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fumarate addition increased oxygen consumption, but decreased ATP levels and mitochondrial 
membrane potential suggesting a mild uncoupling of oxidative phosphorylation. Malate also 
increased NADPH, NAD, and the NAD/NADH ratio. Fumarate reduction, glyoxylate shunt 
activity, and mild mitochondrial uncoupling likely contribute to the lifespan extension induced 
by malate and fumarate by increasing the amount of oxidized NAD and FAD cofactors. 
3.2 Introduction 
Metabolic control of the aging process is widely accepted, yet little progress has been 
made in this field due to the complexity of organismal metabolism. Studies of lifespan in model 
organisms have yielded important roles for organelles [1, 2], especially mitochondria, in 
regulating the aging process. The mitochondrial electron transport chain (ETC) is the main 
producer of damaging reactive oxygen species in the cell and therefore has the potential to 
regulate lifespan as postulated by the free radical theory of aging [3]. However, recently data has 
accumulated that questions the theory that free radicals are the main regulators of lifespan [4, 5].  
Although mitochondrial-derived oxygen radicals have been questioned as the main driving force 
for the aging process, changes in mitochondrial metabolism almost certainly play a role. Dietary 
restriction (DR), which extends lifespan [6], also delays the aging-induced ETC dysfunction in 
rodents [7]. DR increases the NAD/NADH ratio in many tissues [8], which stimulates 
mitochondrial tricarboxylic acid (TCA) cycle dehydrogenases that utilize NAD as a cofactor.  
The increased TCA cycle function likely necessitates increased anaplerosis, important for 
longevity [9]. 
Alteration of mitochondrial TCA cycle (Fig. 1.1) function influences lifespan in C. 
elegans.  For example, RNAi knockdown of aconitase or two of the subunits of mitochondrial 
NAD
+
-dependent isocitrate dehydrogenase have been shown to increase lifespan [10, 11].  
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Mutations in the thiamine pyrophosphokinase gene, tpk-1, which converts thiamine to the 
essential co-factor thiamine pyrophosphate, essential for pyruvate and α-ketoglutarate 
dehydrogenases as well as several other enzymes, also extended lifespan [12]. Furthermore, 
addition of the TCA cycle intermediate oxaloacetate has been shown to extend lifespan in C. 
elegans through an aak-2/AMP kinase and daf-16/FOXO-dependent mechanism [13]. 
Supplementation with other metabolites that increase flux through the TCA cycle has also shown 
beneficial effects on lifespan. Addition of acetate [14] or pyruvate [15] or activation of pyruvate 
dehydrogenase with dichloroacetate [16] increased lifespan, while the addition of metabolites 
that feed more upstream into glycolysis, such as glucose or glycerol, decreased lifespan [17], 
perhaps due to increased methylglyoxal formation [18]. 
As a soil-dwelling nematode, C. elegans has evolved to be more metabolically flexible 
than many other multicellular organisms.  C. elegans can survive anaerobically for short periods 
of time by utilizing a metabolic process known as malate dismutation (Fig. 1.1) or the 
phosphoenolpyruvate carboxykinase (PEPCK)-succinate pathway [19, 20].  Here, a portion of 
the intracellular malate is converted to fumarate and then to succinate, which can be excreted 
from the cell. This process leads to the oxidation of reducing equivalents providing NAD and 
FAD essential for cellular metabolism. C. elegans also has a glyoxylate shunt, not present in 
mammals, that converts isocitrate and acetyl-CoA to succinate, malate, and CoA using 
glyoxylate as an intermediate (Fig. 1) [21].  This shunt bypasses two NADH and CO2 generating 
steps in the TCA cycle, conserving NAD levels and preventing carbon loss, which is 
advantageous for biosynthetic reactions in the cell. The glyoxylate shunt is upregulated in many 
long-lived C. elegans mutants [22]. 
61 
 
 
Figure 3.1. The mitochondrial TCA cycle with the glyoxylate shunt and malate dismutation. Numbered 
reactions are catalyzed by 1.fumarase, 2a. isocitrate lyase, 2b. malate synthase, 3. mitochondrial succinate 
dehydrogenase/fumarate reductase (complex II), 4. soluble fumarate reductase, 5. cytoplasmic malate 
dehydrogenase, 6. mitochondrial malate dehydrogenase, and 7. malic enzyme. It is unknown if the 
glyoxylate shuntis present in mitochondria, peroxisomes, or glyoxysomes in C. elegans. 
 
In this report, we tested the effect of added succinate, fumarate, and malate on C. elegans 
lifespan, and determined the effects on mitochondrial function, redox status, and determined 
which metabolic enzymes and longevity pathways were necessary for lifespan extension. 
3.3 Results 
3.3.1 Malate extends lifespan in WT but not eat-2, daf-16, sir-2.1, or hsf-1 mutant worms 
In Fig. 3.2A we show that the addition of 10 mM L-malate and 10 mM fumarate, but not 
10 mM succinate, to the growth medium of C. elegans increased lifespan. A summary of all 
lifespan experiments is shown in Table 3.1.  
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Table 3.1.  Summary of lifespan experiments 
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Malate increased mean lifespan by 14% and the increase was consistently observed 
(p<0.001) in nine total replicates using either live E. coli (n=6) or heat killed E. coli (n=3) as the 
food source. The increased lifespan was not due to reduced food intake from diminished 
pharyngeal pumping as malate treated (164 pumps per minute ± 4 SEM) showed similar rates as 
control (168 ± 3 SEM) worms (p=0.37). Fumarate increased mean lifespan by 16% (p<0.001 
n=4). Interestingly, a mass spectrometry-based metabolomics analysis identified 188 total worm 
metabolites and indicated that there was a 2-fold reduction in fumarate levels with aging in C. 
elegans (data not shown).  Therefore, added fumarate or malate may compensate for altered TCA 
cycle function in aged worms.  Like succinate, the TCA cycle intermediate α-ketoglutarate failed 
to extend lifespan. Aspartate, a metabolite of the mitochondrial malate-aspartate NADH shuttle 
also failed to induce lifespan extension. 
Malate addition was unable to extend the lifespan of sir-2.1(ok434) mutant worms (Fig. 
3.2B). SIR-2.1 is a sirtuin family member and is the closest worm homolog of the mammalian 
SirT1 NAD-dependent protein deacetylase [23]. In Fig. 3.2C, it is shown that malate did not 
extend the lifespan of long-lived eat-2(ad1116) worms that have reduced pharyngeal pumping 
rates and are a model of dietary restriction. Treatment with succinate blocked the lifespan 
extending effects of dietary restriction (DR) in eat-2 worms, as the maximal lifespan was similar 
as the N2 control strain and much shorter than untreated or malate treated eat-2 worms. Fig.3.2D 
shows that malate did not extend the lifespan of daf-16(mgDf50) worms. Therefore, DAF-16 is 
required for malate-induced lifespan extension. DAF-16 is the worm homolog of mammalian 
FOXO transcription factors and is required for lifespan extension in several mutant strains, most 
notably in reduced insulin receptor signaling daf-2 mutant worms. Malate also failed to 
significantly extend the lifespan of heat shock factor-1 mutant, hsf-1(sy441) worms (log-rank 
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p=0.08) (Figure 2E), although a protective effect occurred early in life. HSF-1 is required for 
lifespan extension that occurs in daf-2 mutants [24] and in some dietary restriction regiments 
[25, 26].  
3.3.2 Malate increased lifespan robustly in hif-1 mutant worms and slightly in aak-2 and 
skn-1 RNAi worms 
Malate and fumarate treatments resulted in increases in the lifespan of hypoxia inducible 
factor-1 mutant, hif-1(ia4) worms. HIF-1 functions downstream of Tor kinase and is necessary 
for the lifespan extension that occurs in mitochondrial mutants [27, 28]. Malate and succinate 
treatments did not significantly increase the mean lifespan of aak-2(ok524) AMP kinase 
(AMPK) mutant worms (Fig. 3.2F). But caution should be used when making conclusions from 
this data, due to the low number of worms used in these experiments. AMPK has been shown to 
be necessary for lifespan extension in worms following oxaloacetate treatment [13], resveratrol 
treatment, and under certain DR conditions [25]. SKN-1 is the C. elegans homolog of 
mammalian Nrf transcription factors involved in cellular detoxification, stress defense, and 
longevity. Malate extended the lifespan of skn-1 RNAi nematodes by 9% (Fig. 3.3A). Consistent 
with this, malate, fumarate, and succinate all failed to induce nuclear localization of SKN-1::GFP 
(data not shown). 
3.3.3 Malic enzyme or malate dehydrogenase knockdown did not block malate-
induced lifespan extension 
Malic enzyme catalyzes the conversion of malate to pyruvate and carbon dioxide with the 
concurrent reduction of NADP to NADPH.To determine if this reaction is essential for the 
lifespan extension elicited by malate, we knocked down the sole malic enzyme gene in C. 
elegans, men-1 by RNAi and determined the effects of malate addition on lifespan.   
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Figure 3.2.  Lifespan analysis of C. elegans strains in the presence of TCA cycle intermediates.  10 mM 
concentrations of malate, succinate, or fumarate were present where indicated. (A)  Malate (log-rank p < 
0.001) or fumarate (log-rank p < 0.001), but not succinate (log-rank p = 0.72) extended lifespan of N2 
worms. (B) Neither malate (log-rank p = 0.97) nor succinate (log-rank p= 0.88) extended lifespan of sir-
2.1(ok434) worms.  (C)  No effect of malate treatment (log-rank p= 0.22) on lifespan and decreased 
lifespan with succinate treatment (log-rank p < 0.001) in eat-2(ad1116) worms. (D) Neither malate (log-
rank p = 0.83) nor succinate (log-rank p = 0.22) extended lifespan of daf-16(mgDf50) worms.  (E) 10 mM 
malate (log-rank p = 0.08) did not extend the lifespan of HSF-1 mutant hsf-1(sy441) worms. (F) Neither 
10 mM malate (log-rank p = 0.18) nor 10 mM succinate (log-rank p = 0.10) extended lifespan of AMPK 
mutant aak-2(ok524) worms.  
 
 
As shown in Fig. 3.3B, the mean lifespan of men-1 RNAi knockdown worms was only 53% of 
controls, but malate addition still extended mean lifespan by 30%, suggesting that high malic 
enzyme activity is not important for malate-induced lifespan extension. Interestingly, malic 
enzyme RNAi knockdown caused an increased rate of body wall muscle contractility (210 body 
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bends per minute ± 12 SEM) when compared to control (147 body bends per minute ± 7 SEM) 
as measured by a thrashing assay (p < 0.001). 
Malate dehydrogenase catalyzes the reversible conversion of malate to oxaloacetate with 
the concurrent reduction of NAD to NADH. There are two confirmed malate dehydrogenase 
genes in C. elegans. The mdh-1 gene codes for a mitochondrial isoform, while the other gene, 
F46E10.10, encodes a cytoplasmic isoform. F46E10.10 is upregulated in long-lived dauer and 
daf-2 worms [19] as well as long-lived mitochondrial mutants [29]. Oxaloacetate, the product of 
the malate dehydrogenase reaction has been shown to extend lifespan in C. elegans. We first 
knocked down the mitochondrial malate dehydrogenase, mdh-1, and determined the effects on 
lifespan in the absence and presence of malate (Fig. 3.3C).The mean lifespan of mdh-1 
knockdown worms was 66% of controls, but malate addition extended mean lifespan of the 
RNAi treatment by 26%, nearly back to that observed in the control worms. We then knocked 
down F46E10.10 and performed lifespan analysis with and without malate (Fig.3.3D). 
Knockdown worms showed a mean lifespan 85% of controls and malate addition extended mean 
lifespan of the F46E10.10 knockdown worms by 8%.   
3.3.4 The glyoxylate shunt is required for lifespan extension induced by malate or fumarate 
The glyoxylate shunt is composed of two enzymes, isocitrate lyase and malate synthase.  In C. 
elegans these enzymes are fused into one bifunctional protein named GEI-7 or ICL-1.  Isocitrate lyase 
reversibly converts isocitrate into succinate and glyoxylate. Malate synthase catalyzes the reversible 
synthesis of malate and CoA from glyoxylate and acetyl-CoA (Fig. 3.1).  Since malate can be 
metabolized by the glyoxylate shunt we determined the lifespan of gei-7 RNAi worms in the absence and 
presence of malate. As shown in Fig. 3.4A, the mean lifespan of gei-7 RNAi knockdown worms was 62% 
of controls and the lifespan was not statistically different in the presence of malate (log-rank p=0.24).   
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Figure 3.3.  Adding malate to the media increased lifespan of C. elegans RNAi knockdown 
strains.  (A) 10 mM malate increased lifespan of skn-1 RNAi knockdown N2 worms (log-rank p 
= 0.03).  (B) 10 mM malate increased the lifespan of malic enzyme (men-1) RNAi knockdown 
N2 worms (log-rank p < 0.001). (C) 10 mM malate increased the lifespan of mitochondrial 
malate dehydrogenase (mdh-1) RNAi knockdown N2 worms (log-rank p < 0.001).  (D) 10 mM 
malate increased the lifespan of cytoplasmic malate dehydrogenase F46E10.10 RNAi 
knockdown N2 worms (log-rank p = 0.006). 
Fumarate addition also did not increase lifespan and even decreased the lifespan of the gei-7 
RNAi knockdown worms by 9% (Fig. 3.4B). Therefore, the glyoxylate shunt appears to be 
essential for the lifespan extension mediated by malate or fumarate treatment.   
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Figure 3.4.  Malate-induced lifespan extension requires fumarase and the glyoxylate cycle.  (A) 10 mM 
malate treatment did not alter the lifespan of glyoxylate cycle gei-7 RNAi knockdown N2 worms (log-
rank p = 0.24).  (B) 10 mM fumarate treatment decreased the lifespan of glyoxylate cycle gei-7 RNAi 
knockdown N2 worms (log-rank p = 0.02). (C) 10 mM malate treatment did not alter the lifespan of 
fumarase (fum-1) RNAi knockdown N2 worms (log-rank p = 0.49).  (D) 10 mM fumarate treatment 
increased the lifespan of fumarase (fum-1) RNAi knockdown N2 worms (log-rank p < 0.001). 
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Interestingly, 10 mM glyoxylate failed to extend lifespan, suggesting a limited conversion of 
glyoxylate to malate in the worms under these culture conditions or alternatively, that the acetyl-
CoA consumed during conversion of glyoxylate to malate may prevent lifespan extension. 
3.3.5 Fumarase is required for lifespan extension induced by malate but not by  
fumarate 
Fumarase catalyzes the reversible conversion of fumarate to malate and is dually targeted 
to both the cytoplasm and mitochondria [30].  We performed a lifespan assay using fumarase 
(fum-1) RNAi knockdown worms in the presence and absence of malate (Fig. 3.4C). The mean 
lifespan of fum-1 knockdown worms was 66% of controls.  Strikingly, fum-1 knockdown 
prevented malate from increasing lifespan (log-rank, p=0.49). But in contrast to malate addition, 
fumarate addition, which is still able to be converted to succinate, did extend lifespan by 18% in 
fum-1 RNAi knockdown worms (Fig. 3.4D). Therefore, added malate must be metabolized by 
fumarase to form fumarate, running a portion of the TCA cycle backwards, to extend lifespan. 
3.3.6 Malate increased lifespan in sdha-1 RNAi knockdown worms, but not in sdha-2 and 
F48E8.3 RNAi knockdown worms 
There are three separate fumarate reductase isoforms in C. elegans. Two of them, sdha-1 
and sdha-2, are exchangeable subunits of the mitochondrial fumarate reductase/succinate 
dehydrogenase complex II of the respiratory chain and the other is a soluble cytoplasmic 
fumarate reductase F48E8.3.  There has been a report of a large decrease in sdha-2 expression in 
long-lived dauer larvae [20], but another group found no change [19]. SDHA-2 protein levels 
were downregulated in long-lived eat-2 worms [31].  Sdha-1 expression levels were unchanged 
[20] or slightly decreased [19] in dauers, while F48E8.3 was strongly upregulated [19, 20].  
F48E8.3 protein levels were not changed in eat-2 worms [31]. Proteomics analysis showed an 
70 
 
increase in sdha-1 levels with aging (data not shown).  It was hypothesized that the sdha-1/sdha-
2 ratio may influence lifespan by regulating the relative fumarate reductase to succinate 
dehydrogenase activity of complex II [19]. However, others hypothesized that complex II 
flavoprotein phosphorylation may play a role in controlling the relative fumarate reductase to 
succinate dehydrogenase activities [32]. 
To determine if sdha-1 plays a role in lifespan extension mediated by malate, we knocked 
it down by RNAi treatment and determined the lifespan in the absence and presence of malate.  
As shown in Fig. 5A, sdha-1 knockdown worms had a mean lifespan 78% of controls and malate 
treatment increased mean lifespan by 20%. The data indicate that sdha-1 does not likely play a 
role in lifespan extension by malate. We next knocked down sdha-2 by RNAi and determined the 
effect of malate treatment. Malate addition did not significantly alter the lifespan (log-rank 
p=0.95) (Fig.3. 5B).  We also knocked down the soluble fumarate reductase F48E8.3 by RNAi.  
These worms only lived 79% as long as controls.  Once again, malate addition did not extend 
lifespan and even caused a 10% decrease in lifespan (Fig. 3.5C). These experiments further 
confirm the role of fumarate reduction and the malate dismutation pathway in the lifespan 
extending effects of malate. 
3.3.7 The effect of malate on lifespan in flavin adenine dinucleotide (FAD) synthase RNAi 
knockdown worms 
One possible difference between succinate and malate metabolism and their different 
effects on lifespan is that following malate conversion to fumarate, fumarate is metabolized to 
succinate by fumarate reductase to increase the FAD/FADH2 ratio in the cell, while succinate 
conversion to fumarate has the opposite effect on the ratio. To gain insight into a possible role 
for FAD levels on lifespan extension by malate, we determined if malate could extend lifespan 
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when the flad-1 gene encoding FAD synthase, the terminal step in FAD synthesis, was knocked 
down by RNAi. As shown in Fig. 5D, flad-1 RNAi knockdown had a mean lifespan of 71% of 
the control, and malate treatment completely restored the lifespan back to that of the control.  
Therefore, FAD levels do not appear to be the limiting factor for malate-mediated lifespan 
extension. It is possible; however, that a low FAD/FADH2 ratio limits normal C. elegans lifespan 
under these growth conditions and malate treatment increases this ratio to increase lifespan. 
3.3.8 Malate, fumarate, and succinate treatment increased stress resistance 
Since many treatments and mutations that extend lifespan also increase stress resistance, 
we determined if malate, fumarate, or succinate could also increase the thermotolerance of the 
worms or decrease oxidative stress. As shown in Fig. 3.6A, malate increased the 
thermotolerance, the survival time of the worms at 38°C, by 32%, while succinate (log-rank 
p=0.03) and fumarate (log-rank p=0.12) were less protective, only increasing thermotolerance by 
13% and 10% respectively. The transcription factor SKN-1/Nrf is upregulated in C. elegans in 
response to oxidative stress and activates transcription of antioxidant genes such as glutathione-
S-transferase-4 (gst-4). By monitoring the fluorescence of a gst-4::gfp oxidative stress reporter 
worm strain [33], we found that malate, fumarate, and succinate all decreased endogenous 
oxidative stress and the oxidative stress following treatment with paraquat, a stimulator of 
mitochondrial reactive oxygen species production (Fig. 6B). Consistent with this protection, 
malate, fumarate, and succinate treatment all induced the nuclear translocation of DAF-16::GFP 
(Fig. 3.6C). 
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Figure 3.5.  Malate treatment did not increase the lifespan of sdha-2 and F48E8.3 RNAi knockdown 
worms.  (A) 10 mM malate increased the lifespan of complex II flavoprotein (sdha-1) RNAi knockdown 
N2 worms (log-rank p < 0.001). (B) 10 mM malate did not increase the lifespan of complex II 
flavoprotein (sdha-2) RNAi knockdown N2 worms (log-rank p =0.95).  (C) 10 mM malate decreased the 
lifespan of soluble fumarate reductase F48E8.3 RNAi knockdown N2 worms (log-rank p =0.002).  (D) 10 
mM malate increased the lifespan of FAD synthase (flad-1) RNAi knockdown N2 worms (log-rank p < 
0.001). 
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Figure 3.6.  Effects of malate, fumarate, and succinate on thermotolerance, oxidative stress, and DAF-
16::GFP nuclear translocation. (A) 10 mM malate increased thermotolerance (log-rank p < 0.001), while 
10 mM succinate (log-rank p = 0.03) and 10 mM fumarate (log-rank p = 0.12) had smaller protective 
effects.  C. elegans were grown at 20°C and then upshifted to 38°C.  (B) 10 mM malate, fumarate, or 
succinate treatment decreased GST-4::GFP fluorescence in the absence (* p < 0.05 compared to untreated 
N2) and in the presence of 10 mM paraquat (# p < 0.05 compared to paraquat treated N2).  (C) 10 mM 
malate, fumarate, or succinate treatment increased the nuclear translocation of DAF-16::GFP. 
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3.3.9 Malate treatment increased the NAD/NADH ratio and decreased the NADP/NADPH 
ratio 
An enhanced NAD/NADH ratio occurs in certain tissues during DR in rodents [8], and 
this ratio may be important for lifespan extension by activating sirtuins [34]. Therefore we 
cultured the worms for 4 days with malate or succinate and then measured NAD and NADH 
levels. As shown in Fig. 3.7A, malate addition greatly increased the NAD/NADH ratio. 
This result was surprising given that malate metabolism through the enzyme malate 
dehydrogenase converts NAD to NADH, which would yield opposite results.  Malate addition 
also strongly increased total NAD+NADH levels, which also occurs in certain tissues during DR 
in mice [8]. Succinate, which did not extend lifespan, showed a smaller increase in NAD levels.   
To determine if normal NAD(H) levels are required for malate-induced lifespan 
extension we individually knocked down two enzymes in the NAD synthesis pathway by RNAi 
and monitored lifespan (Table 3.1). We knocked down the NAD synthetase gene qns-1 and the 
nmnat-2 gene (W06B3.1) by RNAi.  Knocking down W06B3.1 decreased lifespan by 6% and 
fully prevented lifespan extension by malate addition, suggesting normal NAD(H) levels may be 
necessary for malate-mediated lifespan extension. However, qns-1 knockdown decreased 
lifespan by 24%, but malate addition increased lifespan by 13% (p=0.07). This somewhat 
inconclusive data indicates further research is necessary to determine the exact role that NAD(H) 
levels play in malate-mediated lifespan extension. 
We also measured NADP and NADPH levels following growth of C. elegans for 4 days 
with malate or succinate (Fig 3.7B). Malate treatment greatly increased NADPH levels to 
decrease the NADP/NADPH ratio, while succinate treatment also increased NADPH levels, but 
to a lesser extent than malate.  Both treatments also increased total NADP+NADPH levels. 
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3.3.10 The effects of malate, fumarate, and succinate on oxygen consumption, ATP levels, 
and mitochondrial membrane potential 
To determine if malate, fumarate, or succinate treatment had an effect on mitochondrial 
function, we measured worm oxygen consumption (Fig. 3.8A), ATP levels (Fig.3.8B), and 
mitochondrial membrane potential (Fig 3.8C). Growth in the presence of malate for 4 days led to 
an increase in the rate of oxygen consumption. Growth in the presence of fumarate also increased 
respiration, while growth in the presence of succinate decreased respiration. Culture of the 
worms with malate or succinate greatly decreased ATP levels, while the decrease of ATP 
following culture with fumarate was small. To determine if TCA cycle metabolite-treated worms 
increased muscle contraction to burn more ATP, we conducted thrashing experiments. Malate 
treated worms showed a slightly decreased rate of thrashing (84.8 ± 2.2 SEM body bends 
 
Figure 3.7. Malate treatment increased C. elegans NAD and NADPH levels more than succinate. (A)  
Relative NAD and NADH levels in day 4 worms cultured with 10 mM malate, 10 mM succinate, or no 
addition (* p < 0.05 compared to control).  (B)  Relative NADP and NADPH levels in day 4 worms 
cultured with 10 mM malate, 10 mM succinate, or no addition (* p < 0.05 compared to control).   
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per minute) compared to controls (94.4 ± 4.0 SEM body bends per minute) (p=0.04) while 
fumarate and succinate treatment resulted in no significant difference in the rate of thrashing 
(87.6 ± 3.3 and 92.8 ± 3.4 SEM body bends per minute, respectively) compared to controls. 
Therefore, decreased ATP levels are not a result of increased thrashing. 
One possible interpretation of the respiratory and ATP results is that malate and fumarate 
are inducing a mild uncoupling of oxidative phosphorylation. Therefore, we monitored the 
mitochondrial membrane potential (ΔΨ) with the cationic fluorescent dye TMRE (Fig. 3.8C).  
Worms grown in the presence of malate, fumarate, or the uncoupler FCCP showed decreased ΔΨ 
compared to control, with malate showing a robust decline, almost to the extent of FCCP. A non-
toxic 10 μM concentration of uncoupler, a concentration that was previously shown to extend 
lifespan [35] was chosen. Succinate treatment showed a non-significant decrease in ΔΨ.   
Therefore, mitochondrial uncoupling is likely the cause for the decreased ΔΨ and ATP levels 
occurring following treatment with malate and fumarate, while decreased respiratory activity is 
likely responsible for the decreased  ATP levels in succinate treated worms. 
3.3.11 Prevention of the malate-induced drop in ATP levels in aak-2, sir-2.1, and hif-1 
mutants and in gei-7 RNAi knockdown worms 
To discern more about the malate-induced drop in ATP levels and to gain insight into 
possible important upstream players of malate-induced signaling pathways, we measured ATP 
levels of different mutant and RNAi knockdown worms grown in the presence or absence of 
malate (Table 3.2). We discovered that malate addition caused a large increase in the ATP levels 
in aak-2(ok524) and sir-2.1(ok434) mutants, while a small increase in ATP levels was observed 
in the hif-1(ia4) mutant and gei-7 RNAi knockdown worms. Malate treatment decreased ATP to 
varying extents in the daf-16(mgDf50) and hsf-1(sy441) mutant strains and the skn-1, sdha-2, and 
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fum-1 RNAi knockdown worms.  This data suggests that SIR-2.1 and AAK-2 may be important 
upstream transducers of malate signaling. 
 
Figure 3.8. The effect of malate, fumarate, and succinate on respiration, ATP, and ΔΨ in C. elegans.  (A) 
The effect of 10 mM malate, fumarate, or succinate treatment on oxygen consumption in day 4 N2 worms 
(p < 0.001).  (B) The effect of 10 mM malate, fumarate, or succinate treatment on ATP levels in day 4 N2 
worms (p < 0.001). (C)  The effect of 10 mM malate, fumarate, or succinate or 10 μM FCCP treatment on 
ΔΨ in day 2 N2 worms. 
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Table 3.2  Effect of 10 mM malate on C. elegans ATP levels 
 
3.4 Discussion 
Mitochondrial electron transport chain function, which oxidizes NADH and FADH2, 
decreases with age across species [36].  This leads to a decreased cellular NAD/NADH ratio in 
specific tissues in aged organisms. Anti-aging therapies such as DR increase the NAD/NADH 
ratio in many tissues as a possible mechanism to delay aging.  We show for the first time that 
malate and fumarate addition extend lifespan in C. elegans, while succinate addition did not. 
Addition of the TCA cycle intermediates increased the NAD/NADH ratio, which may be 
important for the mechanism of lifespan extension. Malate and fumarate treatment also increased 
oxygen consumption and decreased ΔΨ, suggesting a mild mitochondrial uncoupling, while 
succinate treatment did not. The glyoxylate shunt and malate dismutation/fumarate reduction 
metabolic pathways were also necessary for lifespan extension. Activation of these pathways 
together with induction of mitochondrial uncoupling likely result in increased cellular NAD 
levels.  Increased NAD levels have been described to activate the histone deacetylase SIR-2.1 
[23] and AMP kinase [37] to increase lifespan. 
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3.4.1 Flavin and pyridine nucleotide levels in aging and lifespan extension   
Since fumarate conversion to succinate by fumarate reductase also oxidizes FADH2 to 
FAD, an increased FAD/FADH2 ratio may play a role in lifespan extension. Malate and fumarate 
likely induce large increases in the FAD/FADH2 and NAD/NADH ratios to extend lifespan, 
while succinate has a smaller effect on the NAD/NADH ratio and likely an opposite effect on the 
FAD/FADH2 levels. In this regard, administration of 5 μM FAD to a short-lived C. elegans 
frataxin RNAi knockdown strain extended lifespan to an extent that surpassed the untreated 
control worms [38]. We also have obtained data that FAD addition to the medium extends 
lifespan (manuscript in preparation).  FAD levels have been shown to decrease in many different 
tissues with age in rats [39], and levels were restored by exercise [40], which extends mean 
lifespan [41, 42]. 
Fumarate reductase has been shown to be essential for the growth of Sacchromyces 
cerevisiae under anaerobic conditions for the re-oxidation of FADH2 [43].  During the dauer state 
and other conditions that extend lifespan, C. elegans transitions to a metabolic state very similar 
to the one it enters during anaerobic conditions [44]. In dauer larvae, fumarate reductase activity 
and the glyoxylate cycle protein GEI-7 are upregulated [20], which decreases the amount of 
NAD reduced to NADH in the TCA cycle. However, oxygen is present under these conditions 
and electron transport chain complex I function continues to oxidize NADH. This metabolic 
transition increases the NAD/NADH ratio and may result in lifespan extension. 
3.4.2 Malate and fumarate may increase lifespan through increasing the NAD/NADH ratio 
Malate likely increases NADPH levels through the action of malic enzyme, converting 
malate to pyruvate with reduction of NADP to NADPH. Malate, as a TCA cycle intermediate, 
increases TCA cycle flux and electron transport chain activity to increase oxygen consumption.   
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However, the results that malate increased the NAD/NADH ratio and decreased ATP levels were 
quite unexpected and may be key to the mechanism of lifespan extension induced by malate.  
Since oxygen consumption was increased and ΔΨ was decreased by malate and fumarate, they 
likely induce mitochondrial uncoupling.  Uncoupling decreases ΔΨ, which often leads to reduced 
reactive oxygen species production. Mitochondrial uncouplers have been shown to extend 
lifespan in C. elegans [35, 45], consistent with the “uncoupling to survive” hypothesis of 
longevity [46]. 
Malate and fumarate may also increase lifespan by increasing mitochondrial respiration.  
Increased electron transport chain function relative to TCA cycle function will increase the 
NAD/NADH ratio, which may extend lifespan. In this regard, one research group has found a 
positive correlation between C. elegans oxygen consumption and lifespan. By examining 
lifespan following RNAi knockdown  of the frataxin gene, the authors proposed that 73% of the 
lifespan decline following frataxin knockdown was due to decreases in the oxygen consumption 
rate [47]. This research group suggests that high rates of respiration are necessary to produce the 
normal reactive oxygen species-mediated cell signaling required for a normal lifespan. They 
further went on to show that glucose restriction increases lifespan by stimulating mitochondrial 
respiration [48] and that daf-2 mutants show reduced glucose uptake, which stimulates 
mitochondrial oxidation of L-proline to increase oxygen consumption and increase lifespan [49].  
Malate and fumarate could also extend lifespan by decreasing the rate of decline of oxygen 
consumption over the lifespan. In this regard, a research group using eight different long and 
short-lived mutant strains, found a strong correlation between the inverse of the rate of decline of 
oxygen consumption with age and the lifespan [50]. For example, long-lived daf-2 worms 
showed a very slow rate of loss of oxygen consumption over their lifespan. 
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Another mechanism through which malate may increase the NAD/NADH ratio is through 
increasing the activity of the ETC, so more NADH is oxidized by complex I. This may be 
possible by activating the NADH-fumarate reductase (malate dismutation) system. Using this 
system, following oxidation of NADH by complex I, electrons can be passed to rhodoquinone 
instead of ubiquinone. Rhodoquinone passes electrons to membrane bound fumarate reductase 
(complex II), which terminally reduces fumarate to succinate. In order for this activity to lead to 
oxidation of NADH at a faster rate, complex I activity must be limited by the amount of oxidized 
coenzyme Q (ubiquinone). If this is true, increasing the amount of oxidized rhodoquinone by 
increasing fumarate levels could increase complex I activity to increase the NAD/NADH ratio.  
Using fumarate as a terminal electron acceptor would also result in decreased ATP levels as only 
one proton is pumped per NADH oxidized instead of 3 protons being pumped when oxygen is 
used as the terminal electron acceptor. Decreased electron flow through complex III of the ETC 
could decrease ROS production and be a mechanism of lifespan extension, as complex III is an 
important generator of ROS [51]. However, since malate addition increased oxygen consumption 
in the worms, fumarate reduction likely only plays a minor role in total ETC function under these 
conditions. 
Glyoxylate shunt activity also increases the NAD/NADH ratio as the shunt bypasses two 
of the three NADH generating reactions of the TCA cycle. We have also shown that glyoxylate 
shunt activity is required for the malate or fumarate-mediated increase in lifespan. The 
glyoxylate shunt gene gei-7 has been shown to be required for lifespan extension mediated by 
daf-16 in daf-2 insulin receptor mutants [52]. So it is not surprising that the glyoxylate shunt is 
also required for the lifespan extension mediated by TCA cycle metabolites, which is also daf-16 
dependent. 
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3.4.3 Does malate increase acetyl-CoA levels to increase lifespan?  
The glyoxylate shunt conversion of malate and CoA to glyoxylate and acetyl-CoA may 
be important for malate-mediated lifespan extension.  Other metabolites that potentially increase 
acetyl-CoA levels, such as pyruvate [15] and acetate [14], have also been shown to increase 
lifespan. Further support of an important role of increased acetyl-CoA levels in lifespan 
extension is that glyoxylate addition did not extend lifespan. Glyoxylate can be converted to 
malate, but at the expense of decreasing acetyl-CoA levels.  DR induces a metabolic shift from 
glucose oxidation to fatty acid oxidation that would also increase acetyl-CoA levels.  Histone 
acetyltransferases (HATs) utilize acetyl-CoA as a cofactor for acetylation of histone tails.  In this 
regard the HAT cpb-1/p300 is induced in daf-2 worms and by DR and is essential for full 
lifespan extension by these interventions in C. elegans [53]. The histone deacetylase inhibitors 
sodium butyrate and trichostatin A also increased lifespan in C. elegans.  In yeast it has been 
demonstrated that acetyl-CoA levels regulate protein acetylation [54] and that prevention of the 
acetylation of the gluconeogenic enzyme PEPCK blocks chronological lifespan extension 
induced by water starvation [55]. 
3.4.4 A proposed mechanism of how malate metabolism results in increased lifespan  
We hypothesize that addition of malate or fumarate to C. elegans somehow leads to 
activation of the glyoxylate shunt.  Regulation of the glyoxylate shunt has not been well studied 
in eukaryotes.  In Gram-negative bacteria, a dual function kinase/phosphatase AceK responds to 
changes in carbon source to control phosphorylation-induced inactivation of isocitrate 
dehydrogenase, which induces flux into the glyoxylate shunt [56]. Lysine acetylation of 
isocitrate lyase and AceK also regulate shunt activity [57]. Upregulation of shunt activity would 
increase NAD levels, which are known to activate AMP kinase [37] and sirtuins [58]. AMP 
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kinase activation can further increase NAD levels and sirtuin activity [59]. However, metabolism 
under these conditions likely becomes limited by FAD levels, so malate dismutation is activated 
to oxidize FADH2 to FAD.  SIR-2.1 is known to activate DAF-16 activity [60], which can lead to 
lifespan extension [61] and further upregulation of gei-7 expression [52] to amplify the lifespan 
extending signaling pathway. 
3.4.5 Does mitochondrial uncoupling play a role in malate-mediated lifespan extension? 
Malate-mediated mitochondrial uncoupling may be essential for lifespan extension. But 3 
experimental results are inconsistent with this suggestion. First, malate addition resulted in 
lifespan extension in hif-1 mutant worms, where ATP levels remain high, suggesting uncoupling 
is not occurring to a great extent in this strain, yet lifespan was still extended. Second, malate 
addition to daf-16 mutants resulted in a large decrease in ATP levels, which may indicate 
mitochondrial uncoupling was occurring, when no lifespan extension was induced.  However, 
one must be careful in ascribing decreases in ATP levels to decreases in oxidative 
phosphorylation. Changes in glycolysis and buffering ATP into phosphocreatine can also cause 
relatively quick changes in ATP levels without altering oxidative phosphorylation. And third, 
lifespan extension mediated by the uncoupler CCCP was described to be daf-16 independent 
[35], whereas the lifespan extension mediated by malate requires daf-16.  Further research needs 
to be performed to determine if activation of mitochondrial uncoupling, or, minimally, a 
decreased ΔΨ, is a common pathway of lifespan extension for compounds that extend C. elegans 
lifespan. In this regard we have found that a blueberry/green tea extract mixture that extended C. 
elegans lifespan also increased oxygen consumption and decreased ATP levels (data not shown).   
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3.4.6 Malate-induced lifespan extension compared to oxaloacetate-induced lifespan 
extension 
Unsurprisingly, the lifespan extension observed following malate addition was similar to 
that observed with oxaloacetate treatment [13].  For example, both required daf-16.  However, 
there were slight differences. Oxaloacetate was reported to extend median lifespan by 25%, 
while we report malate only increased mean lifespan by 14%. Under our liquid culture 
conditions we found that 10 mM oxaloacetate extended mean lifespan by 49% (data not shown).   
This larger effect than malate or fumarate may be due to a higher NAD/NADH ratio in 
oxaloacetate fed worms.  Also, we found that malate-induced lifespan extension was completely 
dependent upon the presence of sir-2.1, while oxaloacetate-induced lifespan was still increased 
in the absence of sir-2.1 [13]. This may be due to different growth conditions, either in liquid or 
on agar medium. 
The worms in most of our experiments were cultured in liquid S medium, which differs 
slightly in nutrient composition from nematode growth media (NGM) commonly used for 
culturing worms on agar. The liquid S medium contains 10 mM citrate (a TCA cycle metabolite), 
in addition to phosphate as a buffer, while the NGM agar lacks citrate, but contains peptone 
powder (2.5 g/l) absent in S medium. The added citrate may not be required for malate-mediated 
lifespan extension as we found that malate extended the lifespan of worms grown on NGM agar 
plates by 10% (see Table 1), but this should be further verified due to the small number of 
worms used in the experiment. Also, it has been reported that adding citrate  to the culture 
medium did not extend lifespan [14]. The worms grown in liquid medium are not dietarily 
restricted as eat-2 worms showed a robust increase in lifespan in liquid medium, as they do on 
agar plates. 
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3.4.7 TCA Cycle function is a key determinant of longevity 
Much data implicate TCA cycle function in the control of longevity. Many TCA cycle 
genes are upregulated in long-lived Ames dwarf and Little mice [62]. Brown Norway rats, a 
long-lived strain, do not shown declines in brain TCA cycle function with age in contrast to 
short-lived strains [63]. In yeast, glucose limitation increases chronological lifespan and 
upregulates TCA cycle gene expression [64]. Yeast mitochondrial ETC gene knockouts do not 
show extended chronological lifespan under DR conditions, but most TCA cycle gene knockouts 
showed even greater extension of lifespan than the wild-type yeast undergoing DR [65]. Yeast 
mutants with increased lifespan had increased levels of TCA cycle metabolites [66]. A 
downregulation of TCA cycle and ETC gene expression occurs in long-lived C. elegans dauer 
larvae [19] while long-lived daf-2 insulin receptor mutants show either unchanged [19] or 
decreased [67] TCA cycle gene expression with either unchanged [19] or increased [67] ETC 
gene expression. Mutations in the Drosophila Indy gene [68], a sodium coupled TCA cycle 
dicarboxylate and tricarboxylate carrier in the plasma membrane extend lifespan.  Similar results 
were found when two of the three C. elegans homologs of Indy were knocked down [69, 70]. But 
others failed to replicate these findings [71]. Knockdown of the mouse homolog of Indy resulted 
in DR-like phenotypes as well [72]. As a whole, there appears to be little consistency in these 
observations in different experimental models. However, proper coordination between ETC 
function and TCA function is likely necessary to maintain a normal to slightly high NAD/NADH 
ratio conducive to long life. High TCA cycle function with low ETC function is not favorable for 
extended lifespan because this would drive down mitochondrial and cellular NAD/NADH 
slowing important NAD-driven reactions likely necessary for extended lifespan. As another 
example, dietary restriction in mammals likely decreases flux through the TCA cycle while ETC 
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function is maintained throughout lifespan, resulting in an increased NAD/NADH ratio in 
several important tissues and lifespan extension. 
3.4.8 Succinate as a blocker of DR-induced longevity 
Since succinate, but not malate addition blocked lifespan extension in eat-2 worms, it is 
possible that reduction of fumarate to succinate or maintaining a high FAD/FADH2 ratio is 
essential for DR-induced longevity in C. elegans. Increased succinate levels likely decrease 
fumarate reductase activity through product inhibition.  However, since long-lived eat-2 worms 
were shown to have a 21-fold increase in the rate of [2-
14
C] acetate oxidation as measured by 
14
CO2 release [73], perhaps eat-2 worms increase both TCA cycle activity (at least the CO2 
generating portion of the cycle) and fumarate reduction to extend lifespan. Interestingly, 
proteomic experiments revealed that the glyoxylate cycle protein GEI-7 was down-regulated 
slightly in eat-2 worms [73], while GEI-7 is upregulated in long-lived dauer and daf-2 worms 
[19]. Therefore distinct metabolic programs may be activated to extend lifespan under these 
different conditions. 
3.4.9 Malate treatment has beneficial effects in mammals 
Although we showed an important role for the glyoxylate shunt and malate dismutation, 
metabolic pathways absent in mammals, in malate-mediated lifespan extension in C. elegans, 
malate treatment has been shown to be very beneficial in mammals as well.  Malate is found at 
high concentrations in unripened fruit, most notably in apples, and may contribute to some of the 
beneficial effects when these fruit are consumed. In addition, livers excised from aged rats that 
had been administered malate for 30 days displayed increased activities of complexes I, III, and 
IV of the electron transport chain (ETC) [74]. Malate also improved antioxidant function, 
leading to increased superoxide dismutase, glutathione peroxidase, reduced glutathione, and 
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decreased lipid peroxidation [75]. Malate supplementation also increased the activity of malate-
aspartate shuttle components [76]. However, malate had no effect on the decreased 
mitochondrial membrane potential measured in aged rat liver [74]. Therefore, many of the 
protective effects of malate treatment seem to be conserved from nematodes to mammals. 
3.4.10 Conclusion 
Malate and fumarate increased the lifespan of C. elegans, while succinate did not. The 
glyoxylate shunt and malate dismutation/fumarate reduction pathways and SIR-2.1 were required 
for malate-mediated lifespan extension. DAF-16 translocation to the nucleus and transcription of 
DAF-16 target genes also plays an essential role in malate-mediated lifespan extension.  
However, since succinate addition can also induce DAF-16 nuclear translocation without 
lifespan extension, other factors are also involved.  In this regard, further research should aim to 
elucidate the mechanisms through which addition of malate and fumarate to the culture medium 
lead to an uncoupling of mitochondrial oxidative phosphorylation and also determine if the 
FAD/FADH2 ratio plays a role in lifespan determination. Since fumarate, malate, and 
oxaloacetate extend lifespan in C. elegans through a mechanism similar to dietary restriction, an 
anaplerotic cocktail of these compounds may be useful for the treatment of human aging-
associated disorders. 
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3.5 Supporting information 
 
Figure 3.9. α-ketoglutarate addition did not alter the lifespan of C. elegans.  C. elegans N2 worms were 
grown in cell culture inserts in 12-well microplates fed heat-killed E. coli with media change every 3 days 
in the absence or presence of 10 mM α-ketoglutarate (log-rank p =0.21 vs. untreated control).  
 
 
Figure 3.10. Aspartate addition did not alter the lifespan of C. elegans. C. elegans N2 worms were grown 
in cell culture inserts in 12-well microplates fed heat-killed E. coli with media change every 3 days in the 
absence or presence of 10 mM aspartate (log-rank p = 0.57 vs. untreated control). 
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Figure 3.11. Malate and fumarate increased the lifespan of hif-1 mutant worms.  C. elegans hif-1(ia4) 
worms were grown in cell culture inserts in 12-well microplates fed heat-killed E. coli with media change 
every 3 days in the absence or presence of 10 mM malate (log-rank p < 0.001 vs. untreated control) or 10 
mM fumarate (log-rank p =0.02 vs. untreated control). 
 
Figure 3.12.  Glyoxylate addition did not alter the lifespan of C. elegans.  C. elegans N2 worms were 
grown in cell culture inserts in 12-well microplates fed heat-killed E. coli with media change every 3 days 
in the absence or presence of 10 mM glyoxylate (log-rank p =0.35 vs. untreated control). 
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CHAPTER 4 
MECHANISMS OF AMINO ACID-MEDIATED LIFESPAN EXTENSION IN 
CAENORHABDITIS ELEGANS
2
 
4.1 Abstract 
Little is known about the role of amino acids in cellular signaling pathways, especially as 
it pertains to pathways that regulate the rate of aging. However, it has been shown that 
methionine or tryptophan restriction extends lifespan in higher eukaryotes and increased proline 
or tryptophan levels increase longevity in C. elegans. In addition, leucine strongly activates the 
TOR signaling pathway, which when inhibited increases lifespan. 
Therefore each of the 20 proteogenic amino acids was individually supplemented to C. 
elegans and the effects on lifespan were determined. All amino acids except phenylalanine and 
aspartate extended lifespan at least to a small extent at one or more of the 3 concentrations tested 
with serine and proline showing the largest effects. 11 of the amino acids were less potent at 
higher doses, while 5 even decreased lifespan.  Serine, proline, or histidine-mediated lifespan 
extension was greatly inhibited in eat-2 worms, a model of dietary restriction, daf-16/FOXO, sir-
2.1, rsks-1 (ribosomal S6 kinase), gcn-2, and aak-2 (AMPK) longevity pathway mutants and in 
bec-1 autophagy-defective knockdown worms. 8 of 10 longevity-promoting amino acids tested 
activated a SKN-1/Nrf2 reporter strain, while serine and histidine were the only amino acids 
from those to activate a hypoxia-inducible factor (HIF-1) reporter strain. Thermotolerance was 
increased by proline or tryptophan supplementation, while tryptophan-mediated lifespan 
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extension was independent of DAF-16/FOXO and SKN-1/Nrf2 signaling, but tryptophan and 
several related pyridine-containing compounds induced the mitochondrial unfolded protein 
response and an ER stress response. High glucose levels or mutations affecting electron transport 
chain (ETC) function inhibited amino acid-mediated lifespan extension suggesting that 
metabolism plays an important role.  Providing many other cellular metabolites to C. elegans 
also increased longevity suggesting that anaplerosis of tricarboxylic acid (TCA) cycle substrates 
likely plays a role in lifespan extension.  
Supplementation of C. elegans with 18 of the 20 individual amino acids extended 
lifespan, but lifespan often decreased with increasing concentration suggesting hormesis.  
Lifespan extension appears to be caused by altered mitochondrial TCA cycle metabolism and 
respiratory substrate utilization resulting in the activation of the DAF-16/FOXO and SKN-1/Nrf2 
stress response pathways. 
4.2 Background 
In C. elegans nematodes free amino acid concentrations change with age [1] and are 
altered in long-lived worms [2]. In humans, altered plasma amino acid concentrations are 
biomarkers of several diseases [3] such as type 2 diabetes [4]. Calorie restriction has long been 
known to delay aging [5] and protein restriction may be responsible for around half of this effect 
[6].  Methionine [7, 8] or tryptophan [9, 10] restriction partially mimics protein restriction to 
extend lifespan and delay aging-related disease in rodents. But the role that other amino acids 
play in longevity and disease has been harder to elucidate. In this regard, experiments with yeast, 
worms, and fruit flies are increasingly being used to address this issue. 
Using the yeast Saccharomyces cerevisiae, it was first discovered that supplementation 
with the branched chain amino acids (leucine, isoleucine, or valine) or threonine extended 
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chronological lifespan by downregulating the general amino acid control (GAAC) pathway [11].  
Others found that glutamate supplementation extended chronological lifespan [12]. Consistent 
with the ability of glutamate to extend lifespan, deletion of genes involved in converting 
glutamate to gamma-aminobutyric acid (GABA) increased replicative lifespan [13] and led to 
increased conversion of glutamate to alpha-ketoglutarate and other TCA cycle intermediates, 
which may be involved in lifespan extension by maintaining mitochondrial respiratory function.  
Others using different conditions found that supplementation with serine, threonine, or valine 
decreased chronological lifespan [14] while limitation of asparagine [15], methionine, aspartate, 
or glutamate [12] extended lifespan. Further research using yeast deletion strains of differing 
lifespans found that intracellular levels of many amino acids positively correlated with lifespan 
[16]. 
In Drosophila, dietary restriction (DR) or protein restriction [17] extends lifespan and 
supplementing methionine in combination with one or more of the essential amino acids  
decreased the lifespan back to the fully fed level [18]. Interestingly, adding methionine by itself 
to DR flies increased protein translation [19] and fecundity [18] without decreasing lifespan, 
uncoupling these events. Increased levels of amino acids, especially leucine [20, 21], activate the 
TOR kinase, which leads to an increased rate of translation. Inhibition of the TOR kinase with 
rapamycin [22] or expressing a dominant negative p70-S6 kinase, a kinase downstream of TOR, 
extended organismal longevity [23]. Metabolism of sulfur containing amino acids was shown to 
be essential for DR-mediated longevity in Drosophila [19], but supplementation of cysteine or 
methionine failed to extend lifespan in fully fed Drosophila [24, 25]. However, supplementing 
casein and methionine together led to lifespan extension [24].  
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In C. elegans, proline supplementation extended lifespan that relied upon its catabolism 
and a transient increase in reactive oxygen species (ROS) production from the mitochondrial 
electron transport chain [26]. Increased tryptophan levels also increased longevity in C. elegans 
as knockdown of an enzyme that catabolizes tryptophan increased lifespan [27]. Unexpectedly, 
knockdown of an aromatic amino acid transporter also extended lifespan [28], suggesting that 
decreased tryptophan or other aromatic amino acid levels may also boost longevity. Others found 
that decreased tyrosine degradation led to increased longevity, but surprisingly supplementation 
of tyrosine to the culture medium did not extend lifespan [29]. The majority of amino acid pool 
sizes are upregulated in long-lived worms [2]. In daf-2 insulin-receptor deficient worms, for 
example, the levels of 8 of the 12 measured amino acids were increased, including the 3 
branched chain amino acids. The branched chain amino acids are of special interest for longevity 
research, since their levels decreased  to wild-type levels in the normal-lived daf-2/daf-16 double 
mutants [2].   
Feeding mice a diet high in branched chain amino acids led to increased mitochondrial 
biogenesis in muscle, decreased ROS production, and  increased average lifespan of males [30].  
However, branched chain amino acid levels declined in long-lived metformin-treated worms 
[31], and increased plasma levels of branched chain amino acids are correlated with the 
development of insulin resistance and type 2 diabetes in humans [32]. Furthermore, studies 
correlating high levels of free amino acids with longevity must be interpreted with caution as a 
decreased rate of translation is frequently associated with or even required for longevity and the 
increased amino acid pools may just be a result of that decreased rate of protein synthesis [33, 
34].   
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Due to the incomplete knowledge of the effects of amino acids on longevity as well as the 
widespread use of amino acid and protein supplementation in the human diet we determined the 
effects of individual amino acid supplementation on C. elegans lifespan. We found that the vast 
majority of amino acids extended lifespan and further determined many of the signaling 
pathways required.  We then tested the ability of several amino acids or tryptophan catabolites to 
induce a heat shock response, the ER stress response, or the mitochondrial unfolded protein 
response, which frequently accompany lifespan extension. The amino acids that extended 
lifespan to the greatest extent were then tested for effects on stress resistance and proteotoxicity. 
4.3 Results 
4.3.1 The effects of individual L-amino acids on the lifespan of C. elegans 
We determined the effects of individually supplementing the 19 L-amino acids or glycine 
on the lifespan of C. elegans at 1 mM (Figure 4.1A), 5 mM (Figure 4.1B), and 10 mM (Figure 
4.1 C) concentrations. The percent change of mean lifespan compared to that of untreated 
controls performed at the same time is also shown as a table. C. elegans worms were grown in 
liquid S medium with heat-killed E. coli as food. Heat killing prevented or at least greatly 
reduced bacterial catabolism of the added amino acid. Unlike nematode growth medium (NGM) 
which is standardly used, the S medium contains no peptone, so the bacterial food source and the 
supplemented amino acid are the only sources of dietary amino acids. The worms feeding on 
heat-killed bacteria had a mean lifespan of 17.2 +/- 0.3 days.  At a 1 mM concentration, the 
amino acids that extended lifespan to the greatest extent (14-17%) were proline, leucine, 
glutamine, glutamate, and tryptophan. At a 5 mM concentration, the greatest lifespan extension 
was observed with proline, serine, cysteine, and glutamine (16-19%). At this concentration 
phenylalanine decreased lifespan (8%). Lastly, at a 10 mM concentration, the greatest increases 
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in longevity were observed with serine, proline, arginine, and methionine addition (14-22%). 
Asparagine, aspartate, phenylalanine, glutamine, and glutamate decreased lifespan at this 
concentration (6-25%). 5 of the amino acids increased lifespan with increasing concentration 
from 1 to 10 mM (arginine, histidine, methionine, threonine, and serine), while 7 of the amino 
acids decreased lifespan with increasing concentration in this range (aspartate, glutamate, 
glycine, phenylalanine, tryptophan, tyrosine, and valine). 3 of the amino acids had the greatest 
lifespan extension at the 5 mM concentration (asparagine, cysteine, and glutamine), while the 5 
mM concentration yielded the least lifespan extension for alanine. Example lifespan curves for 
serine, proline, histidine, and tryptophan at concentrations that yielded the greatest effects on 
mean lifespan are shown. 
4.3.2 The rate of amino acid uptake may limit the effect on lifespan 
To determine if the rate of transport of amino acids into the worms may have limited their 
effects on lifespan, we administered the cell-permeable histidine analogs N-acetyl-histidine or 
histidine methylester, which get cleaved by intracellular enzymes to form histidine and 
monitored lifespan (Table 4.1). These compounds yielded greater lifespan extension than 
histidine at the 1 mM dose, suggesting that the rate of transport of the amino acids into the 
worms is likely limiting their effect on lifespan. The highest concentration of histidine methyl 
ester (10 mM) did not extend lifespan as expected for a hormetic dose response. If the same 
observation made for histidine holds for other amino acids, then the rate of amino acid 
absorption by the intestine may be an important factor controlling their ability to extend lifespan. 
The rate of transport of hydrophilic antioxidant compounds into C. elegans has also been shown 
to limit their effect on lifespan [35]. 
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4.3.3 The effects of D-amino acids on the lifespan of C. elegans 
To determine if the effects on lifespan were specific for L-amino acids, we also 
determined if there were effects on longevity when supplementing the 4 D-amino acids found 
endogenously in C. elegans [36], D-alanine, D-serine, D-aspartate, or D-glutamate (Table 4.1) as 
well as D-proline (Table 4.1), which is found naturally at low concentrations in mammals [37]. 
D-alanine and D-asparatate showed greater lifespan extension then their corresponding L-
isomers. D-glutamate addition yielded effects on lifespan somewhat similar to its corresponding 
L-isomer. In contrast to the strong pro-longevity effects observed with L-serine, D-serine 
supplementation did not lead to lifespan extension at any of the concentrations added and even 
slightly decreased lifespan at the higher concentrations. And lastly, D-proline supplementation 
did not extend lifespan as well. These lifespan results are consistent with metabolism of the D-
amino acids being required for lifespan extension as D-alanine, D-aspartate, and D-glutamate are 
present in the E. coli food source and have been shown to be catabolized by the products of the 
C. elegans genes daao-1, ddo-1, and ddo-3, respectively. D-serine was not found to be present in 
the E. coli diet, but was instead found to be synthesized endogenously by C. elegans. However, 
no C. elegans enzyme has yet been found to mediate D-serine [36] or D-proline degradation. 
4.3.4 Amino acid-mediated lifespan extension, except for tryptophan, is DAF-16 dependent 
To determine if lifespan extension induced by amino acids requires specific longevity 
pathways, individual amino acids were administered to mutants of known longevity pathways at 
the concentration that maximally extended lifespan. First, the amino acids alanine, cysteine, 
glutamine, histidine, lysine, proline, serine, tryptophan, and tyrosine were individually 
supplemented to short-lived daf-16(mgDf50) mutants (Table 4.2). DAF-16/FOXO is a central 
transcription factor that translocates to the nucleus to activate a stress response program in 
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insulin-receptor signaling-deficient worms [38]. Tryptophan was the only supplemented amino 
acid that extended lifespan in the daf-16 mutant strain indicating tryptophan activates a longevity 
pathway independent of daf-16, while the other 8 amino acids require DAF-16 mediated gene 
expression for the increased longevity. Cysteine and histidine even decreased lifespan when 
supplemented to this strain.    
To confirm that amino acids activate DAF-16 transcriptional activity, we measured the 
fluorescence of a sod-3p::gfp DAF-16 reporter strain of worms following culture in the presence 
of individual amino acids (Figure 4.2A).  As expected from the lifespan data, serine and proline 
increased fluorescence of these worms. The presence of tryptophan also increased fluorescence, 
so tryptophan likely activates both DAF-16-dependent and DAF-16-independent pathways for 
lifespan extension. There was also a strong trend for leucine to increase fluorescence.  
Unexpectedly, histidine did not increase expression of sod-3p::gfp. The reasons for this finding 
are unclear as we found that DAF-16 was required for histidine-mediated lifespan extension. 
4.3.5 Most amino acids activate SKN-1 transcriptional activity  
The SKN-1/Nrf2 signaling pathway increases cellular antioxidant and detoxification gene 
expression to extend lifespan. We determined the effect of serine, tryptophan, histidine, or 
proline addition on lifespan of skn-1 knockdown worms.  As shown in Table 4, tryptophan or 
serine supplementation extended lifespan, but not to the extent as in control worms, while there 
were only insignificant trends toward increased lifespan following histidine or proline addition.  
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Figure 4.1. Individual supplementation of most amino acids extends mean lifespan in C. elegans.  Mean 
lifespan of C. elegans supplemented with a (A) 1 mM, (B) 5 mM, or (C) 10 mM concentration of each of 
the 20 amino acids (* log rank p < 0.05 vs. control). 
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Table 4.1  The effects of D-amino acids and membrane-permeable L-histidine analogs on C. 
elegans N2 lifespan. 
Treatment Concentration % of 
untreated 
mean lifespan 
p-value # of 
worms 
Replicates 
D-alanine 1 mM 
114 <0.001 219 
2 
5 mM 
116 <0.001 273 
2 
10 mM 
116 <0.001 240 
2 
D-aspartate 1 mM 
107 0.024 233 2 
5 mM 
118 <0.001 269 2 
10 mM 
108 <0.001 228 
2 
D-glutamate 1 mM 
114 <0.001 207 
2 
5 mM 
118 <0.001 249 2 
10 mM 
97 0.165 232 2 
D-serine 1 mM 
100 0.600 209 2 
5 mM 
91 <0.001 198 2 
10 mM 
93 <0.001 220 2 
D-proline 5 mM 
101 0.734 113 2 
N-acetyl-L-histidine 0.1 mM 
103 0.383 142 2 
1 mM 
112 0.002 188 2 
10 mM 
110 0.008 196 2 
L-histidine methyl ester 0.1 mM 
108 <0.001 215 2 
1 mM 
109 <0.001 246 2 
10 mM 
104 0.11 193 2 
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Table 4.2. The effects of amino acids on lifespan in daf-16 mutant and skn-1 knockdown C. 
elegans 
 
Strain Treatment % of N2 
mean 
lifespan 
% of 
untreated 
mean 
lifespan 
p-value # of 
worms 
Replicates 
daf-16(mgDf50) control 73 
 
<0.001 608 7 
5 mM histidine  92 <0.001 286 2 
5 mM proline  106 0.0871 133 2 
1 mM alanine  102 0.111 107 2 
1 mM tryptophan  118 0.008 183 2 
10 mM serine  105 0.104 161 2 
10 mM glutamine  95 0.107 125 2 
5 mM cysteine  95 0.107 115 2 
10 mM cysteine  81 <0.001 105 2 
5 mM tyrosine  96 0.578 140 2 
5 mM lysine  99 0.907 130 2 
N2 (skn-1 
RNAi) with live 
bacteria 
control  59 
 
<0.001 156 3 
1 mM tryptophan  107 0.042 125 3 
10 mM serine  107 0.01 175 3 
5 mM histidine  103 0.296 139 3 
5 mM proline  105 0.088 111 2 
N2 with live 
bacteria 
control - 
  
298 5 
1 mM tryptophan  109 <0.001 317 5 
10 mM serine  109 <0.001 375 5 
5 mM histidine  110 <0.001 277 5 
5 mM proline  108 <0.001 268 4 
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Figure 4.2. The effects of amino acid addition on DAF-16, SKN-1, and HIF-1-mediated gene expression. 
(A) The effects of amino acid addition on sod-3p::GFP fluorescence as a measure of DAF-16 
transcriptional activity.  (B) and (C)  The effects of amino acid addition on gst-4p::GFP fluorescence as a 
measure of SKN-1 transcriptional activity.  (D) and (E) The effects of amino acid addition on nhr-
57p::GFP fluorescence as a measure of HIF-1 transcriptional activity. 20 µM potassium cyanide was 
used as a positive control (* p < 0.05). 
 
To further check the ability of amino acids to activate SKN-1, we used a gst-4p::GFP SKN-1 
reporter strain of worms (Figure 4.2B and Figure 4.2C). We found that 8 of the 10 amino acids 
tested that increased lifespan increased GFP expression of the reporter strain. Amino acids that 
activated gst-4p::GFP expression included serine, proline, glutamine, alanine, leucine, lysine, 
and tyrosine, while tryptophan and cysteine did not. We also tested the effects of 2 amino acids, 
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phenylalanine and asparagine, which decreased lifespan on the fluorescence of this reporter 
strain and observed no induction of expression. Overall, there was a small correlation between 
the amount of SKN-1 activity and the extent of lifespan extension as serine and proline extended 
lifespan to the greatest extent and also increased fluorescence of the SKN-1 reporter strain to the 
greatest extent.  It has previously been hypothesized that proline catabolism transiently increases 
ROS production that leads to SKN-1 activation [26]. Our results are consistent with this 
hypothesis. Cysteine is a strong antioxidant and likely quenched ROS required for SKN-1 
activation likely explaining the lack of activation by this amino acid.       
The RNAi feeding experiments require live bacteria, while heat-killed bacteria were used 
in all other lifespan experiments. It is possible that the live bacteria used in the SKN-1 RNAi 
lifespan experiments metabolized the added amino acids dampening the degree of lifespan 
extension. Therefore, we performed control experiments supplementing amino acids to C. 
elegans feeding on live control HT115(DE3) E. coli.  C. elegans fed live control bacteria had a 
mean lifespan of 16.1 +/- 0.2 days, slightly less than worms fed heat-killed bacteria (mean 
lifespan of 17.2 +/- 0.3 days). Histidine extended lifespan to a similar extent in the presence of 
live or heat-killed bacteria as shown (Table 4.2). However, tryptophan-induced lifespan 
extension was slightly blunted by the use of live bacteria, and serine or proline-induced lifespan 
extension was blunted by roughly 50% by the use of live bacteria. A faster rate of E. coli 
catabolism of serine and proline than tryptophan and histidine likely explain these observations. 
4.3.6 Histidine and serine increase HIF-1 target gene expression 
The hypoxia-inducible factor-1 (HIF-1) protein is degraded quickly during standard 
conditions, but is stabilized during hypoxia or by other specific stresses to increase lifespan in C. 
elegans [39]. Therefore, we tested the HIF-1 reporter strain nhr-57p::GFP [39] for amino acid-
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induced changes in GFP fluorescence (Figure 4.2D and Figure 4.2E). Cyanide was used as a 
positive control as it inhibits cytochrome c oxidase, the protein complex which binds molecular 
oxygen, the terminal electron acceptor in the electron transport chain, to mimic the effects of 
hypoxia on mitochondria. We found that histidine or serine increased fluorescence, while 
tryptophan, proline, tyrosine, alanine, cysteine, glutamine, lysine, or leucine did not. These data 
indicate that stabilization of HIF-1 may be one of the mechanisms through which histidine and 
serine extend lifespan, although lifespan experiments with HIF-1 mutant worms are needed to 
confirm this hypothesis. 
4.3.7 Amino acid-mediated lifespan extension is AAK-2 (AMPK) dependent     
Next we individually administered C. elegans our test set of 10 amino acids except 
leucine to aak-2(gt33) worms, which are depleted of one of the two catalytic subunit of AMP-
activated protein kinase (AMPK) and performed lifespan analysis (Table 4.3). AMPK signaling 
inhibits target of rapamycin (TOR) kinase signaling to stimulate autophagy to recycle cellular 
components. AMPK also stimulates the sirtuin deacetylase SIR-2.1, SKN-1/Nrf2, and DAF-
16/FOXO pro-longevity pathways [40]. None of the amino acids extended lifespan in this mutant 
strain.  Tyrosine decreased lifespan while the other 8 amino acids tested had no significant effect.  
Therefore, AAK-2 is required for the longevity benefits provided by the amino acids. 
4.3.8 Many amino acids require SIR-2.1 for lifespan extension 
Next the effects of individual supplementation of these same 9 amino acids as well as 
phenylalanine on lifespan of the sir-2.1(ok434) NAD-dependent sirtuin deacetylase mutant were 
determined (Table 4.3). Small to moderate lifespan increases occurred with cysteine, glutamine, 
lysine, and low dose phenylalanine supplementation, but there were no significant effects of 6 
other amino acids tested on the lifespan of this strain. Therefore SIR-2.1 was required for 
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lifespan extension mediated by slightly more than half of the amino acids tested. Surprisingly, 
high dose (10 mM) phenylalanine supplementation did not lead to a decreased lifespan in this 
strain as it did in the N2 control worms. 
4.3.9 Amino acids do not significantly extend lifespan in long-lived DR worms 
Restricting a specific amino acid such as methionine from the diet can be utilized to 
extend lifespan and gain some of the benefits of dietary restriction (DR) [8], but there is not 
much evidence that specific amino acid supplementation can yield enhanced longevity effects.  
Therefore, we administered individual amino acids to eat-2(ad1116) mutants that are dietarily 
restricted and long-lived because of reduced pharyngeal pumping. The non-treated control eat-2 
mutants had a mean lifespan 44% longer than N2 controls indicating that our control worms 
were not dietarily restricted under our growth conditions. None of the 5 amino acids tested 
yielded statistically significant lifespan extension (Table 4.3). However, 4 of the amino acids 
yielded strong trends toward lifespan extension (p-values between 0.08 and 0.10). Therefore the 
individual amino acids are likely utilizing some portion of the DR signaling pathway for lifespan 
extension. 
4.3.10 Autophagy is required for the lifespan extension induced by serine, proline, or 
histidine supplementation, but not by tryptophan 
Since autophagy has been shown to be required for DR-mediated lifespan extension [41], 
we determined if autophagy was also required for amino acid-mediated longevity. To block 
autophagy we knocked down bec-1, the C. elegans Beclin-1 homolog and monitored lifespan 
following supplementation with serine, proline, histidine, or tryptophan.  
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Table 4.3. The effects of amino acids on lifespan in aak-2, sir-2.1 and eat-2 mutant and bec-
1 knockdown worms 
       
Strain Treatment 
% of N2 
control 
mean 
lifespan 
% of 
untreated 
mean lifespan 
p-value 
# of 
worms 
Replicates 
aak-
2(gt33) 
control 80  <0.001 786 8 
5 mM histidine  100 0.877 189 2 
5 mM proline  100 0.919 187 2 
1 mM alanine  100 0.943 209 2 
1 mM tryptophan  102 0.060 220 2 
10 mM serine  101 0.137 204 2 
5 mM lysine  87 0.373 180 2 
5 mM cysteine  85 0.952 140 2 
10 mM cysteine  90 0.122 145 2 
5 mM tyrosine  80 <0.001 200 2 
5 mM glutamine  94 0.436 180 2 
10 mM glutamine  103 0.126 200 2 
sir-
2.1(ok434) 
control 86 
 
<0.001 299 4 
5 mM histidine  100 <0.830 154 2 
5 mM proline  104 0.211 114 2 
1 mM alanine  98 0.225 165 2 
1 mM tryptophan  102 0.673 121 2 
10 mM serine  101 0.482 136 2 
10 mM glutamine  110 <0.001 180 2 
5 mM cysteine  105 0.244 192 2 
10 mM cysteine  110 <0.001 190 2 
5 mM tyrosine  93 0.231 131 2 
5 mM lysine  107 0.017 146 2 
1 mM phenylalanine  105 0.049 155 2 
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Strain Treatment 
% of N2 
control 
mean 
lifespan 
% of 
untreated 
mean lifespan 
p-value 
# of 
worms 
Replicates 
10 mM phenylalanine  101 0.402 176 2 
eat-
2(ad1116) 
control 142 
 
<0.001 135 2 
10 mM serine  108 0.078 161 2 
1 mM tryptophan  105 0.099 138 2 
5 mM glutamine  100 0.841 134 2 
5 mM histidine  106 0.091 153 2 
5 mM proline  107 0.076 176 2 
N2 (bec-1 
RNAi) 
with live 
bacteria 
control 123  <0.001 184 2 
1 mM tryptophan  107 <0.001 162 2 
10 mM serine  101 0.316 152 2 
5 mM histidine  99 0.274 117 2 
5 mM proline  98 0.09 102 2 
 
Knockdown of bec-1 by RNAi feeding increased lifespan as has previously been shown 
in [42] and prevented lifespan extension induced by supplementation with serine, proline or 
histidine, but not by tryptophan (Table 4.3).Therefore, the majority of amino acids, but not 
tryptophan, require autophagy for lifespan extension, once again suggesting that tryptophan 
extends lifespan through a mechanism distinct from other amino acids.   
The PHA-4/FOXA transcription factor is required for induction of autophagy and 
lifespan extension in response to DR. In addition, expression of the PHA-4 transcription factor 
has been shown to be upregulated by roughly 50% by DR [43]. Therefore, we determined if 
individual amino acid administration could increase PHA-4 protein levels by using a strain of 
Table 4.3 (Continued) 
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worms engineered to express PHA-4:GFP:3xFLAG using the endogenous pha-4 promoter [44]. 
Surprisingly, we found that serine, histidine, or tryptophan addition did not alter the GFP 
fluorescence of this strain. However, leucine addition resulted in a strong trend toward increased 
fluorescence (p=0.08). On the whole, individual amino acid supplementation did not appear to 
have much of an effect on fluorescence in this strain. However, we cannot yet rule out the 
possibility that changes in PHA-4 localization or post-translational modification play a role in 
individual amino acid-induced longevity.  It is also possible that the added GFP and FLAG tags 
affect the stability of the protein.  Lifespan studies using pha-4 RNAi are needed to determine a 
role, if any, for PHA-4 in amino acid-mediated lifespan extension. 
4.3.11 Inhibition of TOR signaling plays a role in amino acid-mediated lifespan extension 
Specific amino acids, most notably leucine, but also to a lesser extent arginine and glutamine can 
be activators of the TOR signaling pathway that limits lifespan [45]. Administering rapamycin, a TOR 
inhibitor, or feeding TOR RNAi to C. elegans induces autophagy and extends lifespan [46, 47]. More 
recently it was found that alpha-ketoglutarate supplementation can lead to TOR inhibition to extend 
lifespan [48]. Knockout or knockdown of the ribosomal S6 kinase, which is downstream of TOR kinase 
in the signaling pathway, also extends lifespan [49]. Part of this effect may rely on a decreased rate of 
protein translation as inhibitors of protein translation can also extend lifespan [49]. Therefore, we 
determined the effects of specific amino acids on lifespan in long-lived rsks-1(ok1255) ribosomal S6 
kinase mutants, where this arm of the TOR signaling pathway is inhibited (Table 4). Unlike the results 
with N2 control worms, addition of serine or tryptophan did not alter the lifespan of this strain, 
while proline or histidine addition slightly decreased lifespan, and tryptophan addition decreased 
lifespan by 20%. Therefore, these amino acids appear to use inhibition of TOR signaling to 
mediate lifespan extension, as the amino acids did not extend lifespan in long-lived mutant 
worms where TOR signaling was already disrupted. 
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4.3.12 A decreased rate of translation is required for the full lifespan extending effects of 
amino acids 
GCN-2 (general control nonderepressible-2) kinase can slow the rate of translation 
initiation by phosphorylating eukaryotic translation initiation factor-2 alpha (eIF-2α) when 
tRNAs become uncharged due to low amino acid levels [34] or in times of mitochondrial 
metabolic stress [33]. We hypothesized that amino-acid supplementation causing amino acid 
imbalance could result in inefficient tRNA charging or cause metabolic stress signaling through 
GCN-2 to extend lifespan. Therefore, we determined the lifespan of gcn-2(ok871) mutants 
supplemented with individual amino acids (Table 4.4). We found that histidine or tryptophan 
supplementation did not lead to increased longevity when using this strain, while only a 4% or 
7% lifespan extension occurred when serine or proline, respectively, were supplemented. To 
further determine a role for decreased translation in amino acid imbalance-mediated longevity, 
we performed lifespan analysis using the ife-2(ok306) strain [50], which is deficient in an 
isoform of the translation initiation factor eIF4E and shown to be long-lived. Surprisingly, under 
our liquid culture conditions using heat-killed bacteria as food, the lifespan of this strain was not 
significantly different than the control. However, supplementation of serine, proline, histidine, or 
tryptophan to this strain did not lead to extended lifespan, while tryptophan addition even 
slightly decreased lifespan. Therefore signaling to slow the rate of translation is likely a general 
mechanism involved in individual amino acid-mediated increased longevity. 
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4.3.13 The effect of individual amino acids on the lifespan of mitochondrial ETC complex I 
and II mutants 
To test the hypothesis that mitochondrial ETC activity is important for amino-acid 
induced lifespan extension we supplemented serine, histidine, or proline to either short-lived 
mitochondrial ETC complex I defective gas-1(fc21) mutant worms or to short-lived 
mitochondrial ETC complex II defective mev-1(kn1) mutant worms (Table 4.4). We found that 
proline supplementation extended the lifespan of gas-1 mutants, but that serine or histidine were 
unable to extend lifespan, although there was a strong trend with histidine (p=0.09). When we 
supplemented each of these 3 amino acids to mev-1 mutants, we found opposite effects. Proline 
did not extend lifespan, although a strong trend was observed (p=0.10), while serine and 
histidine extended lifespan. Therefore normal complex I (NADH dehydrogenase) activity is 
required for the full serine and histidine-mediated lifespan extension, while normal complex II 
activity is required for proline-mediated lifespan extension. This data may be explained in that 
proline dehydrogenase generates FADH2 which feeds electrons into the ETC at complex II and 
histidine and serine catabolism generates NADH that feeds electrons into the ETC at complex I.  
4.3.14 Most supplemented metabolites extended lifespan at an optimal concentration 
Since supplementation with an optimal concentration of most amino acids extended the 
lifespan of the worms, it is possible that their breakdown to TCA cycle intermediates may play a 
role in lifespan extension. It has previously been shown that supplementation with pyruvate [51], 
acetate (that can be readily metabolized to the TCA cycle substrate acetyl-CoA) [52], or the TCA 
cycle intermediates malate, fumarate [53], oxaloacetate [54], and alpha-ketoglutarate [48] 
extended lifespan in C. elegans. We therefore determined the lifespan of the worms individually 
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supplemented with 1, 5, or 10 mM concentrations of the TCA cycle intermediates citrate, 
isocitrate, alpha-ketoglutarate, or succinate (Table 4.1). 
We previously found that 10 mM succinate did not extend lifespan, but did induce 
translocation of the pro-longevity factor DAF-16 to the nucleus [53]. But here we find that 
lowering the concentration of succinate to 5 mM or 1 mM resulted in lifespan extension (Figure 
4.3A), consistent with a recent report of a longevity benefit [48].  Citrate is present at 10 mM in 
all of our experiments as a standard buffer component of the S-medium.  We found that 
removing it did not affect the lifespan (Figure 4.3B).  Previous findings also failed to find an 
extension of lifespan with citrate supplementation [48, 52]. We found that alpha-ketoglutarate at 
any of the 4 concentrations tested from 0.1 to 10 mM extended lifespan (Figure 3C), as recently 
reported for an 8 mM dose [48].  Adding DL-isocitrate to the medium led to an increase in 
lifespan at the 5 mM concentration, but a decrease in lifespan at the 10 mM concentration 
(Figure 4.3D).  It is unknown if the non-naturally occurring L-isomer contributed to this effect, 
but since we found the non-naturally occurring isomer D-malate to decrease lifespan at all 3 
concentrations tested (Table 4.1), it is a strong possibility. Another group observed no effect of 8 
mM isocitrate on lifespan [48]. Therefore, of the 7 TCA cycle intermediates that we have tested, 
6 were able to extend lifespan at an optimal dose. 
We hypothesized that catabolism of the amino acids for anaplerosis or energy production 
was likely playing a role in the lifespan extension. If this is true supplementing other common 
cellular metabolites should also extend lifespan. Therefore, we performed lifespan analysis of 
worms supplemented with sugars or other metabolites lacking nitrogen atoms.  
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Table 4.4  The effects of amino acids on lifespan of rsks-1, gcn-2, ife-2, gas-1, and mev-1  
strain treatment % of 
N2 
control 
mean 
lifespan 
% of 
untreated 
mean 
lifespan 
p-value # of 
worms 
replicates 
rsks-
1(ok1255) 
control 109 
 
<0.001 362 4 
1 mM tryptophan  71 <0.001 130 2 
5 mM histidine  93 0.031 135 2 
5 mM proline  94 0.042 140 2 
10 mM serine  101 0.236 162 2 
gcn-2(ok871) control 90 
 
<0.001 479 4 
1 mM tryptophan  99 0.489 160 2 
5 mM histidine  100 0.335 163 2 
5 mM proline  107 0.001 205 2 
10 mM serine  104 0.006 183 2 
Ife-2(ok306) control 97  0.245 112 2 
1 mM tryptophan  94 0.029 138 2 
5 mM histidine  98 0.597 110 2 
5 mM proline  102 0.352 117 2 
10 mM serine  99 0.791 96 2 
gas-1(fc21) control 69 
 
<0.001 119 2 
5 mM histidine  104 0.092 110 2 
10 mM serine  98 0.327 106 2 
5 mM proline  109 0.003 115 2 
mev-1(kn1) control
 
69 
 
<0.001 273 2 
5 mM histidine  104 0.021 215 2 
10 mM serine  109 <0.001 258 2 
5 m  102 0.102 256 2 
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Table 4.5 The effects of TCA cycle intermediates on C. elegans lifespan 
 
treatment concentration % of 
untreated 
mean lifespan 
p-value # of 
worms 
replicates 
succinate 1 mM 
111 <0.001 590 4 
5 mM 
110 <0.001 570 4 
10 mM 
104 0.098 607 4 
citrate1 10 mM 
98 0.414 229 2 
α-ketoglutarate 0.1 mM 
110 <0.001 261 3 
1 mM 
115 <0.001 345 3 
5 mM 
111 <0.001 337 3 
10 mM 
107 0.042 333 3 
DL-isocitrate 1 mM 
103 0.202 452 4 
5 mM 
113 <0.001 523 4 
10 mM 
72 <0.001 217 4 
D-malate 1 mM 
85 <0.001 106 1 
5 mM 
76 <0.001 77 1 
10 mM 
79 <0.001 142 1 
1
compared to a medium lacking citrate. All other experiments contain 10 mM citrate as part of the 
standard culture media. 
Glucuronolactone, glyceraldehyde, fructose, propionate, or dihydroxyacetone did not 
extend lifespan and the last 4 of these compounds even decreased lifespan by 13-25% at the 10 
mM dose. Glyceraldehyde, fructose, and dihydroxyacetone are readily converted into glycolytic 
intermediates leading to the formation of toxic methylglyoxyl from glyceraldehyde phosphate or 
dihydroxyacetone phosphate, which could contribute to their toxicity, while propionic acid is 
known to be neurotoxic at high levels [28]. Since many amino acids activated SKN-1, while 
TCA cycle intermediates did not, we hypothesized that nitrogen-containing metabolites might be 
slightly more potent inducers of lifespan extension. The effects of many nitrogen-containing 
metabolites on lifespan are shown in 4.13.  At an optimal dose carnosine, beta-alanine, betaine, 
homocysteine, ornithine, agmatine, putrescine, taurine, and theanine extended lifespan. 
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Figure 4.3. Individual supplementation of many TCA cycle metabolites extends mean lifespan in C. 
elegans.  (A) Succinate extends lifespan, (B) citrate does not extend lifespan, (C) alpha-ketoglutarate 
extends lifespan, and (D) isocitrate extends lifespan at one or more of the concentrations tested. 10 mM 
citrate is a standard component of the S-medium. It was removed to determine the effect of citrate on 
lifespan. 
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For the majority of these compounds, the lowest concentration, such as 1 mM, yielded 
greater lifespan extension than the highest 10 mM concentration suggesting a hormetic dose 
response. Supplementation with creatine, or the histidine catabolites histamine or urocanic acid 
did not extend lifespan at any of the 3 concentrations tested. Although most of the nitrogen-
containing compounds extended lifespan at an optimal dose, the extent of lifespan extension was 
not noticeably different than when supplementing with compounds lacking nitrogen. 
4.3.15 C. elegans lifespan was not limited by nitrogen availability 
We used heat-killed E. coli as a food source to prevent the bacteria from metabolizing the 
added metabolites, but we have found that heat-killing E. coli causes the loss of one or more 
essential growth-limiting nutrients during heating. So lowering the concentration of heat-killed 
bacteria in the growth media by just a factor of 2 did not allow completion of larval growth into 
adulthood, but instead led to dauer formation. The concentration of live bacteria could be 
reduced by 30-40 fold before dauer formation during larval development. To test if the worms 
may have been nitrogen limited under our culture conditions, we supplemented the worms with 
peptone or other nitrogen containing compounds and measured the lifespan. Interestingly, 
peptone at 1.25 g/L, half the concentration present in nematode growth media (NGM) decreased 
lifespan by 22% (Additional file 6: Table S3). This concentration contains roughly 10 mM total 
amino acids. These results support published findings where 5 g/L (2x NGM)  and 10 g/L (4x 
NGM) peptone also decreased C. elegans lifespan in liquid S medium [55]. Lowering the 
peptone concentration to 0.125 g/L (0.1x NGM) yielded a similar lifespan as untreated controls.  
We next added ammonium chloride as a nitrogen source. Concentrations of ammonium 
chloride from 1 to 10 mM did not extend lifespan. So amino acids do not increase lifespan solely 
by providing nitrogen to the worms. 
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4.3.16 Phenylalanine and alpha-ketoglutarate activate a HSF-1 reporter strain 
Since supplementation of many of the amino acids and other metabolites showed less 
lifespan extension at higher concentrations, we hypothesized that C. elegans mounted a stress 
response that resulted in lifespan extension at lower amino acid levels, but at higher levels the 
stress response was overwhelmed leading to decreased lifespan. Therefore, we determined if 
amino acid supplementation activates a Phsp-16.2::GFP heat shock reporter strain of worms.  
HSP-16.2 is a small cytoplasmic heat shock protein and target of the HSF-1 transcription factor 
[56]. We first tested the effects of glutamine, histidine, methionine, serine, tryptophan, or 
tyrosine, amino acids that extended lifespan, or phenylalanine, an amino acid that decreased 
lifespan on GFP fluorescence in the Phsp-16.2::GFP reporter strain using heat shock as a 
positive control (Figure 4.4 A). Of these amino acids, only phenylalanine activated GFP reporter 
gene expression.    
We next tested the effects of TCA cycle intermediate or pyruvate supplementation on the 
Phsp-16.2::GFP reporter strain, as amino acids are broken down into TCA cycle intermediates 
when they are present in excess. When administered to the Phsp-16.2::GFP reporter strain 
alpha-ketoglutarate, but none of the other TCA cycle intermediates supplemented increased GFP 
fluorescence (Figure 4.5A). Many of the amino acids showing the largest stimulatory effects on 
lifespan (proline, arginine, histidine, glutamine, and glutamate) are catabolized through 
glutamate into alpha-ketoglutarate in the TCA cycle. 
4.3.17 Histidine, tryptophan, and citrate induce an ER stress response 
We next determined if amino acids activated the endoplasmic reticulum (ER) stress 
response by using a reporter strain of worms engineered to contain a heat shock protein-4 (hsp-4) 
promoter driving expression of green fluorescent protein (GFP) [57]. We tested the effect of 
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glutamine, histidine, methionine, serine, tryptophan, or tyrosine supplementation on expression 
of GFP in the Phsp-4::GFP reporter strain of worms using heat shock as a positive control 
(Figure 4.4B). Histidine and tryptophan induced GFP expression, methionine and glutamine 
reduced GFP expression, while the other amino acids had no effect.  
Subsequently we determined the effects of supplemented TCA cycle intermediates and 
pyruvate on the Phsp-4::GFP ER stress response reporter strains of worms (Figure 4.5B).  
Citrate activated Phsp-4::GFP reporter gene expression, and there was also a strong trend 
(p=0.08) for increased expression with alpha-ketoglutarate, while the other TCA cycle 
intermediates had no effect. Chelation of calcium or other metal ions is a possible mechanism as 
to how some of these compounds or their metabolites activate ER stress. 
4.3.18 Tryptophan induces the mitochondrial unfolded protein response 
We further tested for activation of the mitochondrial unfolded protein response using 
Phsp-6 and Phsp-60 reporter strains and ethidium bromide treatment as the positive control.  
HSP-6 is the worm homolog of mammalian mitochondrial hsp-70, while HSP-60 is also 
localized to the mitochondrion. Both mitochondrial heat shock proteins play a role in the 
mitochondrial unfolded protein response, but this response is not always associated with 
longevity [58]. For the Phsp-6::GFP reporter strain we tested glutamine, histidine, serine, 
phenylalanine, and tryptophan (Figure 4.4C). We found phenylalanine and tryptophan to robustly 
increase expression, while the other amino acids did not increase expression. We further tested 
the effects of glutamine, histidine, phenylalanine, proline, serine, tryptophan, and tyrosine on 
GFP expression in the Phsp-60::GFP reporter strain (Figure 4.4D). We found only tryptophan to 
increase expression. There was also a strong trend for proline to increase expression (p=0.06), 
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while serine slightly decreased expression. Overall, most amino acids do not rely upon the 
mitochondrial unfolded protein response pathway for lifespan extension. 
Next, we determined the effects of the TCA cycle intermediates and pyruvate on the 
mitochondrial unfolded protein response reporter strains. None of the metabolites affected 
expression of the Phsp-6::GFP reporter (Figure 4.5C), while pyruvate, succinate, and malate 
slightly decreased expression of the Phsp-60::GFP reporter strain (Figure 4.5D). Overall, the 
data suggest that TCA cycle intermediate supplementation does not require the mitochondrial 
unfolded protein response pathway for lifespan extension.   
4.3.19 Tryptophan metabolites nicotinic acid, nicotinamide, and picolinic acid induce both 
ER stress and mitochondrial unfolded protein responses 
Since tryptophan activated expression of the ER stress response and 2 mitochondrial 
unfolded protein response reporter strains, we determined if one or more of its breakdown 
products or structurally related metabolites could also induce these responses or activate 
expression in the HSF-1 reporter strain.  Therefore we added many of the tryptophan degradation 
products or tryptophan-related cellular metabolites including serotonin, anthranilic acid, nicotinic 
acid, nicotinamide, NAD, glutaric acid, kynurenic acid, quinolinic acid, and picolinic acid to the 
HSF-1 reporter strain, the ER stress reporter strain, and the 2 mitochondrial unfolded protein 
response reporter strains (Figure 6A-D). Strikingly, nicotinic acid activated expression of the 
same ER stress response and mitochondrial unfolded protein response reporters as tryptophan, 
while picolinic acid and nicotinamide activated expression of all 4 GFP reporter strains, although 
activation of hsp-60::GFP by nicotinamide was low (p=0.07). Picolinic acid is an isomer of 
nicotinic acid and an important endogenous metal chelator [59]. Quinolinic acid induced 
expression of the 2 non-mitochondrial heat shock protein reporters. Therefore, we performed 
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lifespan experiments adding 1 mM picolinic acid or 1 mM quinolinic acid to the culture medium 
(Additional file 6: Table S3). Picolinic acid addition showed a trend (p=0.13) toward increased 
lifespan.  In contrast, quinolinic acid addition decreased worm lifespan by 26%, as might be 
expected from its known neurotoxicity [60]. NAD precursors have previously been shown to 
induce the mitochondrial unfolded protein response [61]. Here, we added a 0.1 mM dose of NAD 
and found it to only activate expression of hsp-4, the marker of ER stress. Although tryptophan 
metabolic byproducts could contribute to the protective effects of supplemental tryptophan, 
others have shown data suggesting that tryptophan itself may be the protective metabolite in a C. 
elegans model of alpha-synuclein toxicity [27].  
4.3.20 Proline and tryptophan increase C. elegans thermotolerance 
Amino acids could have induced expression of other heat shock or stress-inducible genes 
to extend lifespan not assayed in our reporter experiments described above. Therefore, we 
determined the effect of individual amino acid supplementation on the thermotolerance of C. 
elegans. We supplemented the growth medium with glutamine, histidine, proline, serine, or 
tryptophan and monitored the viability of the worms following transfer from 20°C to 35°C. 
Proline provided a 30% increase in thermotolerance and tryptophan provided a 10% increase in 
thermotolerance, while there was no significant effect of the other amino acids. The effect of 
proline is not too surprising given that proline stabilizes proteins and membranes and is 
overproduced to protect plants and some microorganisms from osmotic, salinity, and temperature 
stresses [62]. 
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We next monitored the resistance to oxidative stress by monitoring the viability of worms 
following administration of paraquat. Paraquat is an inducer of superoxide production through 
redox cycling. None of the tested amino acids including proline, serine, histidine, tryptophan, or 
leucine significantly protected the worm viability against this stress, although there was a strong 
trend for protection with histidine (p=0.08).  
4.3.21 Little effect of amino acid supplementation on Alzheimer’s amyloid-beta toxicity 
Since many of the amino acids extended lifespan when they were supplemented to the 
culture medium, we also determined if individual amino acid supplementation could delay 
toxicity in C. elegans models of human neurodegenerative disorders. We first determined the 
effects of serine, histidine, proline, tryptophan, or methionine supplementation on the rate of 
paralysis development when the amyloid-beta peptide, which builds up in Alzheimer’s disease 
brain, is expressed in worm body wall muscle from a temperature-inducible promoter [63].  
Overall, amino acid supplementation only had a minimal effect on the rate of paralysis. We 
found that serine (p=0.07) (Figure 4.7A) or histidine (p=0.05) (Figure 4.7B) supplementation 
gave strong trends to delay muscle paralysis, while no significant effects were found with 
proline, methionine, or tryptophan (Additional file 4.8). 
4.3.22 Tryptophan protects from alpha-synuclein and polyglutamine toxicity 
 
We next determined the effects of supplementation with histidine, proline, serine, or tryptophan 
on alpha-synuclein aggregation in worms expressing an alpha-synuclein-green fluorescent 
protein fusion (Figure 4.7C). Tryptophan was highly protective giving a 17% reduction in 
aggregate fluorescence, while the other amino acids were without effect.  We also tested the 
effects of tryptophan, serine, and proline on aggregates formed from the expression of a 
polyglutamine (Q35)–GFP fusion protein [64] (Additional file 4.9). 
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Figure 4.4. The effects of amino acids on heat shock, mitochondrial unfolded protein response, and ER 
stress response. Amino acids were added at the concentration tested that yielded maximal lifespan 
extension except phenylalanine, which did not extend lifespan. (A) Phsp-16.2::GFP (B) Phsp-4::GFP 
(C) Phsp-6::GFP (D) Phsp-60::GFP.  For panels A and B heat shock at 35°C for 2 hours was used as a 
positive control.  For panels C and D 50 µg/ml ethidium bromide treatment for 2 days was used as a 
positive control (* p < 0.05 vs. control). 
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Figure 4.5. The effects of TCA cycle metabolites and pyruvate on heat shock, mitochondrial unfolded 
protein response, and ER stress response.  (A) Phsp-16.2::GFP (B) Phsp-4::GFP (C) Phsp-6::GFP (D) 
Phsp-60::GFP (* p < 0.05 vs. control).  For panels A and B heat shock at 35°C for 2 hours was used as a 
positive control.  For panels C and D 50 µg/ml ethidium bromide treatment for 2 days was used as a 
positive control (* p < 0.05 vs. control). 
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Figure 4.6. The effects of tryptophan metabolites on heat shock, mitochondrial unfolded protein 
response, and ER stress response.  (A) Phsp-16.2::GFP (B) Phsp-4::GFP (C) Phsp-6::GFP (D) Phsp-
60::GFP (* p < 0.05 vs. control).  For panels A and B heat shock at 35°C for 2 hours was used as a 
positive control.  For panels C and D 50 µg/ml ethidium bromide treatment for 2 days was used as a 
positive control (* p < 0.05 vs. control). 
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Figure 4.7. Amino acids do not provide much protection in models of proteotoxicity. (A) Serine and (B) 
histidine supplementation yield slight protection against muscle amyloid-beta toxicity. (C) Tryptophan 
supplementation decreases alpha-synuclein aggregate fluorescence.  (D) Amino acid supplementation 
does not protect against TDP-43 toxicity. 
 
 
129 
 
We found a strong trend toward a decreased number of aggregates with the addition of 
tryptophan (p = 0.07), but no significant effect of the other two amino acids tested.  It is not 
surprising that tryptophan supplementation was protective in these C. elegans proteotoxicity 
models as depletion of the TDO-2 enzyme that degrades tryptophan has been shown to increase 
worm tryptophan levels and be protective in several worm models of proteotoxicity [27]. It was 
also shown that tryptophan supplementation was able to increase the motility of Q40 
polyglutamine expressing worms. 
4.3.23 Alpha-ketoglutarate, but not amino acids, protects C. elegans expressing TDP-43 
Tar DNA-binding protein-43 (TDP-43) is mostly a nuclear protein under normal 
conditions, but cytoplasmic accumulation is associated with ALS and other neurodegenerative 
diseases. Overexpression of TDP-43 leads to toxicity in C. elegans and is used as an ALS model.  
We therefore tested if several amino acids including histidine, methionine, proline, serine, and 
tryptophan could alter the reduced lifespan of TDP-43 overexpressing worms (Figure 4.7D and 
Additional file 4.10). However, none of these amino acids protected against the reduced lifespan, 
while histidine addition even further reduced the lifespan. But, we did find a protective effect of 
alpha-ketoglutarate supplementation in this model, supporting data from a study in which alpha-
ketoglutarate in combination with other metabolites was protective in the SOD1-G93A mouse 
model of ALS [65]. 
4.3.24 Serine and tryptophan partially block lifespan reduction in high glucose culture 
media 
High glucose in the bloodstream is a marker of insulin resistance and diabetes and high 
levels of glucose in C. elegans culture medium is known to reduce lifespan [66, 67]. Therefore 
high glucose supplementation has been used as a model of diabetes in C. elegans. Since 
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alterations of amino acid levels also accompany diabetes, we determined if select amino acids 
could alter the decreased lifespan resulting from the addition of 50 mM glucose to the culture 
medium. We found glucose addition decreased lifespan by 30 percent and that serine (Figure 
4.8A) or tryptophan (Figure 4.8B) supplementation partially blocked lifespan reduction. 
Histidine, proline, or tyrosine addition had no significant effect, while glutamine addition 
decreased lifespan to a greater extent than glucose by itself. 
4.3.25 Amino acid supplementation does not significantly alter C. elegans oxygen 
consumption and ATP levels 
Since amino acid supplementation may transiently increase ROS production for the 
activation of SKN-1, we hypothesized that the added amino acids may be catabolized to increase 
mitochondrial ETC function. Therefore we measured worm oxygen consumption and ATP 
levels.However, we did not find significantly altered oxygen consumption or ATP levels 
following addition of the individual amino acids serine, proline, histidine, tryptophan, leucine, 
asparagine, or phenylalanine to the worms. Therefore, the supplemented amino acids are either 
not being metabolized at a substantial rate or are being metabolized in replacement of respiratory 
substrates present in the E. coli food source preventing an overall increase in metabolic rate.   
4.4 Discussion 
Individual supplementation with 18 of the 20 proteogenic amino acids at an optimal 
concentration increased the lifespan of C. elegans. This metabolite-induced lifespan extension 
was not specific for only amino acids as supplementation with TCA cycle intermediates and 
many different classes of cellular metabolites also led to significant lifespan extension, 
suggesting altered cellular metabolism or TCA cycle anaplerosis plays a prominent role.   
131 
 
 
Figure4. 8.  Serine or tryptophan partially prevent high glucose from reducing C. elegans lifespan. (A) 
Serine extends C. elegans lifespan in the presence of high glucose (p < 0.001). (B) Tryptophan extends C. 
elegans lifespan in the presence of high glucose (p < 0.001). 
 
Of the 20 amino acids, serine and proline extended lifespan to the largest extent. 
Strikingly, these and other top amino acids did not significantly extend the lifespan of long-lived 
dietary restricted eat-2 mutants. If similar effects occurred in humans, imbalanced amino acid 
diets could be developed as a dietary restriction mimetic to delay aging and aging-related 
disease. In this regard a methionine restricted diet has been used clinically to treat metabolic 
syndrome [68]. However, whether or not amino acid supplementation strategies will apply to 
higher eukaryotes remains to be determined as individual supplementation of methionine failed 
to extend the lifespan of fruit flies [24], while supplementation of methionine decreased the 
lifespan of mice [69]. 
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4.4.1 Individual amino acid supplementation may decrease the rate of translation to extend 
lifespan 
Most of the well-studied longevity pathways in C. elegans such as DAF-16, SKN-1, 
AAK-2, SIR-2.1, and HIF-1 appear to be involved in the lifespan extension mediated by 
histidine, serine, and proline, with the exception of the HIF-1 pathway for proline. However, 
tryptophan extends lifespan in a SKN-1 and DAF-16 independent manner, although tryptophan 
did increase fluorescence of a DAF-16 reporter strain of worms. These different longevity 
pathways may converge to decrease the rate of translation by the ribosome for lifespan 
extension. A small to moderate amount of amino acid imbalance could hinder correct aminoacyl-
tRNA synthetase charging of tRNAs slowing the rate of translation in a GCN-2 dependent 
manner to increase lifespan, while a higher amount of amino acid imbalance may lead to a toxic 
reduction in translation rates decreasing lifespan. Previously, a decreased rate of translation has 
been shown to be essential for lifespan extension in mitochondrial mutants [33], during TOR 
inhibition, or during dietary restriction [34]. Furthermore, long-lived daf-2 mutants were also 
shown to have a reduced rate of translation [70]. Reduced mitochondrial translation causing 
mitonuclear protein imbalance has also been shown to lead to increased lifespan [71]. High rates 
of translation during aging may overwhelm protein chaperone systems resulting in 
proteotoxicity. Slowing translation or increasing heat shock protein activity may delay this 
proteotoxicity to increase longevity. 
The branched chain amino acid leucine most strongly activates TOR kinase, which can 
increase the rate of translation and lead to decreased lifespan. Therefore, we were surprised to 
find that supplementation with 1 mM leucine greatly increased lifespan.  In fact, leucine was the 
second most potent amino acid at this concentration for promoting longevity. Under our standard 
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growth conditions TOR signaling may already be highly activated by amino acids present in the 
bacterial food source and so may not be able to be further activated.  Instead, we hypothesize that 
leucine metabolism or the amino acid imbalance caused by excess leucine may have activated 
other signaling pathways leading to TOR inhibition.  In this regard, the lack of lifespan extension 
by amino acids in rsks-1 mutants suggests that individual amino acid supplementation inhibits 
TOR signaling to extend lifespan. Of the other two branched chain amino acids, valine 
supplementation showed similar lifespan trends as leucine, even though it is not a potent inducer 
of TOR activity, and isoleucine supplementation showed little effect on lifespan. At higher 
concentrations, branched chain amino acids did not affect lifespan as much as at the lower 
concentrations. Therefore, high levels of branched chain amino acids do not always directly 
correlate with lifespan extension.  Consistent with this hypothesis, decreased levels of branched 
chain amino acids were found in long-lived Ames dwarf mice [72]. However, amino acid 
imbalance cannot explain the increased longevity conferred upon supplementation with many 
other diverse cellular metabolites. Therefore, TCA cycle anaplerosis leading to a reprogramming 
of mitochondrial metabolism may be the molecular mechanism responsible for lifespan 
extension. 
4.4.2 NAD precursors and tryptophan induce the ER stress response and the mitochondrial 
unfolded protein response 
Another significant finding in this report is that supplementation with tryptophan, 
nicotinamide, nicotinic acid, or its isomer picolinic acid resulted in the activation of both the 
mitochondrial unfolded protein and the ER stress response pathways, while NAD addition 
induced only the ER stress response. In mouse muscle and heart, decreased nuclear NAD levels 
with aging cause a hypoxia inducible factor-1α (HIF-1α)-induced decrease in mitochondrial 
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transcription leading to mitochondrial dysfunction that was reversed by supplementation with an 
NAD precursor [73]. In addition to reversing this aging-induced mitochondrial dysfunction, 
supplementing NAD precursors (or tryptophan) can further protect cells by inducing an ER stress 
response and a mitochondrial unfolded protein response, although it has already been shown that 
NAD precursors induce a mitochondrial unfolded protein response [61]. Picolinic acid is a strong 
metal chelator that is frequently taken with chromium as a possible treatment for metabolic 
syndrome, although the efficacy of this treatment has been questioned [74]. But picolinic acid 
itself has been shown to be neuroprotective [59]. It will be important to determine if the 
protective effects of picolinic acid are due to metal chelation and if picolinic acid, nicotinic acid, 
and nicotinamide also induce the ER stress response or mitochondrial unfolded protein response 
in mammalian cells. 
4.4.3 Is catabolism of amino acids important for their longevity effects? 
The catabolism of supplemented amino acids likely mediates their effects on longevity, 
but there are likely exceptions to this rule. We were surprised to find no increase in oxygen 
consumption or ATP levels as markers of increased metabolism when amino acids were added to 
the culture medium. It was previously shown that proline catabolism and the resulting transient 
increase in ROS production by the electron transport chain were essential for its pro-longevity 
effects [26]. Most other amino acids may also be metabolized to emit a transient ROS signal 
leading to SKN-1 dependent lifespan extension. Possible evidence for this includes that enzymes 
for proline, tryptophan, phenylalanine, glutamine, and D-alanine degradation are upregulated in 
long-lived daf-2 insulin receptor mutant worms [26], where SKN-1 is also activated [75].  
However, alpha-ketoglutarate-mediated lifespan extension was shown to be independent of ROS 
production [48].  Therefore more downstream TCA cycle catabolites such as alpha-ketoglutarate, 
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succinate, malate, and fumarate extend lifespan through SKN-1independent, but DAF-16 
dependent mechanisms [53]. In addition, cysteine and tryptophan-induced lifespan extension 
were independent of SKN-1, so supplementation with these amino acids did not likely alter 
mitochondrial metabolism to increase ROS production. Consistent with this, knockdown of the 
tryptophan 2,3-dioxygenase (TDO-2) enzyme that degrades tryptophan led to increased lifespan 
and increased tryptophan levels, but no changes in the levels of many of the downstream 
metabolites of tryptophan degradation suggesting that increased tryptophan levels and not altered 
levels of the catabolic byproducts were responsible for the increased lifespan and protection from 
proteotoxicity [27]. 
Future studies will aim to determine the metabolic mechanisms through which amino 
acids activate SKN-1 activity and through which serine and histidine activate HIF-1. For 
example, enzyme knockdown studies using RNAi may be used to determine whether serine 
catabolism is required for serine-mediated lifespan extension, as serine can be directly 
deaminated to pyruvate, which extends lifespan [51].  However, serine can also be used as a one-
carbon donor for methylation events such as histone methylation, which can alter gene 
expression patterns leading to increased longevity as well [76]. 
4.4.4 TCA cycle metabolism and longevity 
Different amino acids are catabolized and enter the TCA cycle through different 
intermediates of the cycle. We did not find that the amino acids yielding the greatest effects on 
lifespan were degraded through one common catabolic pathway. Additional file 13: Figure S7, 
Additional file 14 Figure S8, and Additional file 15: Figure S9 show the specific TCA cycle 
intermediate into which each of the amino acids is catabolized and how lifespan was affected by 
1 mM, 5 mM, and 10 mM amino acid concentrations, respectively. As mentioned previously, the 
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only trend in the data set is that amino acids broken down into alpha-ketoglutarate yielded larger 
than average lifespan extensions. However, this cannot explain the large lifespan extension 
induced by serine addition, which is catabolized to pyruvate. Surprisingly, we previously 
discovered that malate or fumarate supplementation increased total pyridine (NAD + NADH) 
nucleotide  levels and also induced mild mitochondrial uncoupling increasing the NAD/NADH 
ratio, both of which may have been involved in the lifespan extension induced by these TCA 
cycle intermediates [53].  Catabolism of other metabolites may result in similar effects. 
Knockdown of mitochondrial aconitase or a subunit of mitochondrial NAD-dependent 
isocitrate dehydrogenase increased lifespan in C. elegans  [77]. The increased longevity of these 
mutants is likely due in part to decreased flux through this portion of the TCA cycle leading to 
increased NAD levels, which has been shown to extend lifespan [78]. The isocitrate 
dehydrogenase and alpha-ketoglutarate dehydrogenase enzymes reduce mitochondrial NAD to 
NADH. Citrate supplementation may not increase lifespan due to the increased flux through this 
portion of the TCA cycle leading to a decrease in NAD levels, although in the cytoplasm citrate 
is metabolized to acetyl-CoA that has been shown to inhibit autophagy, which can also prevent 
lifespan extension [79]. However, isocitrate supplementation would also not be expected to 
increase longevity as its normal metabolism is predicted to lower NAD levels. However, there is 
also an NADP-dependent isocitrate dehydrogenase isoform present that may help prevent 
declines in NAD levels and allow for isocitrate-mediated lifespan extension at least in a narrow 
range of concentrations.   
It is possible that supplementation with amino acids broken down into alpha-
ketoglutarate may extend lifespan by running isocitrate dehydrogenase in the opposite direction 
of its normal mode to oxidize NADH to NAD while alpha-ketoglutarate and carbon dioxide are 
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metabolized into isocitrate. Some cancer cells have been shown to use this metabolism when 
oxidizing glutamine as a primary energy substrate [80]. The citrate produced from isocitrate is 
then exported to the cytoplasm where acetyl-CoA and oxaloacetate are formed by ATP citrate 
lyase. This metabolic flexibility in TCA cycle metabolism may be required for specific amino 
acid and TCA cycle metabolite-mediated longevity and is a hypothesis for future testing, as 
running the TCA cycle in the reverse of its normal direction was shown to be needed for malate 
and fumarate-mediated lifespan extension [53]. 
4.4.5 Glycolysis as a lifespan shortening metabolic pathway in C. elegans  
Since supplementation with glucose and other glycolytic precursors decrease lifespan in 
C. elegans as shown here and in [66, 67], there are likely specific metabolic pathways such as 
glycolysis that decrease lifespan. We propose that many of the supplemented metabolites that 
increased lifespan are catabolized by mitochondria to increase TCA cycle metabolite levels. The 
DAF-16/FOXO longevity pathway has been shown to be activated by increased TCA cycle 
metabolite levels [53]. So the TCA cycle appears to be lifespan-extending metabolic pathway in 
C. elegans. In addition increased TCA cycle flux could also transiently increase mitochondrial 
ETC ROS production to activate the SKN-1 longevity pathway as previously suggested [26].  
This metabolite oxidation for energy production would also decrease reliance on lifespan-
shortening glycolysis as a source of mitochondrial respiratory substrates.  
4.4.6 Refinements in C. elegans culture media for lifespan experiments by limiting peptone 
levels and using heat-killed bacteria during adulthood 
When performing lifespan experiments, sources of stress should be removed from the 
environment, so control animal lifespan is not limited. Unfortunately when working with C. 
elegans, this has proven difficult due to the slight toxicity of their live E. coli food source. We 
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and others [55] have also found that the peptone present in nematode growth media (NGM) also 
induces a type of stress that decreases lifespan. It is unclear which component of peptone 
decreases lifespan as it contains not only proteolyzed proteins (amino acids and oligopeptides), 
but also fats, metals, salts, vitamins, and other compounds. Because of the slight toxicity 
associated with the use of peptone and live E. coli, we chose to perform C. elegans lifespan 
experiments using heat-killed E. coli in liquid S-medium, which lacks peptone. Due to partial 
degradation of one or more nutrients in the E. coli food source needed for larval development 
during the heat-killing treatment, it may be advantageous, especially in certain mutant 
backgrounds, to treat the worms with live E. coli during larval development to ensure adequate 
nutrition, and then switch them to heat-killed E. coli during adulthood to prevent the bacteria 
from metabolizing added nutrients. Further refinements in experimental methods will allow C. 
elegans to become an even more valuable model for investigating the effects of altered 
metabolism on lifespan. 
4.5 Conclusions 
Individual amino acid supplementation increased the lifespan of C. elegans and increased 
stress resistance with serine, proline, and tryptophan showing the greatest effects. Many 
longevity pathways including DAF-16, SKN-1, AAK-2, SIR-2.1, GCN-2, heat shock, autophagy, 
DR, and inhibition of TOR signaling are involved in these protective effects. Anaplerosis and 
altered mitochondrial metabolism transiently increasing ROS production to activate SKN-1 
appear to be involved in the longevity signaling. The exact pathways involved vary slightly from 
one amino acid to the next. For example, serine and histidine stimulated transcriptional activity 
of HIF-1, while 6 other amino acids did not. Likewise 8 lifespan-extending amino acids 
increased the transcriptional activity of SKN-1, but not tryptophan, cysteine, or the lifespan-
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decreasing amino acids phenylalanine and asparagine. Uniquely, tryptophan activated the ER 
stress response and mitochondrial unfolded protein response pathways and lifespan extension 
was independent of SKN-1 and DAF-16. Future experiments will aim to develop an improved 
axenic medium that can be used to determine the effects of amino acid restriction on the lifespan 
of C. elegans. Through the use of both amino acid supplementation and restriction, a diet may 
one day be developed that can substantially increase stress resistance and slow aging and the 
onset of aging-associated disorders. 
4.6 Supporting information  
Table 4.6  The effect of amino acid supplementation on C. elegans lifespan 
 
 
      
Strain Concentration Amino acid 
% of 
control 
mean 
lifespan 
n 
# of 
worms 
p-value 
N2 1 mM 
alanine 
108 3 264 0.015 
N2 5 mM 104 3 277 0.305 
N2 10 mM 111 3 274 0.003 
N2 1 mM 
arginine 
108 4 428 0.007 
N2 5 mM 111 4 412 <0.001 
N2 10 mM 115 4 438 <0.001 
N2 1 mM 
asparagine 
101 3 350 0.331 
N2 5 mM 105 3 319 0.032 
N2 10 mM 75 3 297 <0.001 
N2 1 mM 
aspartate 
103 3 477 0.15 
N2 5 mM 100 3 495 0.052 
N2 10 mM 94 3 544 0.001 
N2 1 mM 
cysteine 
109 2 200 0.029 
N2 5 mM 116 2 190 <0.001 
N2 10 mM 102 2 195 0.513 
N2 1 mM 
glutamate 
114 2 156 0.005 
N2 5 mM 111 2 191 0.034 
N2 10 mM 92 2 172 0.005 
N2 1 mM glutamine 115 2 184 0.002 
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Strain Concentration Amino acid 
% of 
control 
mean 
lifespan 
n 
# of 
worms 
p-value 
N2 5 mM 116 2 196 0.002 
N2 10 mM 94 2 214 0.001 
N2 1 mM 
glycine 
110 3 321 0.008 
N2 5 mM 103 3 298 0.538 
N2 10 mM 96 3 327 0.09 
N2 1 mM 
histidine 
104 3 338 0.155 
N2 5 mM 109 3 269 <0.001 
N2 10 mM 112 3 282 <0.001 
N2 1 mM 
isoleucine 
103 3 344 0.079 
N2 5 mM 103 3 290 0.066 
N2 10 mM 103 3 360 0.033 
N2 1 mM 
leucine 
116 2 265 <0.001 
N2 5 mM 106 2 238 0.042 
N2 10 mM 107 2 240 0.032 
N2 1 mM 
lysine 
107 4 562 <0.001 
N2 5 mM 108 4 583 <0.001 
N2 10 mM 106 4 547 <0.001 
N2 1 mM 
methionine 
104 2 160 0.094 
N2 5 mM 108 2 162 0.002 
N2 10 mM 114 2 148 <0.001 
N2 1 mM 
phenylalanine 
97 2 167 0.491 
N2 5 mM 92 2 165 <0.001 
N2 10 mM 88 2 164 <0.001 
N2 1 mM 
proline 
117 3 369 <0.001 
N2 5 mM 119 3 322 <0.001 
N2 10 mM 118 3 329 <0.001 
N2 1 mM 
serine 
108 5 495 <0.001 
N2 5 mM 118 5 501 <0.001 
N2 10 mM 122 5 607 <0.001 
N2 1 mM 
threonine 
100 3 317 0.901 
N2 5 mM 103 3 326 0.179 
N2 10 mM 108 3 279 <0.001 
N2 1 mM 
tryptophan 
114 3 289 <0.001 
N2 5 mM 106 3 234 0.003 
Table 4.6 (Continued) 
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Strain Concentration Amino acid 
% of 
control 
mean 
lifespan 
n 
# of 
worms 
p-value 
N2 10 mM 101 3 203 0.643 
N2 1 mM 
tyrosine 
110 2 198 <0.001 
N2 5 mM 105 2 186 0.001 
N2 10 mM 102 2 168 0.014 
N2 1 mM 
valine 
113 3 338 0.155 
N2 5 mM 108 3 269 <0.001 
N2 10 mM 99 3 282 <0.001 
 
 
Figure 4.9.  Example lifespan curves for several amino acids that strongly extended lifespan in C. 
elegans. (A) serine, (B) proline, (C) tryptophan, and (D) histidine. Concentrations chosen for display were 
those that stimulated lifespan extension to the greatest extent (log rank p < 0.001). 
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Figure 4.10. Supplementation of several D-amino acids found endogenously in C. elegans extends 
lifespan. (A) D-alanine, B) D-aspartate, or C) D-glutamate extended lifespan at one or more of the 
concentrations tested (log rank p < 0.05), while (D) D-serine supplementation did not extend lifespan at 
any of the concentrations tested. 
 
 
Figure 4.11.  The effect of amino acids on the fluorescence of a pha-4p::gfp:pha-4 reporter strain of C. 
elegans. ( * p < 0.05) 
143 
 
Table 4.7 The effect of sugars and other metabolites lacking nitrogen on C. elegans lifespan 
 
Treatment  % of N2 
control 
mean 
lifespan  
p‐value  # of worms  Replicates  
1 mM ribose  109  <0.001  333  3  
5 mM ribose  109  <0.001  345  3  
10 mM ribose  101  0.726  377  3  
     
10 mM glycerol  121  <0.001  134  1  
     
1 mM dihydroxyacetone  77  <0.001  275  2  
10 mM dihydroxyacetone  75  <0.001  269  2  
     
1 mM glyceraldehyde  74  <0.001  113  1  
10 mM glyceraldehyde  87  <0.001  186  1  
     
1 mM inositol  103  0.0397  220  1  
10 mM inositol  117  <0.001  235  1  
     
10 mM xylose  106  0.038  133  1  
     
1 mM galactose  101  0.887  296  2  
10 mM galactose  106  0.0349  250  2  
     
1 mM gluconate  108  0.0263  127  1  
5 mM gluconate  117  <0.001  124  1  
10 mM gluconate  116  <0.001  120  1  
     
1 mM glucuronolactone  102  0.717  290  1  
5 mM glucuronolactone  103  0.829  300  1  
10 mM glucuronolactone  103  0.831  310  1  
     
1 mM propionate  85  <0.001  104  1  
5 mM propionate  87  <0.001  106  1  
10 mM propionate  82  <0.001  110  1  
     
1 mM fructose  96  0.010  251  2  
10 mM fructose  86  <0.001  233  2  
     
1 mM phosphoenolpyruvate  112  <0.001  180  1  
5 mM phosphoenolpyruvate  112  <0.001  170  1  
10 mM phosphoenolpyruvate  108  0.002  149  1  
     
0.01 mM caprylate  101  0.356  192  2  
0.1 mM caprylate  107  0.019  165  2  
1 mM caprylate  95  0.001  186  2  
5 mM caprylate  82  0.001  165  2  
     
1 mM DL‐lactate  103  0.35  213  1  
5 mM DL‐lactate  106  0.03  220  1  
10 mM DL‐lactate  102  0.62  189  1  
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Table 4.8 The effects of nitrogen containing metabolites on C. elegans lifespan 
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Figure 4.12. Thermotolerance and paraquat-induced toxicity. (A) Proline or tryptophan supplementation 
increases thermotolerance in C. elegans. (log rank p < 0.001)  Serine, histidine, or glutamine 
supplementation did not significantly affect thermotolerance. (B) Amino acid supplementation did not 
significantly delay paraquat-induced toxicity. However, there was a strong trend toward protection with 
histidine (p=0.08), but no effect with serine, proline, tryptophan, or leucine. 
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 Table 4.9 The effects of amino acids on amyloid-beta-induced muscle paralysis 
 
 
 
 
 
Figure 4.13.  Tryptophan slightly decreased polyglutamine aggregates in C. elegans. The GFP 
fluorescence of five worms placed side by side are shown in each photo. There were on average 7 less 
aggregates in tryptophan treated worms than in controls (p = 0.07). 
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Table 4.10 The effects of amino acids on lifespan in human TDP-43 transgenic C. elegans 
 
 
 
 
 
Table 4.11 The effects of amino acids on C. elegans lifespan in the presence of 50 mM 
glucose. 
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Figure 4.14.  Amino acid supplementation did not significantly alter C. elegans oxygen consumption or 
ATP levels.  A) The amount of oxygen in the medium following a 30 minute incubation in the well of an 
Oxoplate. B) ATP levels.  
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Figure 4.15. Metabolism and effects on lifespan of a 1 mM dose of amino acids.  A diagram of the TCA 
cycle metabolites to which the 20 amino acids are catabolized is shown. It is also shown how 
supplementation of a 1 mM concentration of the amino acids or some of the TCA cycle metabolites 
affected C. elegans lifespan. 
 
 
Figure 4.16. Metabolism and effects on lifespan of a 5 mM dose of amino acids.  A diagram of the TCA 
cycle metabolites to which the 20 amino acids are catabolized is shown.   It is also shown how 
supplementation of a 5 mM concentration of the amino acids or some of the TCA cycle metabolites 
affected C. elegans lifespan. 
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Figure 4.17. Metabolism and effects on lifespan of a 10 mM dose of amino acids.  A diagram of the TCA 
cycle metabolites to which the 20 amino acids are catabolized is shown.  It is also shown how 
supplementation of a 10 mM concentration of the amino acids or some of the TCA cycle metabolites 
affected C. elegans lifespan. 
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CHAPTER 5 
D-BETA-HYDROXYBUTYRATE EXTENDS LIFESPAN IN C. ELEGANS
3
 
5.1 Abstract 
The ketone body beta-hydroxybutyrate (βHB) is a histone deacetylase (HDAC) inhibitor 
and has been shown to be protective in many disease models, but its effects on aging are not well 
studied. Therefore we determined the effect of βHB supplementation on the lifespan of C. 
elegans nematodes. βHB supplementation extended mean lifespan by approximately 20%.  
RNAi knockdown of HDACs hda-2 or hda-3 also increased lifespan and further prevented βHB-
mediated lifespan extension. βHB-mediated lifespan extension required the DAF-16/FOXO and 
SKN-1/Nrf longevity pathways, the sirtuin SIR-2.1, and the AMP kinase subunit AAK-2. βHB 
did not extend lifespan in a genetic model of dietary restriction indicating that βHB is likely 
functioning through a similar mechanism. βHB addition also upregulated ΒHB dehydrogenase 
activity and increased oxygen consumption in the worms. RNAi knockdown of F55E10.6, a 
short chain dehydrogenase and SKN-1 target gene, prevented the increased lifespan and βHB 
dehydrogenase activity induced by βHB addition, suggesting that F55E10.6 functions as an 
inducible βHB dehydrogenase. Furthermore, βHB supplementation increased worm 
thermotolerance and partially prevented glucose toxicity. It also delayed Alzheimer’s amyloid-
beta toxicity and decreased Parkinson’s alpha-synuclein aggregation. The results indicate that D-
βHB extends lifespan through inhibiting HDACs and through the activation of conserved stress 
response pathways.  
                                                          
3
 This chapter have been previously published in Aging, 2014, 6(8): 621–644 and have been 
reproduced with permission from Aging 
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5.2 Introduction 
Aging leads to a progressive decline of cell and tissue function and is the primary risk 
factor for many ailments, including the prevalent neurodegenerative disorders Alzheimer’s 
disease (AD) and Parkinson’s disease (PD). Mitochondria are the central hub of cellular 
metabolism and mitochondrial dysfunction, especially in stem cells [1], has been shown to cause 
the development of premature aging phenotypes in mice [2]. Paradoxically, slight inhibition of 
mitochondrial respiration can also lead to small increases in reactive oxygen species (ROS) 
production and extend the lifespan of yeast, C. elegans, Drosophila, and mice [3-6]. Even in 
young animals, roughly 0.15% of electrons passing through the mitochondrial electron transport 
chain (ETC) combine with molecular oxygen to form superoxide [7, 8]. Mitochondrial ROS 
production increases with age and leads to progressive damage of cellular macromolecules as 
outlined in the mitochondrial free radical theory of aging [9].  
Dietary restriction (DR) increases the lifespan of many organisms including C. elegans 
[10].  As interest in the molecular mechanisms responsible for the effect of DR on lifespan have 
expanded, so has the discovery of the pathways involved and the search for DR mimetic 
compounds that promote survival and stress resistance [11, 12]. The ketone body beta-
hydroxybutyrate (βHB) has been described as a DR mimetic compound [13], in part because it 
increases in the plasma during DR and when administered exogenously leads to decreased levels 
of oxidative stress [14].  In mammals, βHB is produced in the liver, primarily from the catabolic 
breakdown of fatty acids, and is used as an alternative energy source when blood glucose is low.  
This is especially important in the brain where only a very limited amount of fatty acid beta-
oxidation takes place [15]. In mitochondria βHB is catabolized to acetoacetate by βHB 
dehydrogenase 1 (BDH1). The reaction is linked to the reduction of NAD to NADH, which fuels 
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mitochondrial ETC complex I. The resulting acetoacetate is catabolized to acetoacetyl-CoA and 
then to acetyl-CoA, which is metabolized as part of the TCA cycle. The βHB dehydrogenase 2 
(BDH2) enzyme localizes to the cytoplasm, but no changes in ketone body metabolism were 
found in BDH2 knockout mice suggesting BDH2 plays a limited role, if any, in ketone body 
metabolism [16]. 
Researchers are investigating DR mimetics not only for their possible lifespan extending 
capabilities, but also for their potential ability to delay the onset and progression of age-
associated diseases such as AD. [17, 18]. Phenotypes of AD brain include extracellular senile 
plaques containing Aß peptide as well as intracellular neurofibrillary tangles consisting of 
hyperphosphorylated tau protein [19]. Intracellular Aß can inhibit mitochondrial ETC complex 
IV and increase ROS production [20]. βHB has shown some efficacy in the protection against 
AD-mediated neurodegeneration in animal models and human trials. βHB protected cultured 
hippocampal neurons from Aß 1–42 toxicity [21]. βHB or a ketogenic diet has shown mixed 
effects on disease phenotypes in mouse models of AD. For example in one study, a ketogenic 
diet lowered Aß levels, but did not affect cognitive impairment [22]. In another study a ketogenic 
diet improved motor function, but did not affect cognition or tau or Aß pathology [23]. However, 
a further study found that supplementation of βHB methyl ester to AD mice was able to restore 
cognitive function and decrease Aß levels, likely due to the fact that the methyl ester is 
transported through the blood-brain barrier more efficiently than the free acid [24]. There is also 
evidence for the clinical use of ketone bodies to treat neurodegenerative disorders as oral 
ingestion of medium chain triglycerides, which are catabolized in part to ketone bodies, 
increased plasma levels of βHB and led to improved cognitive function in human patients with 
AD [25]. 
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PD, another aging-associated disorder, is characterized by an accumulation of Lewy 
bodies in the substantia nigra region of the brain. The alpha-synuclein protein is a major 
component of Lewy bodies and can also localize to mitochondrial membranes [26] causing 
decreased ETC complex I activity with an accompanying increase in ROS production [27]. This 
may be partly responsible for the increased mitochondrial oxidative damage that has been 
observed in brains from autopsied PD patients [28, 29]. βHB has also been shown to be 
efficacious in several animal models of PD. Mice treated with βHB showed partial protection 
against neurodegeneration and motor deficiency induced by the neurotoxin 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP), which induces PD-like symptoms [30]. Additionally, βHB 
protected cultured neurons from toxicity induced by the structurally related ETC complex I 
inhibitor 1-methyl-4-phenylpyridinium (MPP(+)) [21]. In human clinical trials, PD patients 
treated with a ketogenic diet for one month improved their Unified Parkinson’s Disease Rating 
Scale scores by a mean of 43% [31].   
Although much is known about the effects of βHB on neurodegenerative and other aging-
associated diseases, not much is known about its effects on aging. Moreover, the mechanisms 
through which βHB are protective are not entirely clear. However, recent evidence suggests that 
βHB protects against oxidative stress through its action as a class I and class IIa histone 
deacetylase inhibitor to increase expression of stress response genes such as FoxO3A and MT2 
[14]. In this report we determined the effect of βHB on lifespan in C. elegans and determined the 
cytoprotective signaling pathways required for this effect. We then determined the effects of 
βHB on proteotoxicity in nematode models of AD, PD, and amyotrophic lateral sclerosis (ALS). 
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5.3 Results 
5.3.1 D-beta-hydroxybutyrate extends the lifespan of C. elegans 
Addition of 2, 10, or 20 mM DL-beta-hydroxybutyrate (βHB) to the culture medium of 
C. elegans feeding on heat-killed E. coli increased lifespan with 20 mM having the greatest 
effect, increasing mean lifespan by 26%, from 17.2  to 21.7 days   (Figure 5.1A). 50 mM and 100 
mM concentrations decreased lifespan. Therefore a 20 mM concentration was used in further 
experiments. When C. elegans were fed live E. coli, 20 mM βHB only extended mean lifespan 
by 14%, from 16.0 to 18.3 days. This is likely due to catabolism of a portion of the βHB by the 
bacteria. To determine if the lifespan extension was due to D-βHB or L-βHB, we performed 
lifespan experiments with each isomer separately and found that only D-βHB addition resulted in 
lifespan extension (Figure 5.1B). 
 
Figure 5.1. D-βHB extends the lifespan of N2 C. elegans worms. (A) Concentration dependency of βHB-
mediated extension of lifespan. (B) D-βHB, but not L-βHB addition led to lifespan extension. When no D 
or L prefix is present, βHB refers to DL-βHB. 
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5.3.2 βHB or butyrate individually, but not when combined, extend the lifespan of C. 
elegans 
The histone deacetylase (HDAC) inhibitors sodium butyrate and valproic acid have been 
shown to extend lifespan in C. elegans [32, 33]. Since βHB has a similar chemical structure as 
butyrate and since βHB has been shown to inhibit class I and IIa histone deacetylases (HDACs 1, 
3, and 4) in mammals with a Ki of 2-5 mM [13], we determined if βHB could further extend the 
lifespan of sodium butyrate treated worms.  As shown in Figure 2A, and as previously found by 
others [33], sodium butyrate extended lifespan, but strikingly the combination of sodium butyrate 
and βHB led to a slightly decreased lifespan. This data is consistent with the possibility that βHB 
is functioning as an HDAC inhibitor as HDAC inhibitors such as valproic acid are known to 
cause decreased lifespan at higher concentrations in C. elegans ([32]. The combination of 
sodium butyrate and βHB likely has an additive inhibitory effect on HDAC activity, thereby 
decreasing lifespan. βHB addition also decreased the lifespan of worms treated with valproic 
acid (Supplementary Table 5.1), likely through a similar mechanism. 
5.3.3 Inhibition of HDA-2 and HDA-3 play a role in βHB-mediated lifespan extension 
Many general HDAC inhibitors inhibit both class I and class II HDAC enzymes [13, 34].  
The C. elegans genome has 3 class I HDACs, hda-1, hda-2, and hda-3. In addition there are 5 
class II HDACs, hda-4, hda-5, hda-6, hda-10, and hda-11, with hda-4 being the only member of 
class IIa [35]. To determine if HDAC inhibition plays a role in βHB-mediated lifespan extension, 
we knocked down the 3 class I HDACs in C. elegans by RNAi in the presence or absence of 
βHB and determined the effect on lifespan. RNAi knockdown of hda-1 had no effect on lifespan 
and βHB addition extended lifespan, but to a lesser extent than in the absence of knockdown 
(Fig. 5.2B).  However, RNAi knockdown of either hda-2 (Fig. 5.2C) or hda-3 (Fig. 5.2D) 
 163 
 
extended C. elegans lifespan, by 13% and 16% respectively, and prevented βHB from further 
extending lifespan. Therefore βHB likely extends lifespan in part through inhibition of hda-2 and 
hda-3.  We also performed lifespan analysis using hda-2(ok1479), hda-3(ok1991), hda-4(ok518), 
and hda-10(ok3311) mutant worms (Supplementary Figure 5.9 A-D). All of the HDAC mutant 
strains had roughly 30% decreased mean lifespans indicating that a partial knockdown, but not 
full knockout of HDA-2 or HDA-3 activity promotes lifespan extension. Consistent with the 
RNAi knockdown results, βHB addition did not extend the lifespan of the hda-2 or hda-3 mutant 
animals.  However, βHB addition did lead to lifespan extension in the hda-4 and hda-10 mutants, 
suggesting βHB primarily extends lifespan through inhibiting the class I HDACs in C. elegans.   
5.3.4 F55E10.6 is likely a D-βHB inducible βHB dehydrogenase gene 
There is no strong homolog of human mitochondrial BDH1 in C. elegans.  However, a 
BLASTP search identified 4 candidate genes with 38-41% protein sequence identity with BDH1 
(dhs-2, dhs-20, dhs-16 (a 3-hydroxysteroid dehydrogenase [36]), and F55E10.6 (similar to 
human microsomal retinol dehydrogenase [37] and hydroxysteroid dehydrogenases [38]).  DHS-
2, DHS-16, and DHS-20 have been predicted to have a mitochondrial localization [39] like 
BDH1, however DHS-20 has also been predicted to have an ER localization [40] as has 
F55E10.6 [41].  Therefore, we knocked down each of the 4 candidates individually in the worms 
grown in the absence or presence of D-βHB and measured D-βHB dehydrogenase activity in the 
worm extracts. None of the knockdowns showed decreased basal D-βHB dehydrogenase activity.  
However, we found that adding D-βHB to the growth medium resulted in a 2-fold increase in D-
βHB dehydrogenase activity and knockdown of F55E10.6 largely prevented this increased D-
βHB dehydrogenase activity (Fig. 5.3A), suggesting that F55E10.6 likely encodes the D-βHB 
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inducible D-βHB dehydrogenase activity. Knockdown of either dhs-2 or dhs-16 increased the 
ability of D-βHB to upregulate D-βHB dehydrogenase activity.   
 
Figure 5.2. βHB-mediated HDAC inhibition plays a role in lifespan extension.  (A) Survival of N2 
worms in the presence of βHB, butyrate, or both compounds together.  (B) Effects of hda-1, (C) hda-2, or 
(D) hda-3 RNAi knockdown on C. elegans lifespan in the presence or absence of 20 mM βHB. 
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We also found that adding L-βHB to the culture medium resulted in a roughly 3-fold 
increase in D-βHB dehydrogenase activity in the worm extracts that was independent of the 
expression of F55E10.6, dhs-2, dhs-16, or dhs-20 (Figure 5.3B), suggesting L-βHB induces a 
separate D-βHB dehydrogenase enzyme. Consistent with this data, when worms were cultured 
with a racemic mixture of 20 mM βHB (DL-βHB) we found an almost additive 4.5-fold increase 
in D-βHB dehydrogenase activity (data not shown). 
We also measured L-βHB dehydrogenase activity in the worm extracts (Supplementary 
Figure 2). There was roughly 5-fold lower basal L-βHB dehydrogenase activity than D-βHB 
dehydrogenase activity in the worm extracts (data not shown). Adding D-βHB to the culture 
medium yielded a roughly 50% increase in L-βHB dehydrogenase activity in control worm 
extracts that was almost completely blocked by RNAi knockdown of F55E10.6. Therefore, the 
F55E10.6 βHB dehydrogenase activity can likely utilize either D-βHB or L-βHB as substrates, 
but the activity with D-βHB appears roughly 10-fold higher than with L-βHB. Interestingly, 
knockdown of dhs-2, dhs-16, or dhs-20 decreased basal L-βHB dehydrogenase activity in the 
extracts (Supplementary Figure 5.10).  Determining whether any of these genes play a direct role 
in L-βHB metabolism, or if a gene encoding an enzyme with L-βHB dehydrogenase activity is 
down-regulated by knockdown of these genes awaits further investigation. 
5.3.5 F55E10.6 is required for βHB-mediated longevity 
To determine if βHB-mediated upregulation of F55E10.6 was essential for the effect of 
βHB on longevity, lifespan was monitored in worms in which expression of F55E10.6 was 
knocked down by RNAi feeding.  RNAi knockdown of F55E10.6 increased lifespan by 7% and 
unexpectedly completely prevented lifespan extension induced by βHB supplementation (Figure 
5.4A).  F55E10.6 is a SKN-1 transcriptional target [42]. 
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Figure 5.3. D-βHB dehydrogenase activity in worm extracts following RNAi-mediated gene knockdown. 
(A) D-βHB dehydrogenase activity following worm culture in the absence or presence of 10 mM D-
βHB. Conditions in the legend refer to the culture conditions. The genes F55E10.6, dhs-2, dhs-16, or dhs-
20 were knocked down by RNAi feeding (* p < 0.05 compared to Control + 10 mM D-βHB; # p < 0.05 
compared to Control). (B) D-βHB dehydrogenase activity following worm culture in the absence or 
presence of 10 mM L-βHB. The assay conditions were the same as panel A (# p < 0.05 compared to 
Control). 
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SKN-1 is a homolog of mammalian Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) 
and a transcriptional regulator that induces the expression of genes involved in antioxidant 
defense and xenobiotic metabolism to promote longevity. Therefore, addition of βHB to the 
culture media activates SKN-1, which induces expression of F55E10.6. F55E10.6 could either 
metabolize βHB or metabolize another endogenous substrate leading to lifespan extension. 
It is possible that metabolism of βHB, either dependent or independent of F55E10.6, is 
required for lifespan extension. This increased βHB metabolism may increase TCA cycle and 
electron transport chain (ETC) activity increasing ROS production, which has been shown to 
lead to lifespan extension in C. elegans [43]. Therefore we determined if administration of the 
antioxidant and glutathione precursor N-acetylcysteine (NAC) prevented the lifespan extension 
induced by βHB. As shown in Figure 5.4B, NAC by itself moderately increased lifespan, but 
NAC supplementation did not prevent lifespan extension mediated by βHB. Therefore, βHB is 
likely extending lifespan through a mechanism that does not require increased ROS production. 
5.3.6 Knockdown of F55E10.6 does not prevent the βHB-mediated increase in oxygen 
consumption 
Since F55E10.6 expression was essential for βHB-mediated lifespan extension, we 
wished to determine if supplemented βHB was being utilized as a respiratory substrate by the 
worms and whether knocking down F55E10.6 would decrease βHB-induced respiratory 
metabolism. Therefore, we determined the effect of βHB supplementation on worm oxygen 
consumption (Figure 5.4C). βHB supplementation increased oxygen consumption by 2.3 fold 
indicating that βHB is being metabolized by the worms. Unexpectedly, we found that RNAi 
knockdown of F55E10.6 in the absence of βHB also increased oxygen consumption by around 
2.3 fold, suggesting that F55E10.6 represses mitochondrial biogenesis or respiratory function.   
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Figure 5.4. F55E10.6 is required for βHB-mediated lifespan extension, but not for βHB-induced oxygen 
consumption. (A) Treatment with βHB did not increase the lifespan of N2 worms fed RNAi to F55E10.6. 
(B) The addition of N-acetyl-L-cysteine (NAC) did not decrease the lifespan of βHB treated worms. (C) 
The effect of 20 mM βHB and RNAi knockdown of F55E10.6 on oxygen consumption (* p < 0.05 vs. 
untreated; # p < 0.05 vs. Control).  (D) The effect of 20 mM βHB treatment on ATP levels in day 4 N2 
worms (p = 0.202). Data are represented as mean +/- SEM. 
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But RNAi knockdown of F55E10.6 did not decrease the βHB-mediated increase in 
oxygen consumption. The results suggest that the metabolism of βHB by F55E10.6 does not play 
a significant role in the use of βHB as an energy substrate for respiration, and so other 
mechanisms likely explain the requirement of F55E10.6 for lifespan extension. 
We also determined the effect of βHB addition on worm ATP levels (Figure 5.4D). ATP 
levels were not significantly altered by βHB addition, although oxygen consumption rates 
increased suggesting that βHB either stimulates energy utilization pathways or decreases the 
coupling efficiency of oxidative phosphorylation. In this regard, we have previously shown that 
growth of C. elegans in the presence of the TCA cycle metabolites malate or fumarate resulted in 
a partial uncoupling of mitochondria [44]. 
5.3.7 SKN-1 and DAF-16 are required for βHB-mediated longevity   
To determine other molecular pathways through which βHB functions to extend lifespan, 
we performed lifespan experiments using worms deficient in common longevity pathways.  In C. 
elegans the SKN-1 transcriptional activator is normally sequestered in the cytoplasm by WDR-
23 and the DDB1/CUL4 ubiquitin ligase complex until the presence of specific xenobiotics or 
reactive oxygen species leads to a disruption of the interaction. This allows nuclear translocation 
of SKN-1 leading to the activation of a phase II detoxification transcriptional response and 
lifespan extension [45, 46]. We next determined if βHB extended the lifespan of worms in which 
SKN-1 levels were knocked down by RNAi feeding. Consistent with a role for SKN-1 and SKN-
1 transcriptional targets such as F55E10.6 in βHB-mediated longevity, βHB did not extend the 
lifespan in these SKN-1 RNAi worms (Figure 5.5A).  Additionally βHB was able to increase 
GFP fluorescence in the gst-4::gfp SKN-1 reporter strain of worms (Figure 5.5B) supporting this 
assertion. βHB was also able to induce expression of this reporter strain following knockdown of 
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the F55E10.6 gene suggesting that F55E10.6 functions downstream of SKN-1 in the longevity 
pathway, as is expected for a SKN-1 transcriptional target. 
Disruption of the DAF-2 insulin receptor signaling pathway is known to extend lifespan 
through activation of the DAF-16 transcriptional activator. DAF-16 is homologous to 
mammalian FOXO genes. βHB supplementation to worms homozygous for the daf-16(mgDf50) 
null allele did not lead to lifespan extension (Figure 5.5C). Furthermore, βHB supplementation 
slightly increased fluorescence of the sod-3::gfp DAF-16 reporter strain of worms (Figure 5.5D), 
supporting the ability of βHB treatment to activate DAF-16 activity for lifespan extension.  
Butyrate treatment also led to a similar small increase in GFP fluorescence of the sod-3::gfp 
worms suggesting a similar mechanism through which βHB and butyrate extend lifespan. 
Another transcriptional regulator linked to longevity is hypoxia inducible factor-1 (HIF-
1) [47]. We hypothesized that βHB catabolism would increase the concentration of TCA cycle 
metabolites that inhibit the alpha-ketoglutarate-dependent degradation of HIF-1 by the 
proteasome [48, 49] initiated by the EGL-9 prolyl hydroxylase [50]. However, we found that 
βHB supplementation did not increase fluorescence in the nhr-57::gfp reporter strain [47] for 
HIF-1 transcriptional activity (Supplementary Figure 3A). In addition supplementation with 10 
mM pyruvate, or the TCA cycle metabolites citrate, succinate, fumarate, malate, or oxaloacetate 
also failed to induce GFP expression (Supplementary Figure 5.12B) suggesting that C. elegans 
HIF-1 may be regulated slightly differently than mammalian HIF-1. 
5.3.8 βHB increases thermotolerance 
Since lifespan extension, and DAF-16 and SKN-1 activation in particular, has been 
linked to stress resistance, we determined the effect of βHB supplementation on thermotolerance 
in C. elegans.   
 171 
 
 
Figure 5.5. SKN-1 and DAF-16 are required for βHB-mediated lifespan extension. (A) βHB addition did 
not increase the lifespan of N2 worms fed RNAi to knockdown expression of skn-1. (B) βHB addition 
increased fluorescence of the gst-4::gfp SKN-1 reporter strain.  Data are represented as mean +/- SEM (* 
p < 0.05).  (C) βHB addition did not increase lifespan in daf-16(mgDf50) mutant worms. (D) βHB or 
butyrate increased fluorescence when administered to the sod-3::gfp DAF-16 reporter strain.  Data are 
represented as mean +/- SEM (* p < 0.05).    
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Figure 6. Treatment with βHB increases thermotolerance (log-rank p < 0.001) in N2 worms when 
upshifted from 20°C to 35°C. βHB mean survival time = 5.7 hours. Control mean survival time = 4.5 
hours. 
 
As shown in Figure 5.6, βHB administration extended the mean survival time of the 
worms after they were shifted to an elevated temperature by 22%. Due to the increased 
thermotolerance we hypothesized that heat shock proteins were induced by βHB 
supplementation. Therefore we monitored GFP fluorescence in 4 heat shock reporter strains of 
worms following βHB treatment.  
We used the strains hsp-6::gfp and hsp-60::gfp to monitor the mitochondrial unfolded 
protein response [51], hsp-4::gfp to monitor ER stress, and hsp-16.2::gfp to monitor heat shock 
factor-1 (HSF-1)-mediated gene expression [52]. βHB supplementation did not induce 
expression of any of these four reporter strains. Therefore βHB supplementation does not induce 
a broad heat shock response, even though thermotolerance was increased. 
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5.3.9 Decreased protein synthesis rates likely contribute to βHB-mediated lifespan 
extension 
Recently it has been recognized that several of the common longevity pathways converge 
to decrease the rate of translation initiation to extend lifespan [53, 54]. This can occur through 
several mechanisms including preventing phosphorylation of ribosomal protein S6 by S6 kinases 
of the TOR signaling pathway, blocking phosphorylation of eukaryotic initiation factor 4E 
(eIF4E) binding proteins (4E-BPs) by the TOR kinase, or by activation of general control 
nonderepressible 2 (GCN2) kinase. GCN2 activation can occur in the presence of uncharged 
tRNAs due to amino acid restriction [55] or during times when mitochondria produce high levels 
of reactive oxygen species [56]. C. elegans appears to lack close functional homologs of 
mammalian 4E-BPs [57] (although one distant homolog has been reported [58]), so they likely 
control the rate of translation initiation mainly through the p70 S6 kinase homolog RSKS-1 and 
the worm GCN2 homolog GCN-2. Therefore, we obtained the mutant strains rsks-1(ok1255) and 
gcn-2(ok871) and performed lifespan analysis in the absence or presence of βHB. The untreated 
lifespan of the rsks-1 mutant was greater than that of the N2 control (Fig. 5.7A) as expected, 
while the untreated lifespan of the gcn-2 mutant was less than the N2 control (Fig. 5.7B). With 
either strain, we found that βHB-mediated lifespan extension was greatly blunted compared to 
the effect on the N2 control strain. There was a 5% mean lifespan extension in the βHB-treated 
rsks-1 mutant and a 8% mean lifespan extension in the βHB-treated gcn-2 mutant compared to 
the 26% lifespan extension in the βHB-treated N2 control. Therefore, the ability to decrease 
translation rates through both the TOR/RSKS-1 and GCN-2 pathways likely allows for full βHB-
mediated lifespan extension in the wild-type N2 animals. 
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Figure 5.7. A decreased rate of protein synthesis contributes to βHB-mediated longevity. (A) βHB-
mediated lifespan extension was blunted in rsks-1(ok1255) mutant worms. (B) βHB-mediated lifespan 
extension was also blunted in gcn-2(ok871) mutant worms. 
 
5.3.10 ETC Complex I function is needed for full βHB-mediated lifespan extension 
Following mitochondrial βHB dehydrogenase function, acetoacetate is converted to 
acetoacetyl-CoA with the concurrent conversion of succinyl-CoA to succinate as a byproduct of 
the succinyl-CoA: 3-ketoacid CoA transferase reaction.  Because of this succinate production, it 
has been suggested that βHB protected a PD cell model by increasing mitochondrial ETC 
complex II (succinate dehydrogenase) activity, bypassing the ETC complex I deficits present in 
the disease [30].  To determine if normal mitochondrial ETC complex I or complex II activity is 
required for βHB-mediated lifespan extension, we determined the effect of βHB supplementation 
on the lifespan of short-lived complex I-defective gas-1(fc-21) mutants [59] (Figure 5.8A) and 
short-lived complex II defective mev-1(kn1) mutants [60] (Figure 5.8B). βHB extended the 
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lifespan of the gas-1 mutant by 11%, but not to the full 26% extent observed in wild-type worms.  
Therefore, normal ETC complex I function is necessary for the full effect of βHB on longevity.  
βHB supplementation fully extended the lifespan of mev-1 mutants indicating that βHB does not 
require normal ETC complex II function to extend lifespan. 
5.3.11 βHB-mediated longevity requires AAK-2, SIR-2.1, CBP-1, and may occur in a 
similar manner as in DR  
To identify if other important longevity regulators are required for βHB-mediated 
longevity, βHB was supplemented to AMP kinase (AMPK) aak-2(TG38) mutant worms (Figure 
5.9A) and sir-2.1(ok434) NAD-dependent protein deacetylase mutant worms (Figure 5.9B) and 
lifespan was monitored.  βHB addition did not extend the lifespan of either strain suggesting that 
both proteins play a role in βHB-mediated longevity. Since ketone body levels rise during caloric 
restriction (CR) in mammals and increased βHB levels may be responsible for some portion of 
the increased stress and disease resistance conferred by CR, we determined the effect of βHB 
supplementation on lifespan in the nematode eat-2(ad1116) model of dietary restriction (DR) in 
which pharyngeal pumping is slowed (Figure 5.9C). We found that treatment with βHB had no 
significant effect on the longevity of eat-2 worms suggesting that βHB extended lifespan using 
some of the same downstream effectors activated in DR. The CREB binding protein-1 (CBP-1) 
transcriptional co-activator and protein acetyltransferase has been shown to be essential for DR-
mediated longevity in C. elegans [33]. Therefore we determined the effect of βHB on lifespan in 
worms where cbp-1 expression was knocked down by RNAi (Fig. 5.9D). Consistent with βHB 
extending lifespan in a manner similar to DR, knocking down cbp-1 prevented lifespan extension 
induced by βHB treatment. 
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Many of the same compounds that extend lifespan in C. elegans in a CBP-1 dependent 
manner also protect against glucose toxicity [61]. It’s been shown that C. elegans shows a 
reduced lifespan when grown in a high glucose containing media [62-64]. When we grew worms 
in 50 mM glucose, lifespan was decreased by roughly 30% (Figure 5.10A). βHB 
supplementation to the glucose-containing media partially restored the lifespan, resulting in a 
lifespan reduction of only 21% compared to the non-glucose treated controls. 
 
 
Figure 5.8. βHB extends the lifespan of short-lived mitochondrial ETC complex I and complex II 
mutants. (A) gas-1(fc21) survival in the absence and presence of βHB. (B) mev-1(kn1) survival in the 
absence and presence of βHB.  
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Figure 5.9. βHB extends lifespan in a similar manner as DR and requires AAK-2, SIR-2.1, and CBP-1. 
(A) βHB does not extend lifespan of AMPK mutant aak-2(TG38) worms, (B) sir-2.1(ok434) worms, or 
(C) eat-2(ad1116) worms. (D) Additionally, βHB does not extend the lifespan cbp-1 RNAi knockdown 
N2 worms. 
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5.2.12 βHB delays Aß-induced paralysis and decreases alpha-synuclein aggregation 
We next performed experiments using a strain of worms engineered to express human 
AD-associated Aß peptide within body wall muscle upon temperature upshift from 16° to 25°C, 
which leads to paralysis of all worms by 32 hours after upshift [65].  Figure 10B shows the 
paralysis over time in these worms in the presence and absence of βHB treatment. βHB increased 
the mean paralysis time following Aß induction by 15%, from approximately 26 to 30 hours.  
Since βHB supplementation was beneficial in this model of proteotoxicity, we next determined 
the effects of βHB administration on a PD-model worm strain expressing human α-synuclein 
fused to yellow fluorescent protein (YFP) in the body wall muscle [66]. Alpha-synuclein protein 
is prone to aggregation and is the major protein constituent of Lewy bodies in PD brain [67].  
YFP aggregation and fluorescence was decreased by 35% in worms treated with βHB for 8 days, 
indicating a protective decrease in the levels of alpha-synuclein aggregates (Figure 5.10C). 
A ketogenic diet has been shown to delay loss of motor performance and loss of spinal 
cord motor neurons in the SOD1-G93A mouse model of amyotrophic lateral sclerosis (ALS) 
[68]. So lastly, we performed experiments using worms overexpressing human TDP-43 [69], 
which forms insoluble aggregates in the nervous system of patients with ALS and other 
neurodegenerative disorders [70] and when expressed in the nervous system of worms [69].   
TDP-43 expression caused a greatly reduced lifespan in C. elegans both when grown at 20°C 
and when grown at 16°C (Supplementary Table 1). 20 mM βHB supplementation was unable to 
prevent the reduction in lifespan (Figure 10D). Concentrations of βHB from 2 mM to 200 mM 
were also tested. Only 30 mM βHB was found to be effective at delaying toxicity and the 
increase in longevity at this concentration was only 5%. 
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Figure 5.10. βHB protects against glucose toxicity and proteotoxicity. (A) Treatment with βHB partially 
protects against 50 mM glucose-induced reduction of lifespan in N2 worms. (B) Survival of the CL4176 
strain of C. elegans expressing Aβ in muscle following temperature upshift. Treatment with βHB 
increases the time to paralysis (log-rank p < 0.001).  βHB-treated mean lifespan = 29 hours, untreated 
control mean lifespan = 26 hours.  The curves are generated from the results of six assays (n > 500 for 
both groups).  (C) Treatment with βHB decreases α-synuclein-GFP aggregation in the NL5901 strain   
GFP fluorescence readings were taken on day 8 of worm lifespan. Data are represented as mean +/- SEM.  
(log-rank p < 0.001) (D) 20 mM βHB did not protect against the shortened lifespan induced by human 
TDP-43 overexpression when the worms were grown at 16°C. 
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5.4 Discussion 
Administering βHB to C. elegans extended lifespan and delayed proteotoxicity and 
glucose toxicity. βHB extended C. elegans lifespan in a SIR-2.1 and AMPK-dependent manner 
that also required the stress-responsive transcription factors DAF-16 and SKN-1. Since βHB did 
not extend lifespan in eat-2 pharyngeal pumping mutants, βHB likely acts as a dietary restriction 
mimetic, as previously hypothesized for its effects in mammals [71]. Even though protective 
effects of D-βHB on rodent disease models are known, this is the first report to identify D-βHB 
as a positive modulator of organismal longevity in wild-type animals. We also identified many of 
the signaling pathways and genes required for this effect. A key finding is that D-βHB-mediated 
lifespan extension requires SKN-1 and its transcriptional target F55E10.6, a short-chain 
dehydrogenase/reductase with βHB dehydrogenase activity, although inhibition of HDACS 
HDA-2 and HDA-3 are also required for the increased longevity. 
5.4.1 The role of F55E10.6 in βHB-mediated lifespan extension 
The βHB dehydrogenase enzyme assay data suggest that F55E10.6 is a D-βHB-inducible 
βHB-dehydrogenase enzyme. However, D-βHB may not be the preferred physiological substrate 
for the enzyme or the substrate required for lifespan extension. Since knockdown of F55E10.6 
did not affect the increased oxygen consumption following βHB supplementation, the enzyme 
does not likely possess a mitochondrial localization producing NADH for ETC complex I 
function.  In this regard in addition to sharing homology with mitochondrial BDH1, F55E10.6 
shares homology with microsomal retinol dehydrogenases [37] and microsomal hydroxysteroid 
dehydrogenases [38]. Due to these homologies and the role that SKN-1 plays in controlling the 
ER stress response [41], F55E10.6 has been putatively assigned an ER localization [41], 
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although no signal peptide was found [40].  Key to its localization, F55E10.6 is predicted to have 
a transmembrane domain [40]. 
It is of interest that knockdown of F55E10.6, a SKN-1 target gene increased C. elegans 
oxygen consumption, suggesting that SKN-1 signaling may decrease mitochondrial biogenesis or 
function. Expression of F55E10.6 has been shown to decline with aging [72], likely due to the 
aging-related decline in activity of SKN-1 [42]. The mammalian SKN-1 homolog Nrf2 is also 
known to play a role in mitochondrial biogenesis. When overexpressed Nrf2 was shown to be a 
negative modulator of mitochondrial mass and membrane potential in a high throughput screen 
using C2C12 myoblast cells [73].  However, when upregulated under physiological conditions 
Nrf2 was found to be a positive regulator of mitochondrial biogenesis by inducing nuclear 
respiratory factor-1 (NRF-1) and peroxisome proliferator-activated receptor gamma coactivator 
1-alpha (PGC- [74], liver [75], and lung [76]. 
5.4.2 Full βHB-mediated lifespan extension requires mitochondrial ETC complex I function  
βHB-induced lifespan extension was partially blocked in ETC complex I mutant worms 
and was unaffected in mitochondrial ETC complex II mutant worms. This likely suggests that 
the lifespan extension is driven partly by βHB metabolism-independent effects and partly by 
metabolism-dependent effects. Normal complex I activity may be needed to maintain a high 
NAD/NADH ratio beneficial for maximal lifespan extension [77]. In this regard, it has been 
shown that rotenone can induce a roughly 10-fold reduction in C. elegans respiration, but only a 
2-fold reduction occurred in the presence of 10 mM βHB [78]. Therefore, βHB either stabilized 
complex I function in the presence of rotenone or stimulated complex II-dependent respiration to 
bypass this block of complex I function. In mammals βHB has been shown to stabilize and 
increase the efficiency of ETC complex I [68, 79]. The increased rate of NADH oxidation in the 
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presence of βHB led to decreased ROS levels in mouse neocortical neurons following glutamate 
excitotoxicity [79]. βHB may also enhance complex I activity in worms, but it may not be able to 
fully do so in the gas-1 mutants preventing full lifespan extension. 
5.4.3 Proposed mechanism for βHB-mediated lifespan extension 
We propose 2 possible mechanisms for lifespan extension mediated by βHB 
supplementation. In the first mechanism (see Supplementary Figure 5), we propose that βHB 
directly inhibits HDACs to increase histone acetylation [14] causing gene expression changes 
ndependent of βHB catabolism. The metabolism-independent 
activation of SKN-1 is consistent with our previous data showing that stimulation of metabolism 
by supplementation of several TCA cycle metabolites did not activate SKN-1 transcriptional 
activity [44]. Next, SKN-1 activity induces expression of F55E10.6 [42, 45], required for proper 
execution of the SKN-1 longevity program. SKN-1 activation has been shown to repress 
expression of the insulin-like peptides DAF-28 and INS-39, decreasing DAF-2 insulin receptor 
signaling to activate DAF-16 [80].  βHB catabolism also likely increases the level of specific 
TCA cycle intermediates, which may contribute to the DAF-16-mediated lifespan extension.  We 
and others have shown that supplementation of the TCA cycle metabolites fumarate, malate, and 
oxaloacetate activated nuclear translocation of DAF-16 to extend lifespan in an AMPK and SIR-
2.1-dependent manner [44, 81]. Others have also found that the TCA cycle metabolite alpha-
ketoglutarate extends lifespan through a TOR kinase-dependent mechanism [82]. Although this 
model is consistent with our data, is also possible that βHB-mediated HDAC inhibition causes a 
direct transcriptional upregulation of DAF-16, as βHB-mediated HDAC inhibition directly 
upregulates expression of the DAF-16 homolog FOXO3A in mammals [14]. 
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In addition, βHB metabolism may increase acetyl-CoA levels that serve as a substrate for 
histone acetyltransferases to increase histone acetylation [83], which could strengthen the effects 
of HDAC inhibition to extend lifespan. However, increased cytoplasmic acetyl-CoA levels have 
also been shown to inhibit autophagy [84], which could potentially dampen lifespan extension. 
However, the acetyl group from mitochondrial acetyl-CoA can be transferred to carnitine to form 
acetylcarnitine and exported from mitochondria to the nucleus, where acetyl-CoA is reformed 
and used for nuclear histone acetylation [85]. This mechanism may allow for increased histone 
acetylation without decreased rates of autophagy. 
The second proposed model of how βHB may extend lifespan is through inhibition of the 
insulin signaling pathway. In mammals, it has been shown, contrary to expectations, that βHB 
administration or a ketogenic diet blocks the insulin signaling pathway in muscle leading to 
insulin resistance [86]. This adaptation likely evolved to allow the brain preferential use of the 
bloodstream glucose during starvation. However, a ketogenic diet has also been shown to be 
effective at lowering blood glucose in patients with type II diabetes due to the decreased 
carbohydrate intake [87]. In mouse studies, βHB administration yielded a 50% reduced 
phosphorylation and activity of Akt/protein kinase B downstream of the insulin receptor 
decreasing insulin signaling [86]. The mechanism for this βHB-mediated inhibition of Akt and 
the insulin signaling pathway was not fully elucidated, but it relied upon administration of D-
βHB and not L-βHB, suggesting that mitochondrial metabolism of D-βHB may be involved. In 
C. elegans, inhibition or decreased expression of Akt or other proteins of the insulin signaling 
pathway have been shown to activate both DAF-16 and SKN-1 leading to lifespan extension 
[88], thereby providing a potential mechanism for the effect of βHB on longevity.       
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5.4.4 βHB does not induce a broad heat shock response, but still increases thermotolerance 
Although βHB did not induce expression of four specific heat shock proteins monitored 
(Supplementary Fig. 3), it did activate the DAF-16 and SKN-1 signaling pathways, which are 
both likely responsible for the increased thermotolerance observed following βHB treatment.  
Previous research has shown that RNAi knockdown of either skn-1 or daf-16 decreased 
thermotolerance [89]. DAF-16 is known to induce expression of several heat shock proteins 
including hsp-12.6, sip-1, and hsp-16.1, which may play a role in the increased thermotolerance. 
The factors that SKN-1 induce to confer thermotolerance are less clear, although SKN-1 function 
has been implicated in the induction of hsp-4 expression and activation of the ER stress response 
[41]. However, we did not find βHB to induce hsp-4::GFP expression, but a positive trend was 
observed (p = 0.18). 
5.4.5 Neuroprotective effects of ketone bodies 
In an AD cell model, βHB has been shown to protect hippocampal neurons from Aß 
toxicity [90]. The protection may have occurred through decreasing ROS levels as decreased 
ROS production is known to lower expression levels of beta-secretase (BACE1), a protease that 
contributes to toxic Aß generation [91]. This mechanism may be responsible for the ketogenic 
diet-induced reduction of Aß levels in a mouse model of AD [22].  The brain’s ability to utilize 
glucose decreases in AD. To prevent deficits in brain ATP levels, βHB has been used as an 
alternative metabolic energy source for patients with AD [25]. Increased inflammation 
accompanies brain aging and may contribute to the development of AD. Increased levels of 
ketone bodies have been shown to reduce inﬂammation [71, 92] and this may result from 
increased mitochondrial efficiency and decreased ROS production [93]. 
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PD is associated with aggregation of alpha-synuclein and death of dopaminergic neurons 
leading to motor decline. Mice treated with βHB showed partial protection against 
neurodegeneration and motor deficiency induced by MPTP [30]. Surprisingly, this was not due 
to increased NADH generation fueling complex I, but was described to be due to an increased 
supply of succinate, a substrate for ETC complex II [94]. As mentioned previously, the 
stimulation of complex II activity by βHB metabolism depends on the increased succinate 
produced as a byproduct of the mitochondrial succinyl-CoA: 3-ketoacid CoA transferase 
reaction. However, since βHB fully extended lifespan in complex II-defective mev-1 mutants, it 
is unlikely that this mechanism plays a substantial role in βHB-mediated lifespan extension. The 
mechanism of βHB-mediated protection in PD models may be similar to the mechanism by 
which βHB supplementation increases lifespan in the complex I-defective gas-1 worms. 
5.4.6 Study limitations and future directions 
Although we were able to dissect many of the pathways through which βHB extends 
lifespan in C. elegans, many questions remain. For example, is the reason that D-βHB but not L- 
βHB extended lifespan due to the increased ability of D- βHB to be metabolized or due to the 
higher efficiency of D-βHB as an HDAC inhibitor? Is HDAC inhibition required for βHB-
mediated upregulation of SKN-1 or DAF-16 activity? In addition to extending lifespan as shown 
here, RNAi knockdown of the class I HDAC hda-3 was shown to protect against polyglutamine-
mediated toxicity in a C. elegans Huntington’s disease, while knockdown of most other HDACs 
increased toxicity [95]. Is HDAC inhibition or SKN-1 activity required for DAF-16 activation by 
βHB? Also is βHB catabolism required for βHB-mediated SKN-1 or DAF-16 activation?  
Furthermore, is the transcription factor PHA-4/FoxA, which is required for DR-mediated 
longevity [96], also required for βHB-mediated longevity? In this regard mammalian Foxa2 is 
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known to induce expression of BDH1 [97]. Do βHB levels increase in DR worms and if so does 
this play a role in DR-mediated longevity? Lastly, are the same signaling pathways required for 
longevity also required for βHB-mediated protection in the C. elegans models of Aß and alpha-
synuclein toxicity? Future experiments will provide answers to these questions and elucidate the 
molecular mechanisms responsible for the protective effects of βHB. This knowledge will allow 
for a broader use of βHB as a therapy for aging-related disorders. 
5.5 Conclusions 
βHB treatment extended lifespan and protected against metabolic, proteotoxic and 
thermal stress in C. elegans. βHB-mediated lifespan extension occurred through induction of the 
DAF-16 and SKN-1 signaling pathways and was dependent upon βHB-mediated inhibition of 
HDACs HDA-2 and HDA-3. Our data support the hypothesis that βHB is a DR mimetic and that 
βHB treatment will likely be useful in the treatment of many human aging-associated disorders.  
5.6 Supporting information 
 
Figure 5.11. L-βHB dehydrogenase activity in worm extracts grown in the absence or presence of 10 mM 
D-βHB. Knockdown of F55E10.6 almost completely prevented the increased L-βHB dehydrogenase 
activity induced by culturing with D-βHB (* p < 0.05 vs. (Control + 10mM D-βHB)). Knockdown of dhs-
2, dhs-16, or dhs-20 decreased endogenous L-βHB dehydrogenase activity in the extracts (# p < 0.05 vs. 
Control). 
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Figure 5.12. The effect of βHB on lifespan in histone deacetylase mutants. βHB addition 
did not extend the lifespan of (A) hda-2(ok1479) mutant worms or (B) hda-3(ok1991) mutant worms. 
βHB addition extended the lifespan of (C) hda-4(ok518) mutant worms (log-rank p =0.001) and (D) hda- 
10(ok3311) mutant worms (log-rank p =0.002). 
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Figure 5.13. βHB addition does not induce expression of several heat shock proteins. The 
effect of βHB addition on the fluorescence of (A) hsp-6::gfp, (B) hsp-60::gfp, (C) hsp-16.2p::GFP, or 
(D)hsp-4::GFP worms. For (A) and (B) 50 _g/ml ethidium bromide treatment for 2 days was used as a 
positive control. For (C) and (D) heat shock at 35°C for 2 hours was used as a positive control. (* p < 
0.05). 
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Figure 5.14. βHB, pyruvate, or TCA cycle metabolites do not activate HIF-1 transcriptional 
activity. The effect of (A) βHB, (B) pyruvate, or TCA cycle metabolites on GFP fluorescence in nhr-
57::gfp worms. 20 _M potassium cyanide was used as a positive control. (* p < 0.05). 
 
 
Figure 5.15. One possible mechanism through which βHB may extend lifespan in C. elegans. 
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CHAPTER 6 
SIGNIFICANCE OF FINDING COMPOUNDS THAT INFLUENCE AGING 
6.1 Summary 
 Our studies focus on discovering supplemented metabolites that attenuate aging and age-related 
decline and elucidating the genetic pathways involved. In Chapter 3 we show that the TCA cycle 
metabolites malate and fumarate increased the lifespan of C. elegans via the non-mammalian glyoxylate 
shunt and malate dismutation/fumarate reduction pathways. Further, we identified that the SIR-2.1 and 
DAF-16 proteins were necessary for malate-mediated lifespan extension. The next step was to examine 
(in Chapter 4) the effects on the rate of aging of amino acids that catabolize into TCA metabolites.  We 
show that individual amino acid supplementation increased the lifespan of C. elegans and the pathways 
involved vary from one amino acid to the next. Various longevity pathways including DAF-16, SKN-1, 
AAK-2, SIR-2.1, GCN-2, heat shock, autophagy, CR, and inhibition of TOR signaling were involved in 
protective effects. Finally, we looked at alternative mitochondrial energy sources and found that βHB 
treatment extended lifespan and protected against metabolic, proteotoxic, and thermal stress in C. elegans.  
βHB-mediated lifespan extension occurred through induction of the DAF-16 and SKN-1 signaling 
pathways and relied upon βHB-mediated inhibition of HDACs.  Our data support the hypothesis that 
βHB is a CR mimetic and that treatment with βHB will likely be beneficial in the management of 
many human aging-related disorders.  
 Although TCA cycle metabolites, most amino acids, and βHB are produced naturally 
within cells, this does not denote that the metabolites, when administered through feeding, will 
act in the same manner. One can assume that CR induced ketosis, when compared to βHB 
supplementation, activates alternate signaling pathways and ketones are catabolized for energy in 
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various tissues to different extents. The same rationale applies to TCA cycle metabolites and 
amino acids.  
6.2 TCA Cycle metabolites and aging 
As described in Chapter 3, changes in energy metabolism influence epigenetic 
mechanisms and can alter the aging process. The TCA cycle is a central pathway for metabolism 
and much data implicate its function in the control of longevity [1]. Proper coordination between 
the electron transport chain and the TCA cycle is necessary to maintain a normal NAD+/NADH 
ratio beneficial to long life. The function of the mitochondrial electron transport chain, which 
oxidizes NADH and FADH2, decreases with age across species [2], which leads to a reduced 
cellular NAD+/NADH ratio during aging. Anti-aging therapies such as CR increase the 
NAD+/NADH ratio in many tissues as a possible mechanism to delay aging.   
 
Figure 6.1. The TCA Cycle 
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In an effort to understand if TCA cycle intermediates could rescue mitochondrial 
dysfunction during the aging process in C. elegans, we performed lifespan assays supplementing 
TCA cycle metabolites into the worm’s diet. Yeast mutants with increased lifespan have been 
shown to have increased levels of TCA cycle metabolites [3].  In Chapter 3, we showed that 
malate and fumarate addition extend lifespan in C. elegans and the addition of TCA cycle 
intermediates increased the NAD
+
/NADH ratio, likely contributing to lifespan extension. 
Increased NAD
+
 levels activate the histone deacetylase SIR-2.1 [4] and AMP kinase [5], both 
known to interact with DAF-16 to increase lifespan. Through knockdown models we showed 
that malate-mediated lifespan extension is dependent upon SIR-2.1 and AMP kinase. Malate 
supplementation resulted in DAF-16 translocation to the nucleus and transcription of DAF-16 
target genes, which likewise plays an essential role in lifespan extension.  In Chapter 4 we show 
that a lower concentration of succinate (when compared to malate) results in lifespan extension, 
which supported data from Chapter 3 indicating that succinate addition induces DAF-16 nuclear 
translocation.  
We also hypothesized that addition of malate or fumarate to C. elegans leads to activation 
of the glyoxylate shunt. Glyoxylate shunt activity increases the NAD
+
/NADH ratio as the shunt 
bypasses two of the three NADH generating reactions of the TCA cycle resulting in a 
conservation of NAD
+
. Isocitrate is reversibly converted into succinate and glyoxylate by the 
isocitrate lyase activity.  The glyoxylate shunt malate synthase enzymatic activity catalyzes the 
reversible conversion of malate and CoA to glyoxylate and acetyl-CoA that may also be 
important for malate-mediated lifespan extension. Upregulation of shunt activity would increase 
NAD
+
 levels, though metabolism under these conditions likely becomes limited by FAD levels, 
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so malate dismutation is activated to oxidize FADH2 to FAD. Further research should target the 
role of the FAD/FADH2 ratio in lifespan determination. We did find that addition of FAD to 
worm media increased lifespan (data not shown). 
6.3 NAD
+
 metabolism and aging 
Mammals convert tryptophan to NAD+ through quinolinic acid in the de novo NAD+ 
synthesis pathway [6]. When looking at the C. elegans genome, the first gene in the pathway for 
quinolinic acid conversion to NAD+ appears to be absent. Therefore it was first assumed that 
worms must utilize the NAD+ salvage pathway rather than direct de novo synthesis. The first 
enzyme in the NAD+ salvage pathway is nicotinamidase that catalyzes the conversion of 
nicotinamide to nicotinic acid. There are three nicotinamidases found in C. elegans, two PNC-1 
isoforms and PNC-2. Male worms with mutations in PNC-1 are infertile while hermaphrodites 
with the same mutation display muscle impairment [7]. Knockdown of the NAD+ salvage 
pathway in worms decreases lifespan, but since it is not lethal there may be additional genes that 
play a role in quinolinic acid conversion to NAD+.  So therefore, there is likely a mechanism 
present in worms to convert tryptophan to NAD+ (see Fig. 2), which I hypothesize to play a role 
in tryptophan-mediated longevity.  During CR in yeast, PNC-1 activity and expression is 
upregulated to convert the Sir2 inhibitor NAM to nicotinic acid, resulting in increased Sir2 
activity [8]. Given that malate supplementation increased lifespan through SIR-2.1, it is plausible 
that PNC-1 is upregulated through the addition of TCA cycle metabolites (Fig 2). This is 
supported by our data that malate supplementation greatly increased NAD(H) levels in C. 
elegans (see Chapter 3).Therefore further investigation of TCA cycle metabolite supplementation 
in conjunction with RNAi knockdown of PNC-1 would further elucidate the mechanism by 
which malate, fumarate, oxaloacetate, and alpha-ketoglutarate extend lifespan.  
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Figure 6.2. The C. elegans NAD salvage pathway. Malate may be increasing NAD through the indirect 
upregulation of pnc-1. 
 
Although increased NAD
+
 levels are important for lifespan extension, the assays used for 
NAD
+
 quantification in C. elegans are difficult. Moreover, when assays optimized for 
mammalian cell culture or tissues are changed and utilized with C. elegans, the possibility of 
errors in the results are increased. The main reason for this is that C. elegans possess a hard 
cuticle that may be incompletely disrupted when performing assays to release small molecule 
metabolites such as NAD
+
. Therefore, the results may be difficult to replicate. Being that C. 
elegans have become a popular model for aging, the need for nematode specific protocols is 
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necessary for accurate and reproducible results. A recent study provided evidence that altered 
NAD
+
 homeostasis and mitochondrial dysfunction accompany age-related decline using a novel, 
non-invasive, resonance-based, in vivo NAD
+
 assay to monitor NAD
+
 concentrations in the 
human brain [9]. This non-invasive method could be adapted for use on C. elegans to follow 
NAD
+
 homeostasis throughout their lifespan. Further, this method could more accurately verify 
if addition of metabolites, such as malate, are increasing NAD
+
 levels in long-lived worms.  
6.4 Mitochondrial membrane potential and aging 
The pumping of protons by the electron transport chain together with phosphate-proton 
symporters in the inner mitochondrial membrane creates a mitochondrial membrane potential 
(MMP) across the inner membrane. Decreased MMP has been shown to increase lifespan in C. 
elegans [10] and yeast [11]. This is not completely intuitive as the magnitude of the MMP is 
directly proportional to the amount of ATP that can be made by ATP synthase.  However, a high 
MMP also increases ROS production and this ROS production, not ATP levels, may limit 
lifespan. Many long-lived mutants and RNAi knockdown of genes that are associated with 
lifespan extension exhibit a lower MMP when compared to wild-type nematodes. Diminished 
MMP of DAF-2 mutants is reliant on DAF-16, suggesting that DAF-16 is essential for lifespan 
regulation and mitochondrial energy homeostasis. Additionally, studies show that protection by 
mitochondrial uncoupling against neuronal excitotoxicity is dependent on the increased 
phosphorylation state of AMPK  [10]. We showed in Chapter 3 that C. elegans longevity by 
malate supplementation is dependent upon AMPK and DAF-16 activation. Malate also increased 
oxygen consumption, decreased ATP, and was associated with a decline in MMP. Therefore, 
malate may act as a mild mitochondrial uncoupler, leading to the activation of DAF-16 by 
AMPK stimulating increased longevity. Although the use of TMRE and TMRM are common 
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assays used to quantify MMP in C. elegans, results are challenging to reproduce since conditions 
of animal culture vary considerably in the literature. One way to follow up and verify the effects 
of metabolites on MMP is to use multiple types of assays that are developed specifically for 
worms, such as the recently developed assay that incorporates the fluorescent cationic, lipophilic 
carbocyanine dye, DiSC3(3) [12]. DiSC3(3) is a membrane potential sensitive dye used for 
examining in vivo changes in MMP and exhibits fluorescence fluctuations upon membrane 
hyperpolarization (when the matrix space of the mitochondrion becomes more negative). 
Multiple techniques and C. elegans specific assays will improve reproducibility of the results. 
6.5 Mitohormesis and alternate mechanisms of metabolite-mediated longevity 
 Small deviations in cellular metabolism such as through metabolite supplementation can 
activate multiple stress response pathways and upregulate genes associated with longevity such 
as HSF-1, SKN-1, and heat shock proteins. In Chapters 4 we investigate the role of amino acids 
in lifespan extension and identify that many amino acids are acting as hormetics and a few as 
mitohormetics, such as tryptophan and proline. To answer some questions left from Chapter 1, 
we also found that alpha-ketoglutarate supplementation upregulates HSF-1 and the ER stress 
response in GFP reporter strains of worms. Most of the amino acids that extended lifespan the 
greatest: proline, arginine, histidine, glutamine, and glutamate, are catabolized through glutamate 
into alpha-ketoglutarate in the TCA cycle. It was recently shown that alpha-ketoglutarate greatly 
extends lifespan of C. elegans by inhibiting ATP synthase and TOR [13].  Citrate also activates 
an ER stress reporter, however, no lifespan extension was seen when citrate was added to worm 
medium. GFP reporter strains can be dim and heat shock proteins are only one part of the 
hormesis story. Understanding the effect of these metabolites on the ROS defense enzymes 
(SOD, catalase) is necessary and can be achieved by western blot analysis or enzymatic assays 
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specific for catalase and SOD. Monitoring ROS levels in TCA cycle treated young and old 
worms would allow for a better understanding of how the mitochondria is affected and if 
homeostasis is being influenced. 
Although we showed an important role for the glyoxylate shunt and malate dismutation 
in malate-mediated lifespan extension in C. elegans, malate treatment has been shown to be 
beneficial in mammals as well. Therefore, many of the protective effects of malate treatment 
seem to be conserved from nematodes to mammals. Since fumarate, malate, succinate, alpha-
ketoglutarate, isocitrate, and oxaloacetate extend lifespan in C. elegans through a mechanism 
similar to calorie restriction, an anaplerotic cocktail of these compounds may be useful for the 
treatment of human aging-associated disorders. 
6.6 Amino acids function through diverse mechanisms to extend lifespan 
 Amino acids can be deaminated into keto acids and then directly or indirectly fed into 
the TCA cycle. In C. elegans, the mitohormetic effect of proline supplementation extended 
lifespan [14] and knockdown of the enzyme that catabolizes tryptophan also led to lifespan 
extension [15]. Feeding mice a diet high in branched chain amino acids led to increased 
mitochondrial biogenesis in muscle, decreased ROS production, and increased average lifespan 
of males [16]. Due to the incomplete knowledge of the effects of amino acids on longevity as 
well as the widespread use of amino acid and protein supplementation in the human diet we 
determined the effects of individual amino acid supplementation on C. elegans lifespan. In 
Chapter 4, we establish that individual amino acid supplementation increased the lifespan of C. 
elegans and increased stress resistance with serine, proline, and tryptophan showing the greatest 
effects. Perhaps these amino acids are transported into the gut at a faster rate and therefore act as 
quick anaplerotics for the TCA cycle intermediates. Because so little is known about many of the 
 206 
 
amino acids, especially serine, future work should aim at investigating how these metabolites 
contribute to longevity in more complex models. 
Of the 20 amino acids, serine and proline extended lifespan to the largest extent. Proline 
was recently found to be mitohormetic in C. elegans and our data confirms this finding. In 
Chapter 4, we show that the well-studied longevity pathways including DAF-16, SKN-1, AAK-
2, SIR-2.1, GCN-2, heat shock, autophagy, calorie restriction, and inhibition of TOR signaling 
are involved in these protective effects. These different longevity pathways may converge to 
decrease the rate of translation by the ribosome for lifespan extension.  In addition, cysteine and 
tryptophan-induced lifespan extension were independent of SKN-1, so supplementation with 
these amino acids did not likely alter mitochondrial metabolism to increase ROS production. 
 
Figure 6.3. Entry of amino acids into the TCA cycle. 
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As discussed in Chapter 4, the pathways involved with lifespan extension vary from one 
amino acid to the next, but the DAF-16 and AMP kinase longevity pathways appeared to be 
activated by supplementation most, if not all, lifespan extending amino acids. Examples of other 
longevity pathways activated include, serine and histidine stimulating transcriptional activity of 
HIF-1, while other amino acids did not.  Eight lifespan-extending amino acids increased the 
transcriptional activity of SKN-1, but not tryptophan, cysteine, or the lifespan-decreasing amino 
acids phenylalanine and asparagine. Proline has been previously shown to extend the lifespan of 
worms through mitohormesis and it showed the greatest lifespan extension of all the amino 
acids. Another mechanism of lifespan extension observed with proline supplementation may be 
FOXO activation of glutamine synthetase, which inhibits TOR signaling by blocking its 
lysosomal translocation and stimulates autophagy to recycle cellular components [17]. Inhibition 
of TOR activity through upregulation of glutamine synthetase expression may also explain how 
alpha-ketoglutarate, glutamine, arginine, and histidine influence lifespan. Proline can be 
catabolized to glutamate through proline dehydrogenase and 1-pyrroline-s-carboxylate 
dehydrogenase. Prior studies show that an increase in proline dehydrogenase increases 
mitochondrial ROS production, which activates stress signaling genes to extend lifespan. 
Perhaps, the impressive lifespan extending ability of proline is due to a combination of 
mitohormesis and inhibition of TOR signaling. Interesting, plants exposed to various stressful 
conditions accumulate abundant proline reserves. Proline acts as a metal chelator and 
overproduction of proline supports osmotic balance  and prevents oxidative damage in plant cells 
[18]. Similarly, this same trend of proline accumulation is seen in E. coli when undergoing 
hypertonic stress [19]. Therefore, additional proline may protect C. elegans from protein 
misfolding during normal aging and during times of stress. Future research should aim to 
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identify a role for proline in protecting nematodes from osmotic imbalance. Additionally, proline 
precursors have been shown to sustain collagen synthesis in mammals [20]. Proline is 
hydroxylated into collagen, which is necessary for the development and maintenance of the 
exoskeleton (cuticle) in C. elegans [21] and collagen remodeling is required for longevity in C. 
elegans [22]. Therefore, proline may not only be protecting through mitohormesis, chelation, and 
osmotic regulation, but it may also contribute to collagen sparing and synthesis in aged worms, 
reducing the rate of cuticle breakdown.  
Of the top lifespan extending amino acids, perhaps the least is known about how serine 
levels affect signaling pathways in mammals. In Chapter 4 we found serine among the top  
amino acids to extend lifespan and the lifespan extension required HIF-1, DAF-16, SKN-1, and 
inhibition of TOR signaling, which, like proline, may converge to decrease the rate of translation 
by the ribosome for lifespan extension. In human endothelial cells serine acts as an antioxidant 
and cytoprotectant through upregulation of Nrf2 and heme oxygenase-1 [23]. Serine is a 
precursor for tryptophan, glycine, cysteine, and pyruvate, which all demonstrate lifespan 
extending capabilities in C. elegans. In tumors, HIF-1 activation increases glycolysis, including 
an increase in pyruvate production [24]. Perhaps serine addition acts on HIF-1 to increase 
pyruvate levels resulting in TCA cycle anaplerosis in aging worms. Serine is also an essential 
building block of phospholipids, such as phosphatidylserine, and therefore necessary for cellular 
membrane composition. The phospholipid cardiolipin accounts for 20% of mitochondrial 
phospholipids and deterioration of cardiolipin is associated with age-related disease and decline. 
Serine supplementation may increase phosphatidylserine synthesis and participate in cardiolipin 
sparing. Quantifying phosphatidylserine and cardiolipin in serine treated worms and isolated 
mitochondria would elucidate any role for serine supplementation in phospholipid metabolism. 
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Interestingly, in human endothelial cells, serine acts as an antioxidant and cytoprotectant by 
increasing expression of Nrf2, its transcriptional target HO-1, and NO. Being that both histidine 
and serine were tested at 10 mM concentrations (while others were tested at 1 or 5 mM 
concentrations), homeostatic dysregulation could also explain why these two metabolites, but not 
the others, induced HIF-1 activity. Careful consideration should be taken when using GFP 
reporter gene fusion animals.  Multiple assays should be utilized to verify findings to make 
certain that results are reproducible under all growth conditions. Amino acid supplementation in 
liquid culture is susceptible to bacterial and fungal contamination, which is only sometimes 
readily detectable. Therefore, any results should be explored with uncertainty and verified by 
multiple techniques and labs.  
As mentioned in Chapter 1, histidine is a zinc and nickel chelator that protects against 
metal toxicity in C. elegans [25] and human astrocytes [26]. Cobalt-induced HIF-1 expression is 
inhibited by histidine in cultured mammalian cells [27], yet HIF-1 activation has been shown to 
be regulated by the conversion of histidine to histamine through histidine decarboxylase 
expression under hypoxic conditions [28]. Future research should identify if histamine, histidine 
analogs, or histidine breakdown products, such as urocanic acid, increase HIF-1 expression. 
Unlike histidine, N-acetyl-histidine and histidine methylester are cell permeable and both were 
slightly more effective than histidine at increasing lifespan when supplemented at a low 
concentration. These results suggest that the rate of amino acid absorption by the intestine may 
be a limiting factor in lifespan extension.   
Another significant finding from my research is that supplementation with tryptophan, 
nicotinamide, quinolinic acid, nicotinic acid, or its isomer picolinic acid resulted in the activation 
of both the mitochondrial unfolded protein and the ER stress response pathways, while NAD
+
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addition induced only the ER stress response.  Although there is no obvious homolog for the first 
gene in the pathway for quinolinic acid conversion  to NAD
+
 in C. elegans, knockdown of the 
NAD
+
 salvage pathway is not lethal to worms indicating that other genes may be involved in 
tryptophan catabolism. As mentioned above, in vivo quantification of NAD
+
 in tryptophan 
treated worms could directly answer if tryptophan alone or its breakdown products are 
responsible for increasing NAD
+
 levels. NAD
+
 precursors and tryptophan can also protect cells 
by inducing an ER stress response and a mitochondrial unfolded protein response. Picolinic acid 
is a strong metal chelator and it will be important to determine if the protective effects of 
picolinic acid are due to metal chelation or increased NAD
+
 levels. 
Different amino acids are catabolized and enter the TCA cycle through separate 
intermediates.  We did not find that the amino acids yielding the greatest effects on lifespan were 
degraded through one common catabolic pathway.  We suggest that through anaplerosis, 
supplemented metabolites that increased lifespan may be catabolized by mitochondria to increase 
TCA cycle metabolite levels. The DAF-16/FOXO longevity pathway has been shown to be 
activated by increased TCA cycle metabolite levels [29]. As shown in Chapter 3, the TCA cycle 
appears to be a lifespan-extending metabolic pathway in C. elegans. 
Future experiments will aim to develop an axenic medium that can be used to determine 
the effects of amino acid restriction on the lifespan of C. elegans. Currently used axenic medium 
appears to induce dietary restriction yielding long-lived worms. Future studies will also aim to 
determine the metabolic mechanisms through which amino acids activate SKN-1 activity and 
through which serine and histidine activate HIF-1. It should also be identified whether serine 
catabolism is required for serine-mediated lifespan extension, as serine can be converted to 
pyruvate, which extends lifespan. Since lifespan extension by serine is so robust, further research 
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is warranted to identify the exact mechanistic details. Research should continue to focus on the 
individual signaling pathways by which amino acids affect health and lifespan. In our studies we 
focused on 1, 5, and 10 mM concentrations, but further research should examine concentrations 
below and above these parameters to identify a proper dose for amino acids that had little to no 
effect on lifespan. It is hoped that an optimal dose will be identified for each amino acid.  
Through the use of both amino acid supplementation and restriction, a diet may one day be 
developed that can significantly increase stress resistance and slow aging and the onset of aging-
associated disorders.  
6.7 Beta-hydroxybutyrate as an alternative energy source 
Under standard dietary conditions, the human body uses glucose to fuel glycolysis, which 
is used as energy or stored as glycogen when present in excess. Glucose oxidation is used 
together with fatty acid and amino acid oxidation for energy production. During times of 
starvation or restricted carbohydrate consumption when glycogen stores are reduced, 
triglycerides in adipose tissue are broken down into fatty acids and transported to peripheral 
tissues to be broken down by mitochondrial beta-oxidation into acetyl-CoA for energy 
production through the TCA cycle. In the liver, fatty acids experience a different fate. There 
acetyl-CoA is converted into the ketone bodies acetoacetate and βHB, which are exported from 
the liver to other tissues as an alternative energy source. This is especially important for neurons, 
which are unable to catabolize fatty acids at an appreciable rate. The ketogenic diet is a high fat, 
low protein and low carbohydrate diet that mimics calorie restriction to provide the body with 
energy when glucose is not freely available. Many of the benefits produced by CR, especially at 
the mitochondrial level, can be attributed to the ketones generated by a low calorie state [29]. 
Like CR, βHB has shown some effectiveness in the protection against Alzheimer’s and 
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Parkinson’s disease-mediated neurodegeneration in animal models and human trials, but until 
now little was known about its effects on lifespan. Because βHB can feed into the TCA cycle, in 
Chapter 5 we determined if it can also extend lifespan in C. elegans.  
We were the first to identify D-βHB as a positive modulator of organismal longevity.  We 
showed that administering βHB to C. elegans extended lifespan and delayed proteotoxicity and 
glucose toxicity in a SIR-2.1 and AMPK-dependent manner that also required the stress-
responsive transcription factors DAF-16 and SKN-1. The mammalian SKN-1 homolog Nrf2 has 
been shown to play a limited role in mitochondrial biogenesis in some tissues. We also found 
that βHB did not extend lifespan in eat-2 pharyngeal pumping mutants and therefore acts as a 
dietary restriction mimetic. An important finding in Chapter 5 is that D-βHB-mediated lifespan 
extension required SKN-1 and its transcriptional target F55E10.6, a short-chain 
dehydrogenase/reductase with βHB dehydrogenase activity, although inhibition of HDACS 
HDA-2 and HDA-3 were also required for the increased longevity. βHB-induced lifespan 
extension was partially blocked in ETC complex I mutant worms and was unaffected in 
mitochondrial ETC complex II mutant worms.  This suggests that the lifespan extension is driven 
partly by mitochondrial metabolism-dependent effects, specifically though NAD(H) metabolism.   
Multiple physiological conditions are associated with a reduction in the cellular 
NADH/NAD
+
 ratio. As discussed in Chapter 1, CR decreases the NADH/NAD+ in yeast, which 
activates Sir2 (NADH is a competitive inhibitor of Sir2), resulting in an increase in lifespan [30]. 
Another situation where a decline in NADH is seen is during the use of metformin, a drug 
prescribed for the treatment of Type II diabetes, which accompanies increased SIRT1 activity 
[31]. Activation of SIRT1 by metformin was associated with lowered blood glucose and 
recovered insulin sensitivity. 
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Figure  6.4. Ketone bodies entry in to the TCA cycle. 
 
Like CR, the ketogenic diet reduces the NADH/NAD
+
 ratio by boosting mitochondrial 
respiration through increased NADH oxidation [32]. So similar are the affects seen during CR 
and the administration of βHB (or the ketogenic diet) that some researchers speculate that CR 
may be beneficial at least in part through increasing ketone levels, which act as HDAC inhibitors 
and increase expression of stress response genes. Not only do both CR and the ketogenic diet 
extend lifespan, reduce the NADH/NAD
+
 ratio, and activate SIRT1 [33], they are associated with 
a reduction in ROS production [29]. Both CR and the ketogenic induce mitochondrial 
biogenesis, which partially compensates for the decline in ATP observed during aging and 
dysfunction [34]. Prior to the irreversible conversion of acetoacetate to acetone, acetoacetate and 
βHB exist in a reversible equilibrium. So, in theory, administration of acetoacetate to C. elegans 
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would increase that NAD
+
/NADH ratio and extend lifespan. Unfortunately, acetoacetate is 
quickly decarboxylated and is very unstable, making its use as a supplement difficult. 
In Chapter 5 we propose two overlapping pathways for lifespan extension mediated by 
βHB supplementation as shown in Figure 4. In the first, βHB directly inhibits HDACs to increase 
histone acetylation leading to DAF-16/FOXO transcription and activation. The second proposed 
protective pathway involves mitochondrial metabolism of βHB, leading to increased citric acid 
cycle metabolites and electron transport chain (ETC) activity, increased reactive oxygen species 
production, and activation of the SKN-1 antioxidant response pathway.   
 
Figure 6.5. Proposed mechanisms of D- βHB mediated lifespan extension in C. elegans. 
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In Chapter 5 we also showed that βHB increased thermotolerance and delayed Aβ-
induced paralysis and decreased alpha-synuclein aggregation in C. elegans models of human 
disease. Although we show compelling evidence for the use of D-βHB as a prophylactic for 
disease in nematode models, questions remain. For example, are the same signaling pathways 
required for longevity also required for βHB-mediated protection in the C. elegans models of 
amyloid beta and alpha-synuclein toxicity? Future experiments will elucidate the molecular 
mechanisms responsible for the protective effects of βHB and this knowledge will allow for a 
broader use of D-βHB as a therapy for aging-related disorders.  
6.8 Metabolites that delay aging 
In order to discover metabolic pathways that delay aging, the effects of large sets of 
metabolites on lifespan were investigated. C. elegans share almost all metabolic pathways with 
humans. We hypothesized that changes in mitochondrial metabolite levels could result in an 
increased lifespan and protection from proteotoxic stress. We have determined that the TCA 
cycle metabolites fumarate, malate, succinate, alpha-ketoglutarate, isocitrate, and oxaloacetate 
extended lifespan in C. elegans, while all of the amino acids except phenylalanine and aspartate 
extended lifespan at least to a small extent at one or more of the 3 concentrations tested with 
serine and proline showing the largest effects. We also found that the ketone body, βHB, extends 
lifespan in C. elegans and we determined the cytoprotective signaling pathways required for this 
effect. Figure 5 highlights the many pathways associated with longevity. 
The major aim of this study was to understand the mechanisms by which natural 
metabolites influence the lifespan of C. elegans. From our studies we have identified many 
metabolites that can increase lifespan and prevent age-related decline.  
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Figure 6.6. The availability of nutrients and external stress roles in longevity. 
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